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Summary 
 
Fibroblast growth factor (Fgf) signaling plays multiple inductive roles during 
development of vertebrates (Itoh 2007). Some Fgfs, such as Fgf8, are locally secreted and 
signal over a long range to provide positional information in the target tissue (Scholpp and 
Brand 2004). Fgf ligands signal in a receptor-dependent manner via tyrosine kinase 
receptors, four of which have been so far identified. Fgf8 signaling was shown to depend both 
on receptor activation as well as endocytosis. The specificity of Fgf ligands and receptors as 
well as the function of receptors in the control of the Fgf signaling range have been, however, 
largely unclear. In order to address the function and signaling mechanisms of Fgfrs in 
development I have systematically analyzed fgfr TILLING and morpholino knockdown 
mutants. I have primarily focused on Fgfr1, which was a candidate for Fgf8 signaling partner.  
I describe here, some insights into the function of Fgfr1, which as we find, is 
duplicated in zebrafish and other teleosts. The functions of Fgfr1a and b appear to overlap 
during early development and to diverge at postembryonic stages. Analysis of Fgfr1a 
TILLING mutant fish as well as Fgfr1a and b morpholino knockdowns revealed that those two 
similarly expressed genes act redundantly during development, thereby producing only mild 
morpholino phenotypes when knocked down independently. Simultaneous knockdown of both 
genes results in progressive loss of posterior mesodermal body structures, which is 
consistent with Fgfr1a knockdown in medaka (Yokoi et al. 2007). The role in promotion of 
mesoderm formation by two fgfr1 genes is paralleled by similar phenotype in Fgf8/Fgf24 
double mutants providing functional link between those receptors and ligands (Draper et al. 
2003). Two Fgfr1a mutants, being presumptive loss-of-function and hypomorph alleles show 
dermal skeleton defects in adults, which reveal different functions of two paralogous fgfr1 
genes during late development. The zebrafish scale phenotype resembles the morphology of 
a scaleless mirror carp. In carp, this phenotype was also linked to Fgfr1 mutations, 
demonstrating how morphological features can be shaped in evolution through modifying 
common molecular pathways.  
Observation of Fgfr1a in the embryo at subcellular level provided some information 
about the endocytosis and intracellular trafficking of the activated receptor in vivo.  
Fluorescently tagged Fgfr1a (being one of presumptive receptors for Fgf8 (Scholpp et al. 
2004; Trokovic et al. 2005; Yokoi et al. 2007)) is found in overlapping subcellular structures 
with Fgf8GFP. Fgfr1a is primarily taken up via clathrin-dependent endocytosis and to a lesser 
degree by caveolin-dependent endocytosis, and it is mostly directed to degradation. Analysis 
of two mutant Fgfr1a constructs, Fgfr1aY753STOP and Fgfr1aY753F, revealed the requirement of 
Y753 for endocytosis as well as Fgf signaling in context of the whole embryo.  
Overexpression of Fgfr1aY753F results in dramatic ligand-dependent expansion of target gene 
induction in gastrulating embryos. This suggests that receptor endocytosis, as well as the rate 
Summary 
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of trafficking is involved in the correct setup of Fgf signaling during early embryo 
development.  
Preliminary analysis of the Fgfr2 TILLING mutant, Fgfr2L545STOP, showed that 
homozygous mutants presumably lose Fgfr2 function through non-sense mediated decay and 
the disruption of the protein function.  Homozygous mutants are viable but dwarfish, harboring 
many skeletal defects and are infertile. The phenotypes are consistent with the phenotypes 
observed in FGFR2 knockout mice, except limb growth, which is abolished in knockout mice 
and appears normal in mutant Fgfr2L545STOP-/- zebrafish (Arman et al. 1998; De Moerlooze et 
al. 2000; Yu et al. 2003).  
The analysis of Fgfr4 loss-of-function in zebrafish, in contrast, showed unexpected fin 
induction defects, which suggests differences between the developmental functions adopted 
by Fgfr2 and Fgfr4 in zebrafish compared to higher vertebrates. Fgfr4 morpholino knockdown 
embryos display a composite of early and late embryonic defects, including reduced eye 
growth, cell death and edema of the hindbrain, deformation of the facial skeleton, lack of 
pectoral fins and curved body axis. Analysis of early inductive events in pectoral fin growth 
revealed that Fgfr4 is required for the induction of the fin field at early segmentation stages 
and that it acts downstream of retinoic acid signaling in the hindbrain, spinal cord and lateral 
plate mesoderm (from which pectoral fins arise). Taken together, Fgfr4 knockdown, 
expression pattern and protein structure analysis suggest that Fgfr4 is essential in early Fgf 
signaling during zebrafish development and it apparently lost many of its functions during 
tetrapod evolution (FGFR4 knockout mice are viable and show no defects (Weinstein et al. 
1998)).  
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Abbreviations 
 
Ab    antibody 
AER   apical ectodermal ridge 
A-P   anterior-posterior 
C    degrees Celsius 
CDE   clathrin dependent endocytosis 
C-terminus   carboxyl terminus (of a peptide) 
Da    Dalton 
DAB    diaminobenzidine 
DEAB   4-(Diethylamino)-benzaldehyde 
DIG    digoxygenin 
DNA    deoxyribonucleic acid 
Dpf    days post fertilization 
D-V   dorsal-ventral 
ECM   extracellular matrix 
Fgf    fibroblast growth factor 
Fgfr    fibroblast growth factor receptor 
GFP    green fluorescent protein 
GPI    glycosylphosphatidylinositol 
Hpf    hours post fertilization 
HRP    horseradish peroxidase 
HSPG    heparan sulphate proteoglycan 
Hyb    hybridisation buffer 
IP    immunoprecipitation 
ISH    in situ hybridisation 
K    kilo 
Kb   kilobase  
mAb    monoclonal antibody 
MESAB   3-aminobenzoate-methanesulphonate salt 
MetOH   methanol 
MHB    midbrain-hindbrain boundary 
mM   milimolar 
MO   morpholino 
mUb    monoubiquitin 
mz   maternal zygotic 
NCE   non-clathrin mediated endocytosis 
N-terminus   amino-terminus (of a peptide) 
nt   nucleotide 
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ORF    open reading frame 
PBS    phosphate buffered saline 
PBST    phosphate buffered saline with Tween 20 
PBSTx                phosphate buffered saline with Triton X 
PCR    polymerase chain reaction 
PFA    paraformaldehyde 
Pol    polymerase 
PTU    1-phenyl-2-thiourea  
pUb   polyubiquitin 
RA   retinoic acid 
RFP    red fluorescent protein 
RNA    ribonucleic acid 
RT   room temperature 
SDS    sodium dodecylsulphate 
TILLING   Targating Induced Local Lesion IN Genomes 
Ub    ubiquitin 
UTR    untranslated region 
WT    wildtype 
YFP    yellow fluorescent protein 
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1.  Introduction 
 
Pattern formation during vertebrate development is an absorbing topic of research 
and although several processes and genetic control of early development have already been 
understood many questions still remain open. Fgf signaling has been shown to play a pivotal 
role in early vertebrate development but the mode of Fgf morphogen signaling and Fgf in vivo 
receptor specificity still need to be elucidated.  
Some cell biological aspects of Fgf signaling have been studied in tissue culture. 
However, they were never verified in the context of the embryonic tissue. Although the role of 
Fgf receptors in development has been studied to some extent in loss-of-function studies and 
tissue culture the regulation of receptor activity during tissue patterning in vivo has not been 
fully addressed. We now have an opportunity to focus on those issues using zebrafish 
embryos which are numerous, easy to manipulate and accessible to imaging at all stages of 
development.  
In this study I used high-resolution confocal microscopy in order to address Fgf 
receptor signaling and trafficking in vivo in response to Fgf8. I also used available gene tools 
in order to investigate the role of Fgf receptors (Fgfrs) in zebrafish development. I 
investigated the regulation of receptor endocytosis in Fgf8 signaling as well as the receptor 
specificity during early zebrafish development. I trust that the theoretical background provided 
in this chapter will be sufficient to follow this study and emerging conclusions. 
 
1.1. Zebrafish as a model organism 
 
Zebrafish is a well-established model vertebrate. Zebrafish embryos are easily 
accessible to observation and manipulation thanks to ex utero development. Translucent 
tissue and a relatively fast rate of embryonic development make the zebrafish an excellent 
model organism for studies of tissue patterning, morphogenesis and cell biology. Imaging 
techniques available to this point made zebrafish the model organism of choice to study 
phenomena bridging developmental and cell biology. The genome has been sequenced 
(started in 2001), however due to sequence repeats and non-coding DNA its assembly is not 
finished yet. With many genes annotated, some still require manual search for their 
paralogous duplicates or genomic organization. Nevertheless, extensive EST databases and 
the progressively completed genome database make zebrafish a convenient model organism 
for many biological fields.  
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1.1.1. Embryonic development of zebrafish 
 
The zebrafish embryo develops ex utero in a protective chorion, which can be easily 
removed for microscopy. The development of zebrafish can be divided into seven periods: 
zygote, cleavage, blastula, gastrula, segmentation, pharyngula and hatching period. This 
work will be focusing mainly on stages from blastula to segmentation, when most patterning 
and cell fate determination processes take place. The illustration below (Figure 1.1) indicates 
some of the stages of early embryonic development. 
 
Figure 1.1 Development of zebrafish 
The stages of zebrafish development are named after morphological features. Percent epiboly 
describes the extent to which the epiblast covers the yolk during gastrulation. Hours are given for 
development at 28,5 °C. All embryos are shown in lateral view, dorsal side to the right for embryos or 
top for older fish. 
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Developmental stages described in this work are named according to the convention 
introduced by Kimmel et al. when embryos are raised at 28.5ºC at non-crowded density (up to 
10 embryos/ml) (Kimmel et al. 1995). Embryos develop very quickly and establish their basic 
body plan already after 24 h post fertilization. The larvae hatch at approximately 2 days and 
start feeding independently after 6-7 days. Zebrafish reach sexual maturity after about 3 
months and live up to 3 years long. The short time frame of embryonic development allows 
processing of transgenic and mutant zebrafish relatively fast, limiting the duration of 
experiments to one or two days. 
  
1.1.2. Forward and reverse genetic approaches to gene function 
 
High numbers of offspring and low space requirements make zebrafish a convenient 
genetic tool. As a result, a variety of mutagenesis screens were performed, which gave rise to 
a relatively large number of available mutants. Accessibility of the embryos at all stages of 
development creates a unique opportunity to examine the role of genes essential for early 
development.  
Many genes with essential and unique functions in development of e.g. brain, midline, 
somites, muscles etc. have been identified through forward genetic mutagenesis screens 
identifying genes (Haffter et al. 1996). Most forward genetic screens have been done with use 
of the methylating agent ethylnitrosourea (ENU), a mutagen with high mutation efficiency. The 
F2 progeny of the mutated parent fish were raised for phenotypic analysis. Identified mutant 
fish are analyzed through complementation tests and gene mapping in order to find the 
position of genes responsible for the phenotype (Rawls et al. 2003; Geisler et al. 2007).  
Another screening technology made use of retroviral insertional mutations, which can 
be easily identified thanks to molecular tags encoded at the site of lesion (Amsterdam and 
Hopkins 2006). Recently, another step has been taken in forward genetics to identify genes 
involved in growth of adult structures like dermal skeleton or defects in wound healing, 
behavior etc. (http://www.zf-models.org/workpackages/wp1.html).  
To increase the chance of linking single genes with their functions, researchers 
begun to explore gene functions using reverse genetics. Because knockouts of genes in 
zebrafish cannot be generated by homologous recombination ES cell manipulation, other 
methods for targeted gene modification have been suggested. Among those TILLING 
mutagenesis became popular due to the organized effort of the zebrafish community to share 
and identify as many mutants as possible (http://www.zf-models.org). The details of this 
method will by described in further sections of the introduction.  
However, due to the limitations of the mentioned methods another technique was 
developed very recently to create targeted mutations in genes of interest. The method is 
based on custom designed zinc finger proteins, which introduce double strand DNA breaks in 
specific sequences (Durai et al. 2005). Such DNA breaks are usually repaired by non-
Introduction 
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homologous endjoining, which leads to mutations. The method is still in the phase of 
development, however, it is very promising for future studies of functions of interesting genes 
(Ekker 2008; Meng et al. 2008). 
Transient gene inactivation is based on the morpholino knockdown technique, also 
described in detail below. Morpholinos, being synthetic drugs are injected into fertilized eggs 
at the one-cell stage for uniform distribution of the blocking agent in the embryo.  
 
1.2. Reverse genetic approach to generating FGFR knock 
out zebrafish 
 
1.2.1. Targeting Induced Local Lesions in Genomes – TILLING 
 
TILLING is used in zebrafish and other organisms (yeast, fly and C.elegans) to 
identify individuals harboring a mutation in the gene of interest (Till et al. 2003; Henikoff et al. 
2004; Winkler et al. 2005; Bokel 2008). Male fish are mutagenized using ENU, which in 
successful screens resulted in 1 mutation in every 150 Mb (Figure 1.2).  The mutagenized 
sperm is then used to fertilize wildtype eggs and the resulting fish are raised and kept as a 
living library for sequence screening of genes of interest. Exons in those genes are amplified 
from DNA (each fish separately) and analyzed for heterozygous mutations. Heterozygous 
single nucleotide changes can be detected by CelI digestion of the PCR product or direct 
sequencing (Stern et al. 2005; Amsterdam and Hopkins 2006).  
Identified carriers of specific mutations are outcrossed for several generations against 
wildtype fish to dilute out background mutations. The mutant phenotype is then analyzed in 
an incross of such genetically “cleaned up” animals. In case of early phenotypes one can 
confirm gene-specificity by morpholino injection. Gene specificity of the phenotype can be 
tested by non-complementation of different alleles or, if no other alleles are available, by 
morpholino knockdown (Araki and Brand 2001). 
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Figure 1.2 TILLING 
Targeting-induced local lesions in genomes - a reverse genetic approach to obtain mutants. This 
flowchart scheme of the TILLING procedure outlines the ways from mutagenesis, through sequencing 
screen for mutations of interest to establishment of a mutant zebrafish line.  
 
1.2.2. Morpholino mediated gene knock-down 
 
Morpholinos (MOs) are synthetic antisense oligonucleotides of about 25 units, which 
are analogous to RNA or DNA, except that they have a mopholine ring instead of a ribose 
ring (Summerton and Weller 1997). They can be delivered to zebrafish embryos by injection 
at one cell stage for uniform distribution, and are stable for several days. Morpholinos 
specifically bind to complementary sequences and block mRNA function in two ways.  
 
1.2.2.1. Types of morpholinos 
 
Translation blocking morpholinos are targeted against the 5’ untranslated region of an 
mRNA or the beginning of the open reading frame, which can efficiently abolish translation. 
Proof of principle morpholino experiments showed that MO mediated-knockdown can 
phenocopy well characterized mutant phenotypes. For instance, Fgf8 morpholino 
phenocopies the genetic Fgf8 mutant, acerebellar (ace) (Araki and Brand 2001).  
A different morpholino based approach, which allows quantification of the knockdown 
efficiency, was developed to block pre-mRNA splicing instead of its translation. Splice 
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blockers are complementary to splice acceptor or donor sites in the unspliced RNA, thereby 
competing with the splicing machinery for the binding site. MO binding leads to either 
erroneous exon excision or intron retention. PCR analysis of the RNA from morpholino-
injected embryos (morphants) provides information about the efficiency of the gene 
knockdown (Draper et al. 2001).  
 
1.2.2.2. Controlling morpholino experiments 
 
Unfortunately, morpholinos also often confer toxicity to the cells and off-target effects 
(Eisen and Smith 2008). Morpholino can cause stress induced cell death in the central 
nervous system and somites by p53-mediated apoptosis. Although morpholinos act in a 
sequence specific manner, there is always a chance of blocking also other genes containing 
similar sequences.  
In order to assess these components of the morpholino phenotype, one has to 
perform a variety of control experiments. As mentioned before, comparison with an existing 
mutant is optimal, however, seldom available. To check MO efficacy it is good to check the 
protein loss on a Western Blot or in whole mount tissue staining. However, this is often limited 
due to unavailability of zebrafish specific antibodies.  
To control off target effects, one can try using multiple morpholinos, which 
independently should induce the same phenotype.  In turn co-injecting them together can 
lead to dilution of off-target effects while preserving the cumulative specific gene knockdown 
phenotype. Additionally, the specific MO phenotype is most convincing if it is possible to 
rescue through mRNA injection. Also, one can control for unspecific effects by injecting a 
mismatch morpholino – a oligonucleotide similar but different by at least 5 units to the working 
morpholino. Such a modified agent should be unable to bind to its target and hence, cause no 
gene knockdown phenotype. 
  
1.3. FGF ligand family 
 
1.3.1. FGF conservation 
 
Fgfs are a family of secreted signaling molecules that act as ligands for 
transmembrane high affinity tyrosine kinase receptors. Fgf binding to the extracellular 
domains of FGF receptors cause their dimerization and subsequent phosphorylation of 
specific tyrosines in their cytoplasmic kinase domains (Eswarakumar et al. 2005). This 
launches cascades of signal transduction inside cells leading to diverse responses like cell 
proliferation, migration, survival and differentiation.  
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Human Fgf ZebrafishOrtholog Ortholog II
Fgf1 Fgf1  
Fgf2 Fgf2  
Fgf3 Fgf3  
Fgf4 Fgf4  
Fgf5 Fgf5  
Fgf6 Fgf6b Fgf6a 
Fgf7 Fgf7  
Fgf8 Fgf8a Fgf8b (former 17a) 
Fgf9 -  
Fgf10 Fgf10a Fgf10b 
Fgf11 Fgf11  
Fgf12 Fgf12  
Fgf13 Fgf13  
Fgf14 Fgf14  
Fgf16 Fgf16  
Fgf17 Fgf17b  
Fgf18 Fgf18a Fgf18b, Fgf24 
Fgf19 Fgf19  
Fgf20 Fgf20b Fgf20a 
Fgf21 Fgf21  
Fgf22 Fgf22  
Fgf23 Fgf23  
Table 1 List of human Fgfs and zebrafish orthologs  (after (Itoh 2007)) 
 
Although Fgfs are well conserved during evolution, the number of Fgf genes in 
organisms varies due to repeated genome duplications and subsequent gene losses. Thus, 
C.elegans and D. melanogaster have only two and three Fgf genes, respectively, whereas 
mouse and human have 22 Fgf ligands.  
The functions of the Fgf system became complemented with every round of gene 
duplications and the functions of individual genes became specified in many processes of 
development, growth and adult homeostasis. Currently there are 27 fgf genes discovered in 
zebrafish, suggesting an additional duplication event before teleost radiation. The gain of 
genes was probably followed by a rapid gene loss, because only 20% of zebrafish fgf genes 
have been found to have a functional paralog (Itoh and Ornitz 2004; Itoh and Konishi 2007).  
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Gene Mouse Phenotype Zebrafish Phenotype 
Fgf1 Viable None identified Differentiation of erythrocytes 
Fgf2 Viable Mild cardiovascular, skeletal, and neuronal defects nd 
Fgf3 Viable Mild inner ear, tail, and CNS defects 
Various CNS defects, pharyngeal 
arched defects, specification of 
epibranchial placodes 
Fgf4 Lethal, E4—5 Inner cell mass proliferation Development of tooth 
Fgf5 Viable Long hair, angora mutation nd 
Fgf6 Viable Subtle, muscle regeneration nd 
Fgf7 Viable Hair follicle growth, ureteric bud growth nd 
Fgf8 Lethal, E8 Gastrulation defect, CNS and limb development 
Fgf8a - Lack of MHB and 
cerebellum, enlarged tectum, eye 
patterning, slight segmentation 
defect, pharyngeal arches and 
heart development 
Fgf8b - unknown 
Fgf9 Lethal, PD0 
Lung mesenchyme, heart, 
gastrointestinal tract, 
skeleton, testes development 
nd 
Fgf10 Lethal, PD0 
Multiple organ development (limb, 
lung, adipose 
tissues, etc.) 
10a – development of swim 
bladder, fin and hepatopancreatic 
ductal system; 
10b - unknown 
Fgf11 - nd nd 
Fgf12 Viable Neuromuscular phenotype nd 
Fgf13 - nd nd 
Fgf14 Viable Neurological phenotype nd 
Fgf15 Lethal, E13.5-PD21 Cardiac outflow tract development 
(Zf Fgf19) – lens and retina 
development 
Fgf16 Viable  Pectoral fin development 
Fgf17 Viable Cerebellar development Fgf17b - Early patterning, redundant with Fgf3 and Fgf8 
Fgf18 Lethal, PD0 Skeletal and lung development Unknown for both Fgf18 a and b 
Fgf20 - nd Essential for initiating fin regeneration 
Fgf21 Viable Not clear Heamatopoiesis 
Fgf22 - nd nd 
Fgf23 Lethal, PW4—13 
Growth retardation, phosphate 
and vitamin D 
metabolism 
nd 
Fgf24 No mouse equivalent nd 
Fin development, pancreas 
development together with Fgf10 
Posterior mesoderm development 
together with Fgf8a 
Table 2 List of murine Fgf knockout phenotypes. Note that mouse FGF15 and human (and 
zebrafish) FGF19 are orthologous. Nd – not determined (table modified after (Ornitz and Itoh 2001). 
 
Using phylogenetic sequence analysis FGFs can be clustered into 8 sub-families, 
which share increased homology and synteny (grouped in further sections of this chapter in 
Table 4). Their functions, however, vary within subfamilies, as revealed by multiple loss-of-
function studies in mice and other model organisms (Ornitz and Itoh 2001). FGF functions 
include patterning of the nervous system, limb formation and skeletal growth. The summary of 
phenotypes resulting from FGF knockouts in mice and the corresponding loss-of-function 
phenotypes in fish is presented in the Table 2 above. 
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1.3.2. FGF responsive genes 
 
Fgf signaling induces sef, family of sprouty and related to them spred genes, family of 
mkp genes and ETS transcription factors. Fgf responsive genes are mostly negative feedback 
regulators, except for transcription factors, which are induced to activate Fgf response. Fgfs 
and other receptor tyrosine kinase dependent factors are both necessary and sufficient to 
induce these factors.  
Sef (similar expression to Fgf) is a putative transmembrane inhibitor of the Fgf 
function, which binds MEK kinase in the cytoplasm, thereby blocking its translocation into the 
nucleus. Therefore, it blocks MAPK pathway without deactivating its components (Tsang et 
al. 2002; Bottcher and Niehrs 2005).  
The family of four sprouty genes (sprouty 1, 2, 3 and 4), discovered in vertebrates, is 
believed to be auto-regulated antagonists of receptor tyrosine kinase signaling. They were 
first identified as inhibitors of Fgf dependent tracheal branching in Drosophila (Casci et al. 
1999). Sprouty proteins bind to the adaptor proteins Grb2 and Sos and block the 
phosphorylation cascade through the MAPK pathway. They can act very effectively as 
heterodimers by binding both Grb2 and Sos proteins at the same time. However, the mode of 
action of Sprouty proteins is not fully understood and many opposing ideas are still being 
tested (Cabrita and Christofori 2008). 
Spred proteins (Sprouty-related proteins with Enabled domain) were recently 
discovered as distant relatives of sprouty genes with a similar RTK inhibitory role (Wakioka et 
al. 2001). In Xenopus, Sprouty and Spred proteins were shown to modulate different 
downstream signaling cascades in Fgf signaling (Guy et al. 2003). Spred is blocking the PLCγ 
pathway and Sprouty is blocking the MAPK pathway in order to jointly regulate cell movement 
and formation of mesoderm during gastrulation (Sivak et al. 2005). No such mechanism was 
confirmed in fish or mouse so far and the PLCγ pathway was shown to have little role in 
response to Fgf signaling when examined in vitro (Cross et al. 2002).  
The Mkp (MAP kinase phosphatase) family comprises of dual-specificity 
phosphatases able to dephosphorylate both tyrosine and threonine residues in activated MAP 
kinases (Kondoh and Nishida 2007). In zebrafish the family of Mkps (named Dusp in 
zebrafish, standing for dual-specificity phosphatase) comprises of at least 9 members, some 
of which have specific and highly restricted expression patterns during development. Dusp6 is 
a well-studied member of this family, which belongs to the Fgf8 synexpression group (Klock 
and Herrmann 2002; Tsang et al. 2004; Vieira and Martinez 2005).  
The ETS transctiptional factors, Pea3 and Erm, are defined by the evolutionary 
conserved Ets domain, which mediates DNA binding (Sharrocks et al. 1997). Both are 
present throughout development and activate gene transcription in response to Fgf. 
Expression of both pea3 and erm can be abolished through Fgfr inhibition at embryonic 
stages and both can be activated by Fgf8 at a long range. Fgf8 overexpression can activate 
ETS factors ectopically (Raible and Brand 2001). 
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1.3.3. Function of Fgf8 during development 
 
1.3.3.1. Roles of Fgf8 in gastrulation, MHB maintenance 
 
Fgf8 is expressed very early in vertebrate development and plays important roles in 
the early patterning events. FGF8 knockout mice die during gastrulation because they fail to 
develop mesoderm (Meyers et al. 1998). In fish, Fgf8 has been shown to contribute to 
patterning of dorsal-ventral cell identity together with the bone morphogenetic proteins 
(BMPs) during gastrulation (Furthauer et al. 1997). However, the zebrafish Fgf8 mutant – 
acerebellar (ace) shows only a mild DV patterning defect, suggesting redundancy with other 
growth factors, such as Fgf24, in this process (Draper et al. 2003). Nevertheless, ace mutants 
display a variety of other phenotypes at later stages, which resemble hypomorphic Fgf8 
phenotypes in mice. Fgf8 plays a role in lateral mesoderm patterning, as it is required for 
induction and establishment of the size of the heart primordium and cell proportion of heart 
progenitors (Reifers et al. 2000) (Marques et al. 2008). Ace fish display severe brain 
segmentation defects, characterized by a lack of cerebellum and midbrain-hindbrain 
boundary (MHB), and enlarged midbrain tectum. The proposed role for Fgf8 in brain is that it 
is necessary to maintain the MHB and to specify hindbrain identity (Brand et al. 1996; Reifers 
et al. 1998). In the absence of Fgf8, axon pathfinding in the retinotectal projection and at the 
forebrain comissures is abnormal (Picker et al. 1999; Shanmugalingam et al. 2000). Fgf8 is 
also involved in left-right patterning and development of pharyngeal arches (hence, 
craniofacial skeleton) (Albertson and Yelick 2005).  
 
1.3.3.2. Role of Fgfs in limb development 
 
Vertebrate limb development may be divided into separate stages: specification, 
induction and maintenance. In chick, FGF8 (and other FGFs) is proposed to act at all these 
stages (Crossley et al. 1996). However, the involvement of Fgf signaling in forelimb (pectoral 
fin in fish) development has been largely debated over the last decade. It has been shown in 
chick that Fgf8 plays a role in early limb development together with retinoic acid signaling. In 
this model Fgf8 and RA together induce expression of Shh in the limb field, which in turn 
induces Fgf8 and 10 in the apical ectodermal ridge of the limb bud (AER). The interplay 
between mesodermal factors and AER expression of Fgfs allows for the outgrowth and 
polarization of the limb (Crossley et al. 1996). 
As mentioned before, FGF8 knockout in mouse is lethal at primitive streak stage 
(Meyers et al. 1998). This does not allow the study of its function later during limb 
development. However, conditional knockout mice in which FGF8 was conditionally disrupted 
in the limb field proved that FGF8 is required for limb induction and patterning (Moon and 
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Capecchi 2000). However the promoter line used in this study did not allow investigating 
potential earlier involvement of FGF8 in the limb field specification. The earliest function of 
FGFs in mouse limb development was associated with FGF10, which acts epistatically 
upstream of FGF8 in AER (Min et al. 1998).  
 
Figure 1.3 Fgf in zebrafish pectoral fin 
development 
A schematic model of Fgf signaling in the 
development of pectoral fin in zebrafish. Fgf24 is 
acting downstream of retinoic acid (RA), Wnt2a in 
the intermediate mesoderm (im) and Tbx5 in the 
fin bud (fb). Fgf24 and other unknown Fgf induce 
mesenchymal expression of Prdm1. Prdm1 
initiates the cascade of other Fgfs, including 
Fgf10 in the mesenchyme, which is required for 
differentiation of the apical ectodermal ridge 
(AER), which expresses Fgf16, Fgf8 and Fgf4. 
Expression of Shh is downstream of Fgf16 and is 
required for the A-P polarization of the limb. 
Figure reproduced and modified after (Mercader 
et al. 2006). 
 
 
 
The zebrafish fgf8 mutant, acerebellar, develops normal fins, which suggests 
redundancy between Fgfs. Fgf24 was the earliest Fgf ligand found in the cascade leading to 
the fin development (see Figure 1.3). It was found to be acting downstream of RA and Tbx5 
(the earliest known marker of fin field specification (Rodriguez-Esteban et al. 1999; Tamura et 
al. 1999)). Fgf24, a zebrafish specific Fgf belonging to the same subfamily with Fgf8, 17 and 
18, is involved in the induction of all growth factors expressed in the AER, including Fgf10, 
Fgf16 and Fgf8 (Fischer et al. 2003; Nomura et al. 2006). Furthermore, Fgf8 in fish was 
shown to act only at the stage of fin outgrowth and patterning. Whether Fgf signaling is 
involved in earlier stages of fin development where the tissue gains its competence for fin 
induction remains to be elucidated.  
Previous studies in our and other labs suggest that fin field specification occurs 
already during gastrulation and early somitogenesis. Inhibition of RA signaling during 
gastrulation causes a strong delay in Tbx5 expression, whereas prolonged RA inhibitor (4-
(Diethylamino)-benzaldehyde, DEAB, blocking activity of RA producing Aldh enzymes) 
treatment results in complete loss of fins (Grandel et al. 2002). So far, more precise study of 
RA involvement in this process was hindered by a lack of appropriate markers that would 
identify prospective fin field at stages earlier than 10 somites.   
 
1.3.4. Fgf8 as a morphogen 
 
Morphogens form a concentration gradient in tissue and induce different responses 
depending on the distance from the source (Gilbert 2006). There is evidence that Fgf8 fulfills 
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many criteria of a classic morphogen. It is secreted from a localized source and it is likely to 
form a gradient of concentration in the receiving tissue to provide positional information in the 
embryo. The fate of cells is determined by the nested expression of Fgf8 target genes, which 
suggests the existence of several inductive thresholds of morphogen concentration. Such 
properties of Fgf8 are best observed during gastrulation, where it is produced at a limited 
number of cells at the margin and spreads in direction of the animal pole, thereby inducing 
long and short range genes like Sprouty 4, Pea3 or Erm.  
One of the most interesting aspects of developmental biology is to understand the 
process of morphogen gradient formation. The problem can be split into several sub-
processes: morphogen release from the source, the mechanism by which it spreads in the 
tissue and the mechanism by which it is received by the target cells. Fgf8 is secreted from the 
producing cells but the mechanism by which it is moves into the receiving tissue was 
unknown until recently. The regulation of the protein reception is also debated, because of 
many factors influencing receptor-ligand binding affinities. 
There have been many models proposed for the distribution of various morphogens, 
which are best summarized by (Kornberg and Guha 2007). According to proposed models, 
proteins can signal over a long range through diffusion, transcytosis, argosomes or 
cytonemes (Figure 1.4). The latter three models assume an active force, which directionally 
transports morphogen particles either through extracellular matrix or repeated cycles of endo- 
and exocytosis. Current evidence suggests that Fgf8 can spread through free diffusion, the 
simplest of mechanisms (Scholpp and Brand 2004) (Rachel Yu, personal communication). 
The diffusion model assumes that Fgf8 molecules can move in a random, non-directional way 
and are not bound to a carrier or actively hindered close to the source.  
 
 
Figure 1.4 Models of morphogen propagation 
Four models of morphogen propagation. Morphogen moves (red) from the source (dark blue) to the 
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receiving tissue (light blue) by free diffusion (A), serial transfer (transcytosis, B), lipoprotein-associated 
transfer (argosomes, C) or direct cell-cell contact through cell protrusions, cytonemes (D). Figure 
modified after (Kornberg and Guha 2007). 
 
The random diffusion model leads to an important assumption, that there is a source 
of Fgf8 and there has to also be “a sink”, i.e. a mechanism of protein decay, which would 
effectively create a gradient of ligand concentration. Recent studies of Fgf8 endocytosis in the 
embryo have suggested that the sink mechanism may be dependent on the rate of ligand 
uptake and intracellular degradation. Inhibition of Fgf8 uptake by overexpressing dominant 
negative dynamin leads to further range of Fgf8 spreading and target gene induction. 
Conversely, promoting endocytosis by overexpression of Rab5 causes the opposite effect, 
shortening the range of Fgf8 signaling and tissue penetration. The evidence based on overall 
endocytosis manipulation led to a conclusion, that the range of Fgf8 signaling is restricted by 
the clearance of Fgf8 from the extracellular matrix through endocytic uptake. Hence, the 
suggested name of the mechanism - restrictive clearance model schematically depicted on 
Figure 1.5 (Scholpp and Brand 2004).  
Many known components of the Fgf signaling pathway are not tested for their 
function in gradient formation. Firstly, the extracellular matrix (ECM) is rich in heparan 
sulphate proteoglycans (HSPGs), which have the ability to bind Fgf ligands with high affinity 
(Allen and Rapraeger 2003). They are also described as important cofactors in the ligand-
receptor interactions, possibly regulating the receptor affinity and ligand access to the cell 
surface (Lin et al. 1999; Park et al. 2000; Pellegrini et al. 2000; Sugaya et al. 2008).  Their 
role in the gradient formation and ligand endocytosis remains to be elucidated. Some 
glypicans are well studied in the context of other signaling pathways. For instance, the role of 
Dally in Dpp signaling in the Drosophila wing disc or in tracheal branching, indicated its 
regulatory importance in protein distribution and receptor binding (Hufnagel et al. 2006; Yan 
and Lin 2007). 
 
Figure 1.5 FGF8 in restrictive clearance model 
Fgf8 as a morphogen (red) induces various target genes depending on its concentration (A). The shape 
of Fgf8 gradient depends on the rate of endocytosis, i.e. on the receptor mediated uptake and 
downregulation. Receptor gets endocytosed upon ligand binding, activation and ubiquitylation (B). 
Schematic modified after (Scholpp and Brand 2004). 
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Secondly, ligand clearance from the ECM is most likely receptor-dependent. There is, 
however, little information about receptor specificity and the mechanism by which the 
endocytosis of the receptor-ligand complex is regulated. Some possible levels of regulation 
will be discussed in further sections about FGF receptor structure and function.   
Finally, during development various tissues may establish Fgf8 gradients in different 
ways. For instance, fgf8 mRNA produced in presomitic mesoderm undergoes progressive 
decay in the somites during growth and elongation of the AP axis. This effectively leads to 
production of a protein gradient proportional to the graded distribution of the mRNA (Dubrulle 
and Pourquie 2004). This alternative model of gradient formation proves that such processes 
may depend on the context and the stage of development. 
 
1.4. FGF receptors family 
1.4.1. Evolutionary conservation, genome duplication 
 
There are four highly conserved FGF receptors (54-69% of overall homology 
between human FGFRs) in mice and human and one FGFR-like gene, sharing about 30% 
similarity with the other four. FGFR genes underwent duplications only in the evolution of 
vertebrates as organisms like C. Elegans and D. Melanogaster have one and two FGF 
receptors, respectively (Itoh and Ornitz 2004). However, in vertebrates, FGFRs are 
alternatively spliced, which leads to production of numerous protein isoforms. The most 
common isoforms for FGFR1-3 are IIIb and IIIc, the latter being most important (Partanen et 
al. 1998; Eswarakumar et al. 2005). This results again in an increased diversity in the 
receptor functions.  
In teleosts, despite expectations to find more duplicates of fgfr genes, only fgfrl1 was 
found to have a paralog (Trueb et al. 2005). In medaka, also Fgfr1 has a paralog. Otherwise, 
the zebrafish has also 4 Fgfrs and their alternative splice variants seem to be conserved at 
least for Fgfr1 (Scholpp et al. 2004). Nevertheless, the assembly of zebrafish genome is still 
under way and there might be more Fgfrs to be found.   
 
1.4.2. Endocytosis and trafficking pathways of receptor tyrosine 
kinases 
1.4.2.1. Paths of endocytosis 
 
Endocytosis is the process in which cells take up matter by a variety of different 
mechanisms (Conner and Schmid 2003). Cells can take up large particles by phagocytosis 
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and small liquid particles by various forms of pinocytosis. Sporadically, cells can take up any 
liquid phase particles in unspecific manner through micropinocytosis. However, the most 
efficient way of internalizing nutrients and growth factors is mediated by attachment to high-
affinity receptors and clathrin-mediated endocytosis (CME). Clathrin facilitated by AP proteins 
form an invagination in the membrane and recruit the cargo with its receptors into it. The 
engulfing of nutrients is successful when an invaginated vesicle pinches off into the cytoplasm 
(Mousavi et al. 2004; Praefcke et al. 2004). Some cargo can also be taken up by cells 
through caveolin-mediated endocytosis, which is lipid-raft associated and has distinct 
functions in the cell (Parton and Richards 2003; Pelkmans et al. 2004). Finally, nutrients can 
be delivered by, so far poorly understood, clathrin and caveolin independent endocytosis as 
well. Both latter types on endocytosis are refered to as non-clathrin mediated endocytosis 
(NCE). 
Most endocytosis processes require dynamin, which acts as a molecular garrote to 
pinch invaginated vesicles off the plasma membrane. Expression of dominant negative 
dynamin almost entirely blocks endocytosis (Henley et al. 1998; Henley et al. 1999; Cao et al. 
2007).  
In order to allow the endocytosed cargo to reach its destination organelle, vesicles 
inside cells have to fuse and localize to specific membrane domains on the right endosomal 
compartments. Trafficking pathways in cells are therefore tightly regulated by membrane 
organizer proteins, which allow cargo recognition, membrane fusion and bringing 
endocytosed molecules to degradation, recycling or other destinations. Among such 
organizers are Rab and SNARE family proteins (McMahon et al. 1993; Chen and Scheller 
2001; Zerial and McBride 2001). Because certain Rab proteins are specifically localized to 
only a restricted pool of vesicles and endosomes inside cells, they are often used as markers 
for subcellular localization of various cellular components. Rab5, for instance, labels only 
early endosomes, which is suggesting a recent uptake. Rab7 and Rab9 label late 
endosomes, which indicates that the cargo is destined to proteasomal degradation. Rab 11 in 
turn, labels exocytic vesicles, as well as a perinuclear recycling endosomes (Ullrich et al. 
1996; Zerial and McBride 2001).   
SNARE proteins are implicated in almost all intracellular trafficking processes. 
SNAREs interact with each other to mediate membrane fusion between vesicles. The active 
SNARE core complex typically consists of three types of SNARE proteins, namely syntaxin, 
VAMP (vesicle associated membrane protein) and SNAP-25 (Chen and Scheller 2001; 
Conner and Schmid 2003). These can also be found in a limited fraction of vesicles and 
endosomes, hence their use as trafficking markers. For example, Cellubrevin is a member of 
the VAMP family and is associated with rapidly recycling vesicles in receptor-mediated 
endocytosis (McMahon et al. 1993).  
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1.4.2.2. Trafficking of RTKs 
 
Intracellular trafficking of receptor tyrosine kinases is best studied for the EGF 
receptor. Upon low EGF stimulation the EGFR complex is internalized mostly through clathrin 
mediated endocytosis (Hanover et al. 1984; Sorkin and Goh 2008). Until recently it was 
assumed that CME directs the EGFR predominantly to degradation, thereby terminating 
signaling. However, recently, it has been shown that CME directs receptors to recycling, 
whereas non-clathrin endocytosis (NCE) leads to receptor degradation. It has also been 
shown that caveolin-mediated endocytosis increases significantly at high-level EGF 
stimulation. About 80-90% of those endocytosed complexes are degraded, whereas most 
CME derived endosomes are recycled.  This discovery is significant to our understanding of 
RTK signal attenuation and downregulation, where early clathrin positive endosomes become 
more important for signaling than for degradation of the receptor complex (Sigismund et al. 
2008).  
1.4.2.3. Ubiquitylation 
 
Ubiquitylation is a regulatory post-translational modification, which serves a variety of 
functions in the cell. Ubiquitin (Ub) moieties are attached by its c-terminus to the lysine 
residues of its substrate, which is catalyzed by specialized enzymes called ubiquitin E3 
ligases. Ubiquitin can be attached to the substrate as a single moiety, but it can also form 
poly-chains, by serial ubiquitylation of subsequent Ub moieties. There have been many types 
of chains characterized so far, however, only little is known about their function in the cell. 
Polyubiquitylation K63 (via ubiquitin lysine 63) and multi-monoubiquitylation (attachment of 
single moieties on several lysines of the substrate) are known to trigger endocytosis or control 
gene transcription. Polyubiquitylation K48 in turn is interpreted and a signal to substrate 
degradation (Dikic 2003; Haglund and Dikic 2005). Ubiquitylation can be controlled in the cell 
by the presence of debiquitylating enzymes (DUBs), such as AMSH or UBPY. 
Deubiquitylating enzymes remove ubiquitylation signal from the substrate and change its 
trafficking along degradation/recycling routes (Naviglio et al. 1998; McCullough et al. 2004).  
Both EGFR and FGFR have been shown to be ubiquitylated by the ubiquitin ligase 
Cbl upon activation (Mori et al. 1995; Dikic 2003). It was, however, unclear so far, what is the 
role of ubiquitylation in FGFR endocytosis (Monsonego-Ornan et al. 2002). It is known that 
ubiquitylation is dispensable for EGFR endocytosis but required for its degradation 
(Soubeyran et al. 2002), whereas in context of TGF receptor it is required for both, 
endocytosis and degradation (Haglund et al. 2003; Huang et al. 2007) (Kavsak et al. 2000). 
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1.4.3. FGFR structure and function 
 
Most vertebrate FGFRs consist of two or three immunoglobulin-like (Ig) domains, an 
acidic box, a short transmembrane domain and a split tyrosine kinase domain on the 
cytoplasmic end (Fig. 1.6 A). Only zebrafish Fgfr4 has four Ig domains, suggesting different 
ligand specificity (Thisse et al. 1995). The acidic box located between IgI and igII increases 
binding affinity to heparin, which in turn promotes ligand-receptor complex formation. The 
stoichiometry of such a complex (FGFR1-FGF2-heparin) was resolved by crystallography and 
proposed to be (for a receptor dimer) 2:2:2, i.e. two ligand molecules, two molecules of 
heparin and 2 receptors (Eswarakumar et al. 2005). 
The affinity to FGF ligands is conveyed by the Ig-like domains and binding of 
cofactors, such as soluble heparans, shed from the cell surface by cleavage. Ligand binding 
triggers conformational changes of the extracellular domain and subsequent homo- or 
heterodimerization of the FGFR (Ullrich and Schlessinger 1990) (Bellot et al. 1991). There are 
at least seven tyrosine residues that can be specifically phosphorylated during receptor 
activation. Their numbers differ for zebrafish and mouse due to different receptor length, as 
summarized in Table 3 (after (Mohammadi et al. 1991; Mohammadi et al. 1996)).  
 
Mouse FGFR1 Zebrafish Fgfr1 Function
Y463 Y451 FRS2/Crk interaction 
Y583/Y585 Y573/Y575 unclear; dispensable for FGFR1 mediated 
proliferation and differentiation 
Y653/654 Y640/Y641 Regulation of kinase activity, activation 
Y730 Y718 unclear; dispensable for FGFR1 mediated 
proliferation and differentiation 
Y766 Y753 PLCγ interaction 
Table 3 Comparative list of autophosphorylation sites on mouse and zebrafish FGFR1 
 
Upon receptor activation adaptor molecules are recruited, which launch a cascade of 
signaling events. A juxtamembrane domain on the FGFR1 associates with FRS2α (Burgar et 
al. 2002), which in turn recruits Grb2 or Grb2/SOS complexes which directly to activate the 
MAP kinase cascade. On the other hand, PLCγ binds directly to the phosphorylated Y766 on 
the receptor (just posterior to the kinase domain) and launches an alternative cascade, 
leading to calcium store release and shape changes in the cell. Deletion of the last 58 c-
terminal amino acids (FGFR1Y766STOP) as well as Y766F substitution proved not only to 
abolish PLCγ interaction but also receptor internalization (Sorokin et al. 1994). It is not clear, 
however, what triggers receptor endocytosis. It could be activation, ubiquitylation or both.  
There are a number of other signaling events that can take place upon FGFR 
activation, which are summarized in more detail in (Eswarakumar et al. 2005). A simplified 
diagram below (Figure 1.6 B) shows four levels of possible regulation at the level of receptor 
dimerization, activation and downstream signaling: 
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Components of the extracellular matrix alter the likelihood of ligand-receptor 
interaction (Park et al. 2000).  
Plasma membrane co-factors such as FLTR3 and Sef can promote or inhibit FGFR 
dimerization (Tsang et al. 2002; Bottcher et al. 2004).  
On the intracellular side, availability of the adaptor proteins regulate the balance 
between various cellular responses to the ligand (such as proliferation, migration, 
differentiation etc.) (Eswarakumar et al. 2005). 
Attachment of ubiquitin (Ub) moieties, mediated by ubiquitin ligase such as Cbl, can 
steer the receptor fate, its trafficking route, its degradation or recycling (Dikic 2003). A set of 
deubiquitylating enzymes (AMSH, DUB) has been shown to balance the activity of ubiquitin 
ligases by removing Ub moieties from the substrate (Naviglio et al. 1998; McCullough et al. 
2004).  
 
 
Figure 1.6 FGFR signaling 
A prototype structure of FGFR (A). Ig domains affect Fgf binding, affinity and selectivity, acidic box is 
required for optimal heparin (HSPG) binding, juxtamembrane domain binds FRS2 and PKC, kinase 
domain binds other adaptor proteins and contains catalytic activity, carboxyterminal domain binds PLCγ 
and is required for receptor endocytosis.  
(B) Fgf8 uptake is receptor dependent and can be regulated on several levels. Components of ECM like 
HSPGs and transmembrane regulators like FLRT3 or SEF modulate ligand association and dimerization 
of the receptors. A group of adaptor proteins (FRS2α, Grb2 etc.) form an active signaling complex and 
facilitate signal transduction via the MAP kinase or PLCγ pathway. Activating the first one leads to 
proliferation and differentiation, whereas the latter is associated with morphogenesis of the cell. Small 
modifiers like ubiquitin can alter receptor downregulation and trafficking, effectively influencing the 
duration of signaling. 
1.4.4. Fgfrs in Fgf8 signaling  
 
Fgfs act in a receptor dependent manner as evidenced by experiments in Xenopus, 
where overexpression of the dominant negative FGF receptor XFD (a form of XlFGFR1, 
which lacks tyrosine kinase domain) blocks Fgf signaling. In frog, XFD blocks mesoderm 
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specification (Amaya et al. 1991). Similarly, the use of pan-FGFR inhibitor SU5402, which 
binds competitively to the tyrosine kinase domain (Mohammadi et al. 1997), results in 
complete blockage of Fgf signaling. The induction of Fgf specific target genes is stopped and 
all Fgf-dependent developmental processes fail to proceed (Raible and Brand 2001).   
During early zebrafish gastrulation all germ layers in the embryo are competent to 
respond to Fgf8. However, Fgf8 is produced locally and effectively signals in a limited zone of 
marginal and dorsal group of cells. The competence of cells to respond to Fgf is mediated by 
Fgfrs expression on the cell surface. Fgfrs are expressed dynamically during development, 
and their in vivo specificity to particular ligands is largely unknown. Tissue culture 
experiments investigated receptor – ligand pairing by testing mitogenic activities of ligands on 
cells expressing different receptor isoforms (Table 4) (Wang et al. 1994; Ornitz et al. 1996; 
Zhang et al. 2006). However, these experiments neglected the tissue context (such as 
presence of ECM components) and expression pattern based associations in the predictions.  
Co-expression of ligands and receptors in the same or adjacent cells constitute some 
circumstantial evidence for functional receptor-ligand pairs. For instance during zebrafish 
development Fgf8 is expressed at the MHB, where Fgfr1 is the only of Fgfrs present. During 
gastrulation Fgfr1 is ubiquitous in contrast to other Fgfrs, which are expressed only later in 
development or in more restricted areas. Therefore, Fgf8 and Fgfr1 act likely in pair during 
early zebrafish development, despite low comparative binding affinity in vitro.  
 
FGF subfamily FGF FGFR activity
Fgf1 subfamily Fgf1 All FGFRs 
Fgf2 FGFR1c, 3c > 2c, 1b, 4∆ 
Fgf4 subfamily Fgf4 
Fgf5 
Fgf6 
FGFR1c, 2c > 3c, 4∆ 
Fgf7 subfamily Fgf3 
Fgf7 
Fgf10 
Fgf22 
FGFR2b > 1b 
Fgf8 subfamily Fgf8 
Fgf17 
Fgf18 
FGFR3c > 4∆ > 2c > 1c >> 3b 
Fgf9 subfamily Fgf9 
Fgf16 
Fgf20 
FGFR3c > 2c > 1c, 3b >> 4∆ 
Fgf19 subfamily Fgf19 
Fgf21 
Fgf23 
FGFR1c, 2c, 3c, 4∆  
      (weak activity) 
Fgf11 subfamity Fgf11 
Fgf12 
Fgf13 
Fgf14 
No known activity 
Table 4. Relative mitogenic activities of Fgf subfamilies through various FGFRs after (Zhang et 
al. 2006) 
 
Another set of evidence is provided through loss of function experiments, which can 
be matched between ligand and receptors. Table 5 presents mouse knockout phenotypes in 
FGFRs. Because each FGFR most probably reacts with more than one of the 22 FGF 
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ligands, receptor phenotypes are usually more complex in nature than those of ligand loss.  
Phenotypes may result from mutual ligand and receptor redundancy in various developmental 
processes.  
In mouse, analysis of FGF8 and FGFR1 loss-of-function phenotypes reveals some 
similarities, suggesting interaction. Both genes are involved in mesoderm induction, limb 
growth and brain patterning. Also in fish, some attempts were made to compare the functions 
of the two. In medaka, loss of Fgf8 leads to complete loss of mesoderm, however the MHB 
seems to be preserved. Similarly, the medaka mutant headfish  (hdf) carrying a single 
disrupting mutation in Fgfr1 lacks mesoderm and trunk and forms only head structures. It is 
believed that the Fgf8-Fgfr1 receptor-ligand pair was conserved through evolution, although 
its function changed between ray-finned fish like medaka and zebrafish (Yokoi et al. 2007; 
Shimada et al. 2008). Morpholino experiments in zebrafish align with the mouse phenotypes, 
in which FGFR1 mutants show reduced MHB fold and abnormal maintenance of this 
structure. In contrast, Fgfr1 morpholino experiments did not reveal any defects in mesoderm 
induction (Scholpp et al. 2004). 
 
Gene Mutations and phenotypes Reference
FGFR1 FGFR1 null; gastrulation defects, lethal at E8.5-9.5, 
mesoderm and somites defects 
(Yamaguchi et al. 1994) 
(Deng et al. 1994) 
 FGFR1IIIb -/- mutants; no obvious defects, defects in 
tail development  
(Partanen et al. 1998) 
 FGFR1 chimeras; defects in migration of mesoderm 
through primitive streak 
(Ciruna et al. 1997) 
 FGFR1 hypomorphs, lethal P0; craniofacial, somite 
and limb defects, abnormal AP patterning 
(Partanen et al. 1998) 
 FGFR1 hypomorphs; pharyngeal region defects, 
neural crest migration defects 
(Trokovic et al. 2003) 
  Conditional FGFR1 knockout at MHB; lack of expected 
neuronal differentiation in MHB region 
(Trokovic et al. 2005) 
(Jukkola et al. 2006) 
FGFR2 FGFR2 null, die at peri-implantation E4.5 (Arman et al. 1998) 
 Hypomorhpic FGFR2; lethal E10.5, defective placenta 
and no limb buds 
(Xu et al. 1998) 
 FGFR1IIIb isoform disruption; craniofacial and inner 
ear defects 
(De Moerlooze et al. 2000) 
(Pirvola et al. 2000) 
 Conditional inactivation of FGFR2 in mesenchymal 
condensations; dwarfism, defects in osteoblast 
proliferation 
(Yu et al. 2003) 
FGFR3 FGFR3 null; skeletal dysplasia, long bones and inner 
ear defects 
(Deng et al. 1996) 
(Colvin et al. 1996) 
FGFR4 FGFR4 null; no obvious phenotype 
FGFR3/FGFR4 double null; late lung defects not 
observed in single receptor-deficient mice 
(Weinstein et al. 1998) 
Table 5. FGFR loss-of-function effects in mouse 
 
In order to study the function of Fgfrs in Fgf8 gradient formation it is essential to see 
what are the trafficking routes of the receptor itself. It is important to know, whether Fgfr1 is 
primarily degraded or recycled in developing embryos and how long in proportion does it 
occupy early endosome populations, from where it is likely to actively signal. It would be 
interesting to determine whether the receptor is just removed from the cell surface to undergo 
degradation or if it recovers and gets recycled together with its cargo (ligand) out into the cell 
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surface and ECM again. The duration of signaling may tell us something about the speed of 
clearance and Fgf8 degradation inside cells.  
 
1.4.5. FGF receptors and human disease 
 
In humans, mutations in FGFR1, FGFR2 and FGFR3 cause a variety of skeletal and 
neurological disorders. Mutations in FGFR1 and FGFR2 cause craniosynostosis 
(characterized by premature fusion of skull sutures) and syndactyly (webbing of fingers and 
toes). Mutations in FGFR3 cause hypochondroplasia (dwarfism), achondroplasia, 
thanatophoric dysplasia and craniosynostosis (Yamaguchi and Rossant 1995). Typically, 
mutations responsible for these disorders are due to single amino acid changes rendering 
receptors dominant active. Some of these mutations result in ligand-independent dimerization 
of the receptors (Eswarakumar et al. 2005).  FGFR mutations are believed to arise de novo in 
the parental germline and in case of mutations in FGFR3 they are found to correlate with 
aging of the father (Horton et al. 2007). The incidence of FGFR related genetic disorders 
vary, depending on the syndrome, between 1:25000 and 1:100000 individuals.  
Children born with Pfeiffer, Apert, Cruzon syndrome or nonsyndromic 
craniosynostosis often suffer from partial syndactyly, shorter bones, craniosynostosis and 
dental problems. Some individuals suffer from problems involving the nervous system (e.g. 
anosmia or deafness) but on average the IQ of such children is normal.  
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1.5. Aims Of The Project 
 
The purpose of this study is to investigate the role of Fgfr1 in Fgf8 morphogen 
gradient formation and to readdress the question of Fgfr specificity in zebrafish. More 
specifically the questions I am hoping to address are: 
What is the function of Fgfr1 in the early zebrafish development? 
How would decoupling of Fgfr endocytosis and signaling processes influence Fgf8 
morphogen gradient formation? 
How does Fgf8 signaling depend on receptor endocytosis? 
What are the phenotypes of Fgfrs 1-4 knockdown/mutations in zebrafish? 
What role do other Fgfrs than Fgfr1 play in Fgf8 signaling? 
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2. Materials and Methods 
2.1. Materials 
2.1.1. Chemicals 
All chemical used in this study were purchased at Sigma, Fluka, Merck and 
Invitrogen, unless stated otherwise.  
2.1.2. Equipment 
Dissection microscope   Olympus SZX16 
Stereomicroscope   Olympus MVX10 with DP71 digital camera 
Compound microscope    Zeiss Imager.Z1 and Olympus BX61 
Confocal microscope    Leica TCS-SP5, upright with 40x and 63x 
dipping lens 
Pneumatic Picopump   WPI PV820 
Micromanipulator   Narishige M-152 
Needle puller     Sutter Flaming/Brown P87 
Needle grinder    Bachofer GmbH 462 
Magnet holders    Kanetec MB-B and Narishige 
Pipette holder    WPI 
Needles    WPI TW100F-3 (injection), TW100-3 
(transplantation) 
Tungsten wire    Fine Science Tools 
Dissection Forceps   Fine Science Tools 
2.1.3. Kits 
DNA Miniprep an Midiprep Kits    Qiagen and Fermentas  
Gel extraction/PCR purification Kit              Qiagen, Fermentas, Macherey-
Nagel 
mMessage RNA synthesis Kit   Ambion 
DIG Labeling Kit                              Roche 
TOPO Cloning Kit    Invitrogen 
Advantage Polymerase Kit   Clontech 
Platinum Pfx Polymerase Kit   Invitrogen 
SMART RACE cDNA Amplification Kit  Clontech 
QuickChange Site 
Directed Mutagenesis Kit   Stratagene 
First Strand SuperScript Kit   Invitrogen 
Brilliant SYBR Green QPCR 
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Master Mix     Qiagen 
T4 Ligase Kit     Promega 
Vectastain Elite ABC Kit    Vector Laboratories, USA 
ECL Chemiluminescence Kit and Films  GE Healthcare/Amersham 
2.1.4. Buffers 
E3 Embryos medium: 
5mM NaCl  
0.17mM KCl  
0.33 mM CaCl2  
0.33 mM MgSO4 
10-5% methylene blue 
 
E2 transplantation medium: 
15 mM NaCl 
0.5 mM KCl  
1 mM CaCl2* 2H2O 
1 mM MgSO4 * 7H2O 
0.15 mM KH2PO4 
0.05 mM Na2HPO4 * 2 H2O 
0,7 mM NaHCO3 
 
PBS: 
1.7 mM KH2PO4 
5.2 mM Na2HPO4  
150 mM NaCl 
 
PBST: 
PBS, 0.1% Tween-20 
 
Ringer Buffer: 
110 mM NaCl 
3.5 mM KCl 
2.7 mM CaCl  
2.5 mM NaHCO3 
 
Danieau Medium: 
58 mM NaCl 
0.7 mM KCl 
0.4 mM MgSO4 * 7H20 
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0.6 mM Ca(NO3)2 
5 mM HEPES (pH 7.2) 
 
2x SDS Loading Buffer: 
50 mM Tris HCl (pH 6.8) 
2% SDS 
0.1% bromophenol 
10% glycerol 
280 mM β-mercaptoethanol 
 
1x TAE Buffer: 
40 mM Tris-acetate 
1 mM EDTA 
 
PAGE Running Buffer: 
25 mM Tris HCl (pH 6.8) 
240 mM glycine (electrophoresis grade) pH 8.3 
0.1 % SDS 
 
10 x Blotting Buffer (1 l): 
30,8 g Tris base 
144.1 g glycine 
20 ml SDS 10% 
10% methanol was added to1x buffer 
 
IP Solubilization Buffer: 
50 mM HEPES (pH 7.5) 
150 mM NaCl 
10% glycerol 
1% triton X-100 
1 mM EDTA 
1 mM EGTA 
10 mM NaF 
30 mM β-glycerol phosphate 
0.2 mM Na3VO4  
Freshly added Proteinase Inhibitor Cocktail 
 
HNTG Buffer: 
20 mM HEPES (pH 7.5) 
150 mM NaCl 
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0.1% Triton X-100 
10% glycerol 
 
PFA 4%: 
4% paraformaldehyde in 100 mM phosphate buffer pH 7.4, stored in aliquots at -20°C 
 
20x SSC Buffer: 
175.3 g NaCl 
88.2 g sodium citrate (* 2H2O) 
800 ml H2O 
1 M citric acid up to pH 6.0 
fill up to 1 l, autoclave 
 
MABT: 
100 mM Maleic acid 
150 mM NaCl 
adjusted to pH 7.5 with solid NaOH, filtered through 0.2 μm filter 
0.1% Tween-20 
 
DIG Block: 
2% Blocking reagent (Boehringer) in MABT 
 
Hyb- Buffer: 
50% formamide 
5x SSC (pH 6.0) 
0.1% Tween-20 
 
Hyb+ Buffer: 
Hyb- 
0.5 mg/ml torula (yeast) RNA 
50 μg/ml heparin 
 
Embryo Genotyping (Digestion) Buffer:  
50 mM KCl 
10 mM Tris HCl pH 8.3 
2 mM MgCl2  
0.1 mg/ml gelatin 
0.45% NP40 
0.45% Tween20 
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Finclip Lysis Buffer: 
100 mM Tris HCl pH 8.3 
200 mM NaCl 
0.2% SDS 
5 mM EDTA 
Proteinase K 100 μg/ml 
 
DNA Extraction Buffer: 
10 mM Tris HCl pH 8.2 
10 mM EDTA 
200 mM NaCl 
0.5% SDS 
200 μg/ml Proteinase K 
2.1.5. Antibodies and Detection Systems 
Anti-DIG-AP FAB fragments, Boehringer 
Anti-Fluorescein-AP FAB fragments, Boehringer 
Fast Red Tablets, Sigma 
DAB, Sigma 
Anti-myc, Santa Cruz Biotechnology 
Anti-GFP, Santa Cruz Biotechnology 
Anti-HA High Affinity, Roche 
Anti-ubiquitin, Sigma 
Anti-DrFGFR1a, Eurogentec (produced in this study) 
2.1.6. Enzymes 
Restrictive enzymes were purchased from Fermentas and New England Biolabs. 
Polymerases and Reverse Transcriptases were obtained from Invitrogen, Fermentas, 
Clontech and Ambion, unless stated otherwise.  
2.1.7. Plasmids and constructs 
Several DNA constructs were used for generation of in situ hybridization probes and 
injection mRNA. In general, constructs used for probes were based on pBluescript II SK 
vector (Stratagene), pCRII vector (Invitrogen) and other, while constructs used for mRNA for 
injection were based on pCS2+ vector (provided by D. Turner, Washington). However, some 
constructs were used for both ISH and RNA (as pointed out in the table). 
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Plasmid insert Vector 
Backbone 
Source Sense/Antisense 
RNA (digest/Pol) 
Cellubrevin-GFP pCS2+ CP Heisenberg Lab Sense: NotI/SP6 
Dlx2a  Monte Westerfield Antisense: BamHI/T7 
Fgf24 pBSK-SK- Druce Draper Antisense: NotI/T7 
Fgf8 PCS2+ Didier Stainier Antisense: XhoI/T7 
FGFR1a pCS2+ (Scholpp et al. 2004) Sense: NotI/SP6 
Antisense: BamHI/T7 
FGFR1a pZL1  Antisense: HindIII/T7 
FGFR1a-GFP pCS2+ This study Sense: BssHII/SP6 
FGFR1a-myc pCS2+myc This study Sense: NotI/SP6 
FGFR1a-RFP pCS2+ This study Sense: NotI/SP6 
FGFR1aW667mRFP pCS2+ This study Sense: NotI/SP6 
FGFR1aY753F pCS2+ This study Sense: NotI/SP6 
FGFR1aY753STOP pCS2+ This study Sense: NotI/SP6 
FGFR1b pCRII-TOPO This study Antisense: KpnI/T7 
FGFR1b incl. 5’UTR pCRII-TOPO This study Antisense: KpnI/T7 
FGFR2 pBSK-SK Bernard Thisse Antisense: XhoI/T3 
FGFR2L545STOP pCS2+ This study Sense: NotI/SP6 
FGFR3 pSPORT Inna Sleptova-
Friedrich 
Antisense: KpnI/SP6 
FGFR4 pBSKII-SK Bernard Thisse Antisense: HincII/T7 
Flag-Ubiquitin4KR pcDNA3.1 Yosef Yarden Lab Sense: Bst1107I/T7 
GFP-GPI pCS2+ P. Keller Sense: NotI/SP6 
Grb2 pCR2+ This study Sense: NotI/SP6 
HA-ubiquitin pcDNA3.1 Yosef Yarden Lab Sense: Bst1107I/T7 
HsCaveolin-GFP pCS2+  Sense: NotI/SP6 
HsRab9-CFP pCS2+ Leah Herrgen Sense: NotI/SP6 
Krox 20 pBSK-SK Trevor Jowett Antisense: PstI/T3 
MyoD pBS-SK Eric S. Weinberg Antisense: EcoRV/T7 
Pea3 pBS-SK Herbert Steinbeisser Antisense: NotI/T7 
Rab11-Cherry pCS2+ Matthias Nowak Sense: NotI/SP6 
Rab5c-YFP pCS2+ Steffen Scholpp Sense: NotI/SP6 
Rab7-CFP pCS2+  Sense: NotI/SP6 
RFP-GPI pCS2+ Arndt Siekmann Sense: NotI/SP6 
SecretedGFP pCS2+ Isato Sense: NotI/SP6 
Sprouty 2 pBS-SK Christine & Bernard 
Thisse 
Antisense: BamHI/T7 
Sprouty 4 pBS-SK Bernard Thisse Antisense: NotI/T7 
Tbx5 pCRII-TOPO Rebecca E.Bielang Antisense: SpeI/T7 
XFD pSP64T Amaya Sense: EcoRI/SP6 
5’UTR-EGFP-FGFR1a pCS2+ Rachel Yu/Maria 
Kolanczyk 
Sense: NotI/SP6 
dnFGFR4-mRFP pCS2+ Rachel Yu Sense: NotI/SP6 
Fgf8-EGFP pCS2+ Rachel Yu Sense: NotI/SP6 
Ntl pBS-SK Stefan Schulte-
Merker 
Antisense: XhoI/T7 
Pax2a pGEM3 Terje Johannsen Antisense: BamHi/T7 
Fgf8-mRFP pCS2+ Rachel Yu Sense: NotI/SP6 
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2.1.8. Fish lines 
Tilling fish lines were obtained as a result of a ZF-Models screen and found in 
Hubrecht TILLING Fish Library in cooperation of Dresden (Germany) and Utrecht (The 
Netherlands) TILLING Labs. Founders were outcrossed into various wildtype backgrounds at 
least 3 times before phenotypic analysis. 
Acerebellar (ace) mutant carrying a loss of function allele (ti282a) in Fgf8 (Reifers et 
al., Development, 1998) was obtained through intercrossing heterozygous carriers.  
Spiegel danio (spd) was sent as homozygous adult carriers from Prof. Christiane 
Nusslein-Volhardt Lab and subsequently used for FGFR1aW671STOP complementation test.  
 
2.2. Methods 
 
2.2.1. Zebrafish raising and maintenance 
Zebrafish were mated, harvested and raised as described in (Westerfield 2000). 
Wildtype embryos used in this study belonged to TL, AB, WIK, Tü or Gol strains. 
2.2.2. Embryo Preparation prior to injection 
Parent fish were setup on the afternoon prior to mating in setup tanks and laid eggs 
within 20 minutes from the start of the day/being setup in one net. The eggs were harvested 
shortly after spawning. Control embryos were kept in E3 medium at 28.5°C and staged 
according to morphological criteria described by (Kimmel et al. 1995). Embryos for injection 
were dechorionated mechanically by forceps or chemically by pronase treatment prior to 
injection. During pronase dechorionation embryos were kept in 1mg/ml enzyme for a couple 
of minutes until first embryos popped out of the chorions. At this point embryos were 
extensively washed in a large Petri dish coated with 1% agarose in E3 medium. 
Dechorionated embryos were always kept in the E3 or E2 medium and transferred to Perti 
dishes coated with 1% agarose in E3 medium.  
2.2.3. Needle preparation 
Needles for injection and transplantation were pulled with the use of two different sets 
of parameters resulting in optimal needle tip length and thickness. Injection needles, 
containing a filament, were filled with a small amount of reagent and the tip was broken with 
dissection forceps. Injection needles were disposed of after use. Needles for transplantation, 
without filament, were broken at standardized diameters of the opening adjusted to the cell 
sizes at desired stages of developmnent.  The needle opening was sanded on a needle 
grinder resulting in a blunt opening. Transplantation needles were stored and used many 
times.  
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2.2.4. RNA injections 
The injection volume of a drop was measured prior to injection in heavy mineral oil 
deposited on a dipping slide. The volume was calculated from the diameter of the drop at 40x 
magnification, at the moment when the drop is round and close to the surface. In general a 
drop of 5 divisions on an ocular scale at magnification 40x was calculated as 1 nl. Injected 
volume was kept between 1-2 nl per embryo and never exceeded 4 nl of an RNA solution at 
50-200 ng/nl in H2O with 0.2% Phenol Red. For some experiments mini-ruby was added as 
lineage tracer. RNA was stored in aliquots at - 80ºC. 
Dechorionated embryos were transferred with a fire-polished glass Pasteur pipette 
into a dish coated with 1% agarose with wells of single embryo width (formed by a custom 
made mold). Aligned embryos were then injected at one cell stage into the cell at the entry of 
the cytoplasmic streaming from the yolk.  
2.2.5. Morpholino preparation and injections 
Morpholino stocks were prepared as advised by Genetools protocols. The 
concentration of stocks was measured on Nanodrop, using 0.1N HCl as medium and the 
custom nucleic acid setup with Constant = 30 and absorption wavelength λ = 265. Master 
stocks of morpholino at 1 mM concentration were diluted 1: 5 or 2: 5 and in Danieau medium 
with 0,02 mg/ml Fast Green dye.  Working stocks of MO were stored at 4ºC. The drop size 
was measured as above and the volume was similarly restricted to 1-4 nl/egg. Embryos were 
injected at 1-2 cell stage as above, into the cytoplasmic streaming. Shortly after the first cell 
divisions started, unfertilized eggs were sorted out and the remaining injected embryos were 
counted in further statistics.  
2.2.6. Cell transplantation 
Petri dishes for transplantation were prepared with a special mould, which printed 
very small one-embryo sized wells in the agarose. Embryos were transferred into these wells 
and oriented with the animal pole up. The manual transplantation setup consisted of a syringe 
fastened to the bench, connected with a narrow insulated tube to the needle holder, which in 
turn was attached to a micromanipulator. The pressure in the needle was controlled manually 
by pulling and pushing the syringe piston gently. The cells were transplanted by careful 
manual suction of single cells out of the donor embryo and injection of these cells into the 
animal pole of the host embryo, just below the epiblast.  
2.2.7. Protein bead implantation 
Acrylic beads of 10 μm diameter were prepared by incubation overnight in 
recombinant zebrafish Fgf8-Cy5/PBS solution. The protein concentration used in this study 
was 150 pg/ml, of which approximately 50% were labeled. The protein stability was tested 
before and showed that beads show high rate of protein degradation already after 5 days in 
4ºC. Therefore, each experiment was performed on beads up to 3 days after preparation.  
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Beads soaked in Fgf8-Cy5 were implanted into the host embryos between sphere 
and 30% epiboly. In order to access the bead by confocal microscopy, beads were implanted 
shallowly under the epiblast, using a Tungsten wire. Embryos for this experiment were placed 
in transplantation Petri dishes with single embryo agarose wells and oriented such that animal 
pole was facing upwards. The time course experiments were conducted in 28ºC in the 
incubator or on a preheated microscope stage.  
2.2.8. Whole mount in situ hybridization 
Embryos were fixed in 4% PFA overnight at a desired stage of development. After 
fixation embryos were washed well in PBST and transferred in 100% methanol and into -20ºC 
for at least 2h for dehydration and freeze cracking. Embryos could be stored this way for 
months. Subsequently, embryos were rehydrated in 50% MetOH/PBST and PBST and 
digested in 10 μg/ml Proteinase K/PBST solution. Duration of the digest was adjusted 
according to the developmental stage of the embryos and the strength of the given enzyme 
stock. Digestion was stopped by washing the embryos in 2% glycine/PBST and subsequent 
fixing in PFA (20 min). After fixing, samples were washed in PBST again and transferred for 
prehybridization into Hyb+ for 2-6 hours. From prehybridization until blocking step embryos 
were always incubated in 68ºC oven on a rocking platform. Hybridization was started by 
replacing Hyb+ on the samples with DIG or Fluorescein labeled probes diluted in Hyb+ 
overnight.  
Washing of embryos after hybridization was achieved by progressive transfer of 
embryos into Hyb- (5 min), 25% Hyb- in 2x SSCT (3x 10 min), 2xSSCT (5 min) and 0.2 SSCT 
(2x 30 min). After that embryos were transferred into 50% MABT/0.2SSCT in the room 
temperature and changed after 5 min into MABT.  
Samples were then transferred into 2% DIG block solution for 1h blocking incubation. 
Subsequently the antibody incubation (2h at RT) was started where the antibody was diluted 
1:4000 in 2% DIG Block buffer.  
The embryos were then washed 4x 15 min in MABT and transferred into a 24-well 
plate. After washing the color reaction was initiated by replacing MABT with BM Purple 
reagent. The reaction was developed in the dark overnight in 4ºC or for 2-5h in room 
temperature until sufficient staining intensity was reached. The color reaction was stopped by 
a few PBST washes and post-fixation in PFA. Subsequently samples were washed 3 times in 
PBS. For imaging embryos were cleared and stored in 70% glycerol.  
For detection of the Fluorescein probe, embryos were incubated 3x 15 min in 
0.1MGlycine/HCl (0.1% Tween20, pH 2.2), washed in PBST and transferred again into 
MABT. After a 45 min blocking in 2%DIG Block/MABT at room temperature embryos were 
transferred into fresh anti-fluorescein-AP antibody at 4ºC overnight (dilution 1:1000).  
Subsequently samples were washed in PBST and preincubated with 0.1M Tris/HCl 
(pH 8.2). After preincubation the color reaction was initiated by putting dissolved Fast Red 
Materials and Methods 
 
 43
Tablet solution on the samples. The reaction was developed in the dark until desired intensity. 
The reaction was then stopped by quick PBST wash and PFA post-fixing.    
2.2.9. Biotin detection 
To detect the transplanted mini-ruby labeled donor cells in a host embryo, Vectastain 
Elite ABC kit was used. First, 16 μl of each solution A (streptavidin) and solution B (biotin-
peroxidase) were diluted in 1ml PBST and incubated for 30 minutes. After in situ 
hybridization, embryos were washed with PBST and then incubated in the previously 
prepared AB solution for 45 minutes at room temperature. Then, they were washed 5 
minutes, 10 minutes and 15 minutes with PBST and stained using DAB tablets (Sigma), 
according to manufacturer’s instructions. The reaction was stopped by several washes in 
PBST. 
2.2.10. Agarose Gel Electrophoresis 
Agarose gels were prepared in TAE Buffer and boiled in a microwave for melting. 
DNA fragments differing by more that 200 bp were resolved on 1% gels, whereas genotyping 
samples characterized by 20-50 bp size differences were resolved on 2% gels.  Gels before 
setting were mixed with 5% ethidium bromide. Electrophoresis was run in a TAE filled 
chamber at a constant voltage of 80-120 V, depending on the chamber and gel size (10-
20V/1cm gel length). After the gel was satisfyingly resolved (as judged by the loading dye 
band separation) the bands were photographed in a UV chamber with an attached camera. 
Alternatively, bands were cut out of the gel with a scalpel under a low-UV illumination.  
2.2.11. Cloning 
Cloning steps were designed using Vector NTI software (Invitrogen). Cloning of 
genes or gene fragments from cDNA was done by RT-PCR and subsequent TOPO cloning 
and TOP10 E.Coli transformation, according to manufacturer’s protocol. DNA fragments, 
which were cloned in specific sequence into one vector, were clone by restrictive digest and 
ligation between chosen restriction sites.  
In order to combine sequences into a fusion protein construct, a neutral and flexible 
linker was used, which was encoded as an overhang into the gene-specific primer. In most 
cases the sequence used for linker (up to 6 aa long) encoded Gly-Ser-Gly-Ser tandem repeat, 
which was shown by David Drechsel (Protein Expression Facility MPI-CBG Dresden) to 
cause least steric tension. In order to propagate cloned DNA, chemically competent E.Coli 
bacteria XL2 Blue were used for transformation and culture.  
Colonies after cloning were checked for presence of an insert either by colony PCR 
(where instead of purified template a whole bacterial colony was added to the reaction) or by 
miniprep, restriction digest and agarose gel electrophoresis. Positive clones were then sent to 
sequencing for verification.   
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2.2.12. RNA isolation 
RNA isolation from fish embryos was achieved using Trizol Reagent (Invitrogen). 
Embryos were homogenized in Trizol by multiple squeezing through a 0.7 mm needle into the 
10 ml syringe. Homogenized embryos were then treated according to the Trizol RNA 
extraction protocol.  
2.2.13. Synthesis of DIG labeled probes for in situ 
hybridization 
DIG labeled antisense riboprobes were synthesized from DNA plasmids containing 
cDNA of the gene of interest. The plasmid DNA was first linearized with the appropriate 
restriction enzyme and then used as a template for RNA synthesis, using a DIG labeling kit 
(Roche Diagnostics, Germany). After synthesis, the DIG labeled RNA was precipitated by 
incubation with LiCl, overnight at -20°C. The RNA was then pelleted by a 30-minute 
centrifugation at 13000 rpm at 4°C, washed with 70% ethanol and re-suspended in 100 μl of 
RNase-free water. This solution was further diluted to 500 μl with hybridization solution. 
Routinely, a dilution of 1:100 of this stock was used for in situ hybridization protocols.  
2.2.14. PCR  
PCR reactions were performed on Eppendorf thermocycler according to standard 
protocols advised by the producer of the polymerase. Genotyping reactions were all 
performed with use of Taq Polymerase using a standard program: 25 cycles, 57ºC annealing 
temperature and 72ºC elongation. All PCR reactions for cloning were performed using 
Platinum Pfx Polymerase or Advantage Polymerase, which guaranteed higher fidelity of the 
amplification. Annealing temperatures used were for the most cases used according to the 
Wallace rule, calculated by the prediction software: Tm = 2°C * (A+T) + 4°C * (G+C). 
The elongation time was calculated roughly to be 1min/kb, e.g. 2,5 kb Fgfr1a gene 
was amplified using 3 min. elongation time. 
In order to achieve increased product specificity and yield, nested PCR with an 
internal primer pair was used. Nested primers for genotyping contained overhangs for forward 
and reverse M13 primer in case the product was to be sequenced. Nested primers for cloning 
often contained overhangs with restriction sites for further specific subcloning into the vector.   
2.2.15. Site Directed Mutagenesis 
Site directed mutagenesis primers for introducing Y753F change in Fgfr1a construct 
were designed as 45 nt long forward and reverse oligonucleotides, complementary to each 
other and to the template, except the change site. The reaction was setup according the 
instruction provided by the manufacturer (Stratagene). Bacteria used for transformation of the 
quickchange product were provided in the kit (Supercompetent XL1 Blue E.Coli). 
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2.2.16. RACE PCR 
RNA for RACE PCR was isolated from one-day-old embryos. The first strand DNA 
was synthesized according to the protocol (Clontech). Gene specific primers were designed 
according to Manual guidelines: long (~30 nt), Tm<70ºC. Two gene specific primers were 
designed for each gene and the nested primer did not overlap with the first primer. 
DNA was then amplified according to the provided protocol using Advantage 
Polymerase (Clontech).  
2.2.17. Quantitative Real Time PCR 
Primers for q-PCR were designed such that the product was about 200 bp for both, 
Fgfr1a and the internal control, 18S. The specificity of primers was validated first on regular 
RT-PCR and the conditions were optimized for best and most specific yield.  
The RNA for q-PCR was isolated as described above from embryos staged precisely 
in order to compare wildtype and mutant embryos. 20 embryos per each sample were pooled 
together.  
The reactions were setup as advised in Brilliant SYBR Green QPCR manual, where 
each Fgfr1 and each internal control 18S were prepared in triplicate. The reactions were run 
on realtime PCR instrument Stratagene MX4000 with SYBR Green and Reference Dye 
measurements after each cycle (total of 30 cycles).  
The measurements were collected and exported to Excel sheet for further 
calculations. The relative amounts of transcripts were calculated using 2-ΔΔCT method 
described in detail by (Livak and Schmittgen 2001). Standard deviations and significance 
were calculated using Excel statistics tools.  
2.2.18. RNA for injection 
Injection plasmid construct was first linearized so that the linear sequence ended 
behind the polyA signal sequence, downstream of the gene of interest. Efficiency of 
linearization was checked on an agarose gel electrophoresis and the linear DNA was purified 
using a Gel Extraction Kit. Subsequently, DNA was used in an in vitro RNA synthesis reaction 
using suitable mMessage kit (containing SP6, T7 or T3 Polymerase). DNA was digested at 
the end of reaction with DnaseI. The RNA was then precipitated in LiCl2 and subsequently 
dissolved in ddH2O. The RNA concentration was determined in a Nanodrop. Most RNA stocks 
were diluted to a working concentration of 200pg/nl, split into small aliquots and stored in -
80ºC.  
2.2.19. Imaging subcellular structures 
Living embryos were mounted in moulds of agarose-coated transplantation dishes, 
containing E3 media. The embryos were oriented with the side of interest facing up. Confocal 
images were acquired on upright Leica SP5 confocal microscope with HCX APO L UVI 
40x/0,8 WATER (dipping) or HCX APO L UVI 63x/0,9 WATER (dipping) objectives. For co-
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localization studies of multiple laser line combinations, images were acquired by line-by-line 
sequential, bidirectional scanning, using a suitable combination of laser excitation lines (458, 
476, 488, 496, 514, 561, 633). For example for GFP/RFP acquisition 488 and 561 laser lines 
were used, whereas mRFP/Cy5 acquisition required the use of 561 and 633 laser lines. The 
pinhole was adjusted to 1 Airy for all and the images were acquired at 1048x1048 resolution.  
In order to collect as much data as possible on subcellular structures, the focus was 
set on first 3 most superficial cell layers in the embryo. The data was stored and processed in 
a database using LAS AF 1.8.2 software. Composites were assembled using Adobe 
Photoshop and Adobe Illustrator. 
2.2.20. Cartilage alcian blue staining 
Larvae were fixed in 4% PFA overnight. The larvae were then washed in PBS and 
incubated twice overnight first in 50% EtOH, then 100% EtOH in order to dehydrate. 
Dehydrated larvae were stained for cartilage and calcified tissue in alcian blue solution 
containing: 70% EtOH, 30% Acetic acid and 20 mg Alcian Blue. After about 24h the larvae 
were neutralized in saturated sodium borate for several hours. Subsequently the samples 
were bleached in 15% of 3% H2O2 and 85% KOH. After bleaching the larvae were washed in 
PBS and preserved in 70% Glycerol.  
2.2.21. Whole mount alizarin red skeletal staining 
2.2.21.1. Staining all internal skeleton 
Adult fish (at least 3 months old) were sucrificed on ice in MESAB overdose and fixed 
in 4% PFA for 2 days. Fixed fish were rinsed in water and incubated in 100% isopropanol 
overnight in room temperature to partially remove fat. Later fish were transferred into bleach 
(80% KOH, 20% of 3% H2O2) at 37ºC for several hours in order to remove the color pattern. 
After bleaching fish were washed in 1% KOH and the scales were removed with a needle. 
Subsequently the tissue was rendered transparent by prolonged trypsin digestion in a solution 
containing: 35% saturated sodium borate, 65% ddH2O and 1% trypsin (Sigma, powder). After 
the tissue reached about 60% transparency the specimens were stained with alizarin red 
(0.1g alizarin red in 1% KOH) for 24h. After that the skeletons were destained in KOH for 2 
days, with occasional buffer change, until the tissue was clear and the bones were dark red. 
The specimens were then preserved and photographed in 70% glycerol. 
2.2.21.2. Staining scales 
Staining scales was performed similarly as staining internal skeleton but without scale 
removal and trypsynization. Scales were also well visible without bleaching.  
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2.2.22. Genotyping Mutant fish 
Embryos and young larvae were first lysed in Embryo Lysis Buffer in 55ºC for several 
hours until the tissue disappeared. Lysates were then used directly as template source. Adult 
fish were fin-clipped under anesthesia (6 ml of 0.4% MESAB in 1% Na2HPO4 * 2H2O per 100 
ml E3). Fin-clips were lysed in Tissue Lysis Buffer in 55ºC until the tissue decomposed. 
Subsequently the DNA was isolated by isopropanol precipitation and resuspended in 100 μl 
H2O.  
Genotyping was always performed in two rounds of PCR reactions with outer and 
inner (nested) primer pairs, amplifying on average 400-600 bp genomic DNA fragments. The 
same primers were used earlier in TILLING screen for sequencing amplicons of interest.  
PCR products were then either directly sequenced or analyzed using Derived 
Cleaved Amplified Polymorphic Sequences method (dCAPS – see list of websites), using 
restriction digest. The table below lists all enzymes that were used to distinguish mutations in 
TILLING mutant lines. PCR products were digested overnight and resolved on 2% agarose 
gels. The band size shifts were then registered and analyzed.  
 
Mutation Enzyme used in dCAPS Gel bands prediction 
Fgfr1W671STOP MboI WT higher band of 269 bp gets cleaved in 
mutant and results in a smaller band of 244 bp 
Fgfr1F679F MboII WT (290 + 202 bp) cleavage site is lost in 
mutant resulting in a higher band of 492 bp 
Fgfr1Y326STOP MseI WT higher band of 206 bp gets cleaved in 
mutant and results in a smaller band of 165 bp 
Fgfr2L545STOP BfmI (SfeI) WT higher band of 183 bp gets cleaved in 
mutant and results in a smaller band of 140 bp 
Fgfr4R36STOP PagI (BspHI) WT higher band of 600 bp gets cleaved in 
mutant and results in 2 smaller bands of 433 
and 166 bp 
Fgfr4Y43STOP EcoRV WT (413 + 152 + 34 bp) cleavage site is lost in 
mutant resulting in a higher band of 447 bp 
 
2.2.23. Western Blot 
2.2.23.1. Sample preparation 
Embryos for Western Blot were pooled at a desired stage and deyolked using ½ 
Ringer Buffer. Embryos were homogenized by pipetting up and down in yellow tip (200 μl). 
After a brief incubation the embryos were spinned in a tabletop mini-centrifuge and the 
supernatant was discarded. The cell pellet was then lysed in 2x SDS Loading Buffer and 
boiled in 95ºC for 5 min. The sample was ready to use or stored in -20ºC for weeks.  
2.2.23.2. PAGE 
Polyacrylamid gels were prepared as described in (Sambrook and Russell 2001) and 
cast in Biorad chambers. Smaller proteins were resolved on 12% developing gels, whereas 
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Immunoprecipitation gels were of 6,5% due to high molecular complexes. The electrophoresis 
was run at constant 40 mA.  
2.2.23.3. Transfer and detection 
Transfer of proteins on Immobilion-P transfer membrane (Millipore) was performed in 
a semi-dry setup (Biorad) at 90 mA per gel for 2 hours. After transfer membranes were 
stained shortly in Ponceau Solution in order to see the resolution and abundance of the 
protein bands. Subsequently, the membrane was washed in PBST and transferred into the 
blocking buffer (3% milk in PBST) for an hour. The primary antibody incubation was usually 
allowed overnight at 4ºC (antibody in blocking buffer). The antibody was then washed off by 
3x 10 min milk/PBST washes and the secondary HRP-antibody was applied for 30 min. The 
second antibody was washed off with PBST ( 3 x 10 min). The exposure was done in a 
photographic cassette using ECL Reagent Kit and detectec in a Kodak Film developer 
machine. Film exposure varied from 30 sec to 20 min.  
 
2.2.24. Immunoprecipitation of FGFR from embryos 
2.2.24.1. Sample preparation 
Embryos for immunoprecipitation were dechorionated and harvested at shield stage. 
In order to pull down sufficient amout of protein 100 embryos were taken per sample. 
Embryos were place on ice in 1 ml solubilization buffer per sample. The lysate was vortexed 
from time to time. After 20 minutes incubation the lysate was centrifuged for 20 mins at 4ºC, 
13000 rpm. The supernatant was then collected into a fresh tube and the protein 
concentration measured.  
2.2.24.2. Immunoprecipitation 
25 μl of 50% slurry of GammaBind G Sepharose (Amersham) was use per sample. 
Initially the necessary amount of sepharose was washed twice with solubilization buffer. The 
beads were then resuspended in approximately 300 μl solubilization buffer with addition of 10 
μg IP antibody (anti-myc or anti-Fgfr1a). The antibodies were allowed to couple with the 
beads for 1h at 4ºC with mild agitation. Coupled beads were subsequently washed 3 times 
with solubilization buffer and resuspended in 200 μl final volume. This volume was then 
aliquoted in equal amounts into the tubes containing the embryo lysate samples.  
The immunoprecipitatation was then allowed at 4ºC with gentle rotation for 1h. After 
IP, the beads were washed 3 times in HNTG. The beads were then centrifuged and the 
excess of buffer was removed. This sample was then boiled in 2x SDS Loading Buffer and 
taken as a ready-to-go Western Blot sample. The western Blot was developed either using 
anti-ubiquitin or anti-HA antibodies, depending on the sample.  
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2.2.25. DEAB retinoic acid inhibition 
In order to inhibit retinoic acid production in developing embryos I used 4-
(Diethylamino)-benzaldehyde, DEAB, which blocks activity of RA producing Aldh enzymes. In 
order to block RA signaling during gastrulation embryos were dechorionated and placed in 
agarose coated dishes with E3 and 10 mM DEAB or DMSO as control. The dishes were 
preincubated in the inhibitor/control solution for a couple of hours in order to equilibrate the 
agarose. The incubation period used was between 30% and TB, when the medium and 
dishes were exchanged. Subsequently, the embryos were fixed at desired stage and treated 
in experimental and control groups. 
2.2.26. Overview of the TILLING approach 
Ligand-receptor specificity can be approached by a direct comparison of phenotypes 
evoked by single ligand and receptor loss-of-function. Knowledge of Fgf8 loss-of-function 
phenotypes in zebrafish provides information about functions of the ligand, which can be then 
compared to the receptor mutant phenotypes.  
In order to produce receptor mutant fish, we have screened the Dresden and 
Hubrecht TILLING Libraries for two regions in each receptor gene. The amplicons, that is 
fragments of genes chosen for lesion detection in the TILLING library, were designed using 
two predictions tools, CODDLE and LIMSTILL (see table of websites in Chapter 6). Both 
prediction softwares help locating amplicons in coding regions of the gene as well as compute 
probabilities of obtaining non-sense mutations. The table below summarizes information 
about screened regions.  
The numbers of exons do not agree with the latest release of zebrafish genome 
assembly (Zv7), because all predictions were made on Zv4 and Zv5, when many genes were 
wrongly annotated.  
Amplicons used for screening ENU TILLING library 
Gene 
Exons 
covered  
Predicted STOP 
chance 
Screened 
area (bp) 
Non-sense 
mutations 
Mis-sense 
mutations 
 Fgfr1a 7 8,95% 427 1  2 
  18,19 6,65% 431 1 3 
Fgfr2  2 6,39% 139  -  1 
  7 6,98% 434 1  - 
Fgfr3 2 6,39% 576  -  7 
  7 6,84% 402  -  1 
Fgfr4 2,3 7,80% 678 2  2 
  13,14 7% 702  - 4  
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 Screened amplicons were located either in the very early positions in the gene (for 
producing early nonsense mutants) or within the tyrosine kinase domain (for producing 
dominant negative mutants). TILLING Facility in MPI-CBG Dresden screened 12288 fish in 
Hubrecht and Dresden Tilling libraries. Among 25 of detected missense and nonsense 
mutations we found six that were likely to result in a dysfunctional protein, which I described 
in this work. We have screened the library for all Fgfr genes found in zebrafish until 2005 (i.e. 
not Fgfr1b), however, we did not find any nonsense or interesting missense (e.g. in conserved 
sites) mutations in Fgfr3. 
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3. Results 
 
Based on extensive studies of Fgf mutants and their expression patterns there is 
some understanding of their functions in early development (Ornitz and Itoh 2001). There is 
still, however, little known about the function of Fgfrs and their specificity for ligands in vivo.  
In the following I present the generation of fgfr loss-of-functions situations by mutagenesis 
and morpholino knockdown. I also describe my approach to study endocytosis of Fgfr1 in vivo 
in overexpression experiments.  
 
3.1. Expression of fgf8a, fgf3 and fgf24 
 
In order to address ligand-receptor specificity I should briefly describe the expression 
of three members of the Fgf ligand family, which were previously shown to play a role in early 
development (Figure 3.1). These are fgf8a, fgf3 and fgf24, which act redundantly or 
cooperatively in zebrafish dorsal-ventral (D-V) patterning, specification of mesoderm, 
positioning of MHB, left-right asymmetry and patterning of the eye, ear, heart and many other 
(Reifers et al. 1998; Picker et al. 1999; Reifers et al. 2000; Phillips et al. 2001; Draper et al. 
2003; Picker and Brand 2005).  
Fgf8a is initialized after midblastula transition in the dorsal marginal zone. Later and 
throughout gastrulation it becomes expressed in the margin (Fig 3.1 A). As epiboly 
progresses, the expression becomes stronger on the dorsal and weaker on the ventral side. 
At about 70% epiboly an additional domain of expression comes up in presumptive hindbrain 
area. At the beginning of somitogenesis, fgf8a starts being expressed also in the 
telencephalon, the hindbrain domain is restricted to prospective rhombomeres 2 and 4, 
whereas posterior expression labels newly arising somites, floor plate, lateral neural plate and 
presomitic mesoderm. Fgf8a is also faintly expressed in the heart primordium. Beyond 8 
somites the hindbrain expression is restricted to MHB only and from about 20 somites Fgf8a 
is also present in the retina. In one-day embryos fgf8a is expressed in the MHB, optic stalks, 
telencephalon, otic vesicle, dorsal somites and caudal fin fold.  
Similarly, fgf3 and fgf24 are both expressed in the margin during gastrulation (Fig 3.1 
B, C). Fgf3 is expressed from midgastrula in presumptive rhombomere 4, whereas fgf24 is 
expressed in anterior axial mesoderm. Later in development expression of the two fgfs 
diverges.  
During somitogenesis fgf3, which belongs to the Fgf8a synexpression group, is also 
expressed in the telencephalon, hindbrain and tailbud. Its expression gets later restricted to 
rhombomere 4 and MHB. Later during somitogenesis, fgf3 is also weakly expressed in 
posterior somites and strongly in neural crest cells. The expression comes up also in otic 
vesicles and some areas of the telencephalon.  
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Expression of fgf24 during somitogenesis is restricted to otic and olfactory placodes, 
polster and tailbud. At later stages (18 s) fgf24 is also expressed in pharyngeal arches, 
pectoral fin primordium and lenses. 
 
 
Figure 3.1 Expression patterns of fgf8a, fgf3 and fgf24 
Fgf8a (A) is expressed in the margin during gastrulation. At midsomitogenesis a domain at the future 
hindbrain comes up. During segmentation, fgf8a is also seen in the telencephalon, somites, the 
presomitic mesoderm and the fin fold. Fgf3  (B) is expressed in the margin during gastrulation. Later it is 
also present in the forebrain, in the MHB and the tailbud. From late somitogenesis fgf3 can be 
additionally detected in the otic vesicles, the fin fold and the neural crest. Fgf24 (C) is expressed in the 
margin during gastrulation. During segmentation it is present in the tailbud, olfactory buds and otic 
vesicles. Late in segmentation it can be also detected in the pectoral fins and in the fin fold.  
 
3.2. Functional analysis of Fgfr1 
3.2.1. Expression of Fgfr1 
 
Both Fgfr1a and b are maternally provided and are ubiquitously expressed until 
midgastrulation (Fig. 3.2 A and 3.3 A). At this stage the ventral expression starts 
disappearing. Fgfr1b is also downregulated in dorsal midline and dorsal margin. From tailbud 
until mid-somitogenesis the ubiquitous dorsal expression of Fgfr1a becomes restricted to the 
forebrain, the MHB, somites and presomitic mesoderm (Fig. 3.2 B and 3.3 B). It is also found 
at low levels in the hindbrain. 
During later somitogenesis (20 somites – 24 hpf) Fgfr1a transcript can be found in 
pharyngeal arches, the MHB, several domains of the telencephalon and the diencephalon, 
including the optic stalk and the olfactory placode (Fig. 3.2 C,D). Fgfr1a is expressed in the 
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lateral line primordium. In the tail expression persists in the posterior somites and tailbud, 
which gets restricted to the tailbud by 24 hpf.  
In comparison, Fgfr1b is expressed in broader domains of diencephalon, midbrain, 
cerebellum and ventral hindbrain (Fig. 3.3 C, D). The telencephalon is completely devoid of 
Fgfr1b, which instead is expressed in the retina. There is a weak expression in the neural 
crest and inner cell layer of otic vesicles, whereas the expression in the trunk and somites 
seems to stay diffuse at low levels. Posterior somites and presomitic mesoderm express 
Fgfr1b strongly until after 24 hpf.  
 
Figure 3.2 Expression pattern of Fgfr1a 
Fgfr1a is maternally provided and expressed ubiquitously throughout blastula and early gastrulation 
stages. Late in gastrulation it is downregulated on the ventral side and still strongly expressed dorsally 
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(panel A). Later the expression becomes restricted to brain and presomitic mesoderm (panel B). At 
24hpf Fgfr1a is restricted to olfactory placode and optic stalks, diencephalon, midbrain-hindbrain 
boundary, ventral hindbrain, otic vesicles, lateral line primordium, few posterior somites and tailbud. At 
24 hpf, expression in somites and telencephalon have disappeared but persists in the lens and 
epiphysis (panels C, D). Abbreviations: f – forebrain, LLP – lateral line primordium, MHB – midbrain-
hindbrain boundary, op – olfactory placode, ov – otic vesicle, pa – pharyngeal arches, PSM – presomitic 
mesoderm, TB – tailbud, vh – ventral hindbrain, vm – ventral posterior midbrain. 
 
Figure 3.3 Expression pattern of Fgfr1b  
Expression of Fgfr1b is almost identical to Fgfr1a at early stages, with some small differences: during 
late gastrulation Fgfr1b in downregulated at dorsal midline and dorsal margin (panel A). Later, during 
somitogenesis it appears to be more ubiquitous than Fgfr1a. Fgfr1b transcript is not found in 
telencephalon but is quite abundant in the eye vesicles. At 24 hpf, it is quite strongly expressed 
throughout neural tube, expect telencephalon and dorsal hindbrain. It is weakly expressed in the spinal 
cord, lenses and otic vesicles. Abbreviations: d - diencephalon, f – forebrain, h – hindbrain, MHB – 
midbrain-hindbrain boundary, pa – pharyngeal arches, psc – posterior spinal cord, PSM – presomitic 
mesoderm, s – somites, sc –anterior spinal cord, TB – tailbud, tm – tectum of midbrain, vh – ventral 
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hindbrain. 
 
3.2.2. Analysis of Fgfr1 loss-of-function 
3.2.2.1. Fgfr1a mutant zebrafish  
Three independent mutations in Fgfr1a were isolated in the TILLING screen for Fgfr 
mutants (summarized in Figure 3.4, the TILLING approach is described in the Materials and 
Methods). The early stop mutation is located in exon 8, which is incorporated exclusively into 
Fgfr1a IIIb isoform. Presumably, this mutation results in IIIb isoform loss-of-function (allowing 
only a small portion of the extracellular domain to be produced). Much like in FGFR1IIIb -/- 
mutant mice there are no embryonic or adult defects detectable in homozygous Fgfr1aY328STOP 
-/- fish.  
 
Figure 3.4 Summary of 
Fgfr1a TILLING 
mutants 
Three mutations were 
found in Fgfr1a gene 
(A). Fgfr1Y328STOP is 
located on exon 8, 
which means it affectes 
Fgfr1 IIIb isoform. 
Fgfr1aW671STOP results in 
partial disruption of 
tyrosine kinase domain. 
Fgfr1F681C is a 
substitution in a 
conservative residue of 
tyrosine kinase. The 
genetic context and the 
nature of mutations is 
summarized in a panel 
of chromatogram traces 
(B). 
 
 
 
 
 
 
We also found a missense mutation - Fgfr1aW681C where a highly conserved 
phenylalanine 679 in the tyrosine kinase domain is changed to a cystein. This mutation also 
did not cause any developmental or adult phenotypes when brought to homozygosity. 
However, another Fgfr1a mutant, a late W671 nonsense mutation in the second kinase 
domain resulted in a near loss-of-function situation and it will be described in detail in further 
sections of this work.  
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3.2.2.2. Maternal zygotic Fgfr1W671STOP shows a strong 
reduction of Fgfr1a message RNA 
 
Homozygous Fgfr1W671STOP mutant fish were viable and fertile. I did not observe any 
abnormal phenotypes during early embryonic development. Based on protein domain and 
crystal structure of FGFR1a one can try to predict functionality of the mutant Fgfr1aW671STOP 
protein. This truncated form lacks some of its functional tyrosines that have been shown to 
play a role in protein endocytosis, PLCγ signaling, activation and regulation (i.e. Y718, Y753) 
(Sorokin et al. 1994) (Cross et al. 2002). Fgfr1aW671STOP retains, however, its juxtamembrane 
domain, its activation tyrosines Y640 and Y641, and its predicted ATP-binding pocket 
(InterPro prediction). Nevertheless, the protein is much shorter and may have lost some of the 
integrity of the remaining domain.  
First, I have examined both the endogenous expression of the mutant protein in vivo 
and the functional characteristics of the mutant protein in overexpression experiments (Figure 
3.5). I mated homozygous mutant fish and analyzed expression of Fgfr1a in maternal zygotic 
(mz) Fgfr1W671STOP
 
embryos by in situ hybridization (Fig 3.5 A).  
 
Figure 3.5 Expression of fgfr1a is reduced in mzFgfr1aW671STOP embryos 
In situ hybridization (A), Q-PCR (B) and RT-PCR analysis (C) unambiguously show that Fgfr1a 
expression is greatly reduced in mzFgfr1aW71STOP homozygotes. Fgfr1a transcript shows over 90% 
reduction also at very early stages of development such as 16 cells (normalized against 18S levels as 
an internal control). 
 
MzFgfr1W671STOP mutant embryos exhibit strongly reduced levels of the Fgfr1a 
transcript compared to wildtype control. In order to verify this result quantitative real time PCR 
and RT-PCR were done on the RNA from embryos at four selected early development time-
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points (Fig 3.5 B and C). Both experiments indicate downregulation of fgfr1a transcript in 
mutant embryos. Relative quantitative analysis estimated mutant fgfr1a transcript levels as 
10% of the wildtype norm.  
 
3.2.2.3. Fgfr1W671STOP uptake and the signaling capacity are 
reduced 
 
To test the functionality of the mutant protein I have cloned Fgfr1aW671-mRFP 
construct. Upon overexpression the fusion protein is capable of inhibiting Fgf signaling in 
gastrulating embryos (Fig. 3.6 A) but to a lesser degree than the overexpression of dominant 
negative FGFR1 – XFD (Fig. 3.6 B). In order to test the ability of mutant Fgfr1a to endocytose 
Fgf8 I performed a transplantation assay (Figure 3.6 C). I implanted receptor-overexpressing 
cells into Fgf8-GFP overexpressing host embryos (the nature of control Fgfr1a-RFP fusion 
protein is described later in section 1.2.3.1). When observed 30 min post transplantation, 
Fgfr1aW671-mRFP expressing cells exhibit less uptake of Fgf8-GFP compared to Fgfr1a-RFP 
cells (Fig 3.6 D).  
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Figure 3.6 Fgfr1aW671STOP inhibits Fgf signaling and Fgf8 endocytosis upon overexpression 
Mutant protein Fgfr1W671STOP, upon overexpression strongly blocks Fgf signaling (A), similar but less 
strongly than dominant negative Fgfr1 (dnFgfr1) (B). Fgfr1W671STOP is not internalized as well as wildtype 
receptor (D). Confocal image shows receptor-overexpressing cells in Fgf8GFP host embryos 30 minutes 
post transplantation. Scale bar 25 μm. The scheme of experiment is presented on panel C. 
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3.2.2.4. Late phenotypes in mutant fish – the role of genetic 
background  
 
Despite my expectations based on earlier studies in mouse (Yamaguchi et al. 1994) 
and zebrafish (Scholpp et al. 2004) I did not find any serious developmental defects in 
mzFgfr1W671STOP. During gastrulation there is a slight delay in development, which is later 
overcome and no other abnormal phenotype was detected. The survival of homozygous fish 
from heterozygous incrosses was below expected Mendelian 25% (see table below). 
 
Date Cross Mutant dCAPs 
No. 
finclip
s 
WT Heterozygotes 
Homozygot
es 
11.01.0
8 
incross hets 
(AB) Fgfr1
W671STOP MboI 45 15 (33,3%) 23 (51,1%) 7 (15,5%) 
07.07.0
8 
incross hets 
(Tu) Fgfr1
W671STOP MboI 17 7 (41,2%) 8 (47%) 2 (11,7%) 
Table 6 Genotyping statistics for TILLING line Fgfr1W671STOP 
 
Simultaneously to our reverse genetic approach, the group of Christiane Nüsslein-
Volhardt found a mutant in a forward genetic screen for adult skeletal phenotypes, which was 
subsequently mapped to the region of Fgfr1a on LG8. This mutant was found to have 
mispatterned and bigger scales in a very similar fashion to a strain of carp called Mirror carp 
(Cyprinus carpio morpha noblis). The Tübingen Fgfr1a mutant line was called analogously in 
German: Spiegel danio (spd), which represents Fgfr1a allele t3R705H. The genetic variance 
characterizing scale-less carp can be also linked to mutations in its Fgfr1 gene, which is 
duplicated in carp (Nicolas Rohner, personal communication). Therefore, we decided to test 
allelic complementation for two Fgfr1a alleles t3R705H (spd) and hu3264 (Fgfr1aW671STOP). 
We intercrossed mzFgfr1aW671STOP and homozygous spd fish and raised their progeny to 
adulthood (Fig. 3.7). We found numerous transheterozygotes with scale patterning defects 
supporting the association of mutations in Fgfr1a and dermal skeleton development.  
The penetrance of this phenotype is, however, background dependent, where 
Tübingen (Tü) background shows maximum scale loss and Tupfel long fin (TL) background 
shows no phenotype. In the intercross of spd fish in Tü background and mzFgfr1aW671STOP in 
TL we found individuals showing a wide spectrum of scale loss severity. Mutant fish in the Tü 
background appeared in general more fragile and only a few homozygous Fgfr1aW671STOP 
individuals survived beyond 2 weeks of age (see Table 1).  
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Figure 3.7 Late phenotypes in homozygous 
Fgfr1W671STOP 
Wildtype fish show a regular array of small scales of 
similar size (A). Spiegel danio homozygotes carrying 
t3H705R alleles show reduction in number, increase in 
size and irregular pattern of scales (B). Similarly, 
homozygous Tilling mutant of allele hu3264 show 
abnormal scale patterning and additionally fin growth 
defect (C). Transheterozygotes of both Fgfr1 mutant 
alleles show similar phenotypes (D). The penetrance of 
the phenotype varies in strength, probably due to the 
presence of a strain specific silencer gene. 
Photography by Nicolas Rohner. Spiegel danio, allele 
t3H705R, strikingly resembles scale phenotype of a 
mirror carp (E). 
 
 
 
 
 
 
 
 
 
 
 
 
3.2.2.5. Fgfr1a morpholino knock-down 
 
Because both Fgfr1aW671STOP and Fgfr1aR705H (spd) might have some residual activity, 
I decided to examine the early role of the gene through morpholino knockdown. I have used 3 
independent translation blocking morpholinos, two of which were described earlier in the 
literature (Scholpp et al. 2004) (Thummel et al. 2006) (Fig. 3.8 A). In all morpholinos, no 
transcriptional changes were detected using pax2a, pea3, sprouty4, erm or fgf8 probes at 28 
hpf (some shown in Fig 3.8 B). Testing their blocking potential on fusion protein constructs 
showed that they could effectively inhibit Fgfr1a-GFP production during gastrulation (Fig. 3.8 
C). All of these morpholinos did affect the rate of development and caused some cell death in 
the area of MHB fold in over 90% percent of injected embryos at one day post fertilization 
(Fig. 3.8 D).  
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Figure 3.8 Fgfr1a morpholino design and analysis of phenotypes 
Three translation blocking morpholinos were used in this study (A). Two were known published ATG and 
5’UTR blockers. Neither of morpholinos affects MHB marker gene expression (B). Both published 
morpholinos blocked Fgfr1-EGFP fusion protein synthesis (C). Both morpholinos showed similar 
morphological phenotype, scattered cell death in the region of the brain, MHB reduction and condensed 
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somites (D). For morpholino sequence information see Appendix 5.5. 
 
3.2.2.6. Novel Fgfr1 – Fgfr1b 
 
The unexpected lack of phenotype upon Fgfr1 loss of function as compared to the 
severe phenotypes observed in mouse, Xenopus and Medaka could be explained by the 
compensatory activity of Fgfr1 gene found in the new assembly of zebrafish genome (Zv7) on 
LG10 in location 34,518,886-34,590,597 (Nicolas Rohner, personal communication). On 
protein level the second Fgfr1 shows 82% identity at core to the already described one, and 
only the very N- and C-terminus are significantly divergent (see Appendix 5.1 for protein 
alignment). Thus, in the following these two genes will be regarded as paralogous Fgfr1a and 
Fgfr1b. I have cloned the full-length cDNA of Fgfr1b and analyzed its expression as already 
shown in the expression pattern section of this chapter. I could show that Fgfr1b is expressed 
during early development and that Fgfr1a and b are expressed in a strikingly similar pattern, 
which supports the notion that they have redundant functions.  
 
3.2.2.7. Morpholino knock-down of Fgfr1b 
 
The morpholino for splice blocking of Fgfr1b was designed and kindly provided by 
Nicolas Rohner. The effectiveness of this morpholino was tested on RT-PCR amplification of 
the fragment encoding both flanking exons (Fig. 3.9 A). 0.4 mM morpholino dose leads to full 
retention of the intron, which in turn introduces a premature stop codon in the transcript. 
Nevertheless, when injected into the wildtype eggs, it did not cause any obvious phenotypes 
at early stages of development, except for some tail growth defects in selected few individuals 
(Fig. 3.9 B).  
Figure 3.9 Fgfr1b 
morpholino design and 
analysis of phenotypes 
Splice blocking morpholino 
targeting splice donor site 
between Exon 1 and intron 1, 
works and leads to full intron 
retention at 0.4 mM 
concentration (A). The 
phenotype is very mild, 
leading to subtle tail growth 
defects (B). For morpholino 
sequence information see 
Appendix 5.5. 
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3.2.2.8. Fgfr1a and Fgfr1b are involved in posterior mesoderm 
development 
 
In order to test for possible redundancy of the two variants of fgfr1 genes, I decided to 
interfere with the expression of both fgfr1 genes simultaneously. To this end I have injected 
fgfr1b morpholino into the maternal zygotic Fgfr1aW671STOP mutant embryos. Interestingly, 
double knockdown embryos developed progressively reduced tails and trunk. The 
phenotypes could be divided into 3 classes of severity, shown on Figure 3.10. Further 
investigation by in situ hybridization revealed that mzFgfr1aW671STOP/fgfr1b MO morphants 
indeed lose mesoderm tissue (myoD, Fig 3.10 B). While neither mzFgfr1aW671STOP nor Fgfr1b 
morphants alone show such phenotype. The brain segmentation and the MHB seems not 
disturbed (krox20, pax2a) upon Fgfr1 a and b loss of function (Fig. 3.10 B). This phenotype 
suggests redundancy between Fgfr1a and b during early mesoderm development. Moreover, 
observed phenotype may reflect only partial Fgfr1a and b loss of function, because splice-
blocking fgfr1b morpholino does not target maternally provided RNA and I cannot rule out 
residual activity of the Fgfr1aW671STOP protein.  
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Figure 3.10 Fgfr1a and  Fgfr1b double loss of function analysis 
MzFgfr1W671STOP mutant embryos injected with fgfr1b morpholino show three classes of phenotypes, 
which display progressive loss of posterior structures, grouped into three classes of severity (A). MyoD 
expression shows relative loss of mesodermal precursors in the tail. Other markers such as pax2a and 
krox20 do not differ in morphants (B). The experiment was performed several times and quantified once 
(C, D). 
 
3.2.3. Trafficking of Fgfr1a 
3.2.3.1. Cloning and testing Fgfr1a-GFP/RFP fusion proteins 
 
Elucidating the function of the receptor in Fgf8 signaling and endocytosis involves 
imaging the subcellular localization and trafficking of the receptor complex. In order to enable 
observations of Fgfr in vivo, I cloned several fusion protein constructs of Fgfr1a with mRFP or 
EGFP (Fig. 3.11).  
 
 
Figure 3.11 Fgfr1a fusion protein constructs  
Schematic representation of the Fgfr1a-eGFP (A), Fgfr1a-mRFP (B), and eGFP-Fgfr1a fusion protein 
constructs. Signal peptide predicted with SignalP online tool (see the list of website). 
 
For cloning of Fgfr1a-EGFP C-terminal fusion protein I used both vector and linker 
(20 amino acids), which were reported to result in a functional EGFR-GFP fusion protein 
(Wouters and Bastiaens 1999). As EGFR share many structural similarities with Fgfr, I 
assumed both EGFP fusions could have similar properties (Fig. 3.11 A). Fgfr1a-RFP was 
cloned in a similar fashion, just with a very short 2 amino acid linker (Fig. 3.11 B).  
The N-terminal fusion was obtained by subcloning EGFP fragment between a 
predicted 22 amino acid long signal peptide and the rest of the Fgfr1a sequence, separated 
by a 6 amino acid linker on each side (Fig. 3.11 C). 
All fusion protein constructs resulted in production of fluorescent proteins upon 
injection of in vitro synthesized mRNA into one-cell stage embryos (experimental setup for all 
colocalization experiments is depicted on Figure 3.12). All fusion proteins localized to the 
plasma membrane and many vesicular structures of varying morphology as indicated by the 
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overlap with membrane markers, such as GPF-GPI and mRFP-GPI (green fusion proteins 
shown in Fig. 3.13).  
 
Figure 3.12 Scheme of colocalization experiments 
setup 
Colocalization experiments start with injection of two 
mRNAs into one-cell-stage embryos, coding for both 
Fgfr1-FP and a marker (A). At late blastula stages 
(sphere) embryos are imaged at the animal pole (B). For 
the optimal resolution, embryos are imaged at the level of 
first few cells deep (C). 
 
 
Figure 3.13 Fgfr1-RFP and GFP-Fgfr1 localize into membranous structures 
Both n-terminal EGFP-Fgfr1 fusion protein (A) and a c-terminal fusion Fgfr1-EGFP (B) largely overlap 
with the membrane marker RFP-GPI. Much of the protein is present in the plasma membrane. Majority, 
however, appears in numerous vesicles inside the cells and a dispersed cytoplasmic staining. Fgfr1-
RFP displays identical localization (not shown here).  
 
I next tested the biological activity of the fusion protein by overexpression and 
detection of Fgf target gene expression. Overexpression of the wildtype fgfr1a even at high 
levels (400 pg) does not cause any phenotype. Fgf target gene expression and the 
progression of gastrulation remain the same. I tested, therefore, whether the Fgfr1a fusion 
constructs behave similarly upon overexpression (Fig. 3.14). At lower injection doses (100 pg) 
Fgfr1a-mRFP does not cause any phenotype. However, when the injection dose was 
increased up to 200-400 pg, Fgfr1a-RFP and other fusions cause ectopic induction of Fgf 
target genes (Fig. 3.14). 
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Figure 3.14 Ectopic activation of Sprouty 4 upon Fgfr1GFP overexpression 
Overexpression of Fgfr1-FP proteins results in a dose dependant ectopic activation of Fgf target genes, 
such as Sprouty 4 during gastrulation.  
 
3.2.3.2. Fgf8 is taken up by Fgfr1a overexpressing cells 
 
To test whether Fgf8 endocytosis can be mediated by Fgfr1a I performed a 
transplantation assay in zebrafish embryos at blastula stages (Fig 3.15). The host embryo 
was injected at one cell stage with Fgf8-GFP RNA. The donor embryo was overexpressing 
Fgfr1a-RFP. At sphere stage single cells were transplanted into the host embryos and the 
uptake of Fgf8-GFP into Fgfr1a-RFP expressing cells was measured. As a control for 
receptor mediated uptake, secreted-GFP, which should be Fgfr1a independent, was used. 
Fgfr1a-RFP cells were readily taking up Fgf8-GFP and both markers were found in 
overlapping punctae inside cells (Fig 3.15 A). In comparison, little secreted-GFP uptake was 
observed (Fig 3.15 B).  
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Figure 3.15 Fgf8 is endocytosed in association with Fgfr1 
Cells overexpressing Fgfr1-RFP, when transplanted into Fgf8-GFP expressing host embryo, readily 
uptake the ligand from the extracellular matrix. Punctae of Fgf8 inside transplanted cells overlap with 
Fgfr1 positive endosomes (B). Control transplantation into a host embryo expressing secreted GFP 
does not show such uptake or colocalization (C). Scale bars 25 µm. 
 
3.2.3.3. Fgfr1a shows partially overlapping subcellular distribution 
with endosomal markers 
 
I took advantage of a possibility of imaging zebrafish embryos during gastrulation 
period, at about sphere stage. In each experiment, I coinjected RNA for an endosome marker 
(100-200 pg) and Fgfr1a-RFP (200 pg) or Fgfr1a-GFP (200 pg) and imaged embryos at late 
blastula at the animal pole using confocal microscopy. Although Fgf8 is expressed only at the 
margin Fgf1 is already expressed ubiquitously. Because at late blastula Fgf target genes are 
expressed almost ubiquitously I interpreted measured embryos as representative of a steady 
and low signaling state of the Fgfrs (Figure 3.16). 
Fgfr1a partially colocalizes with Rab5c and Cellubrevin, both of which label small, 
early endosomes in clathrin dependent endocytosis. About 30-40% of intercellular receptor 
punctae colocalize with either of the two markers (Figure 3.16 A,E). Cellubrevin labels also 
part of the fast recycling endosomes (McMahon et al. 1993). A low level of overlap with 
caveolin marker (Figure 3.16 C) shows that Fgfr1a can be endocytosed through both CDE 
and NCE.  
Fgfr1a was also found to largely overlap with Rab7 (Figure 3.16 B) – a marker of late 
endosomes suggesting progression of the cargo towards lysosomal degradation. These 
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endosomes were also morphologically distinct, bigger and often located at the periphery of 
the nucleus.  
 
Marker % overlap P-value Morphology 
Rab5 39,7% 0,0002 small periferal endosomes 
Rab7 38,3% 1,9E-05 large perinuclear endosomes 
Caveolin 20,1% 0,0009 subcortex membrane invaginations 
Rab11 1,4% 0,2 small periferal endosomes 
Cellubrevin 29,9% 2E-06 small periferal endosomes 
Table 7. Estimation of average overlap of Fgfr1a-RFP and endocytic markers 
The values in the table are an approximation derived from manual counting all Fgfr1a-RFP and co-
localized punctae in cells, n=7. Morphology of endosomes based on size and subcellular localization. P-
value calculated in a two-tailed paired t-test. The p-value of Rab11 suggests that the amount of 
observed overlap is statistically insignificant. 
 
In attempt to estimate the extent of receptor recycling at a steady state Rab11-GFP 
was used together with Fgfr1a-RFP (Fig 3.16 D). Unfortunately, the nature of recycling 
endosomes, being very small and extremely close to the cell membrane, made it difficult to 
truthfully judge the extent of colocalization. The amount of observed overlap with the Rab11 
punctae deeper in the cell is statistically insignificant, however the population at the cell cortex 
was not optically resolvable from the membrane in vivo. In order to more precisely assess the 
amount of recycling, one would need to create a recycling assay on dissociated zebrafish 
cells.  
 
Figure 3.16 Fgfr1a is present in many types of endocytic vesicles 
Fgfr1a can be found overlapping with early endosomes (Rab5, Cellubrevin in A and E) of clathrin 
dependent endocytosis. It is to a lesser degree found also in caveolae (C), mostly close to the 
membrane. Fgfr1aRFP is also largely overlapping with Rab7 positive late endosomes (B). In contrast, 
there is almost no overlap with Rab11 recyccling endosomes (D). Scale bar 25 µm. 
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3.2.3.4. Fgfr1a Antibody 
 
None of the commercially available FGFR1 antibodies works for detection of 
zebrafish Fgfr1a. In order to visualize endogenous expression of the Fgfr1a protein I decided 
to produce custom-made peptide antibody against fish protein (using the service of 
Eurogentec). The peptides were designed in the areas of greatest polymorphism between all 
Fgfr receptors  (see Appendix 5.2 for Fgfr1-4 protein alignment), and with the greatest 
antigenicity prediction (see websites list for the URL of the used prediction algorithm). The N-
terminal peptide antibody (LQSQGRAIQDEAPAE) should recognize the protein on the 
extracellular side and the C-terminal peptide antibody should detect cytoplasmic end of 
Fgfr1a (CKFPPHPNRGVAFKKR).  
Four isolated purified anti-sera were tested and only one of them resulted in the 
detection of bands of predicted Fgfr1a size (100 kDa) on a Western Blot. The specificity of 
this antibody is confirmed by the detection of the over expressed fusion protein as well as 
endogenous truncated protein in Fgfr1aW671X mutant embryos (Figure 3.17). However, the 
antibody may detect also other Fgfrs, because in Fgfr2L545STOP (mutant fish strain described 
later) samples it detected smaller protein products. Despite many trials in various conditions I 
did not get a reliable signal on whole mount staining. Overall, the antibody could be used only 
in biochemical experiments from embryos extracts and was not used in colocalization 
experiments due to low affinity to fixed tissue.  
 
 
 
Figure 3.17 Fgfr1 antibody 
Two Western Blots on whole embryo lysates show detection of Fgfr1 at about 110 kDa and presumably 
other Fgfrs. The lanes 1-5 represent: 1 – wildtype, dome stage, 2 – wildtype dome stage, 3 - wildtype 24 
hpf, 4 - huFgfr1W671STOP 24 hpf, 5 – huFgfr1W671STOP 24 hpf, 6 – huFgfr2L545STOP 24 hpf. At 24 hpf, a 
shorter Fgfr1 isoform is produced, which is probably analogous to human Fgfr1IIIa secreted isoform. 
The predicted sizes of Fgfr1W671STOP and Fgfr2L545STOP are of 75 kDa and 60 kDa, respectively. The new 
Fgfr1 antibody recognizes Fgfr1 and additional bands in Fgfr2 mutant, suggestive possible incomplete 
specificity. 
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3.2.3.5. Fgfr is ubiquitylated in vivo in gastrulating zebrafish 
embryos 
 
Ubiquitylation is a progressively well understood type of posttranslational protein 
modification, which allows directing the substrate to degradation, regulating its trafficking in 
the cell or its activation (Haglund and Dikic 2005). The extent of receptor ubiquitylation may 
have an effect on the speed of Fgfr endocytosis and degradation.  
In order to examine the extent of Fgfr ubiquitylation in vivo I performed 
immunoprecipitation. Two hundred embryos per sample were either lysed at sphere stage 
and used for pull-down with Fgfr1a antibody (described above) or dissociated and treated with 
a pulse of high concentration recombinant Fgf8 (100 ng/µl) prior to lysis and pull-down. 
Subsequently, Ubiquitin moieties were detected on a Western Blot with resolved Fgfr1a IP 
samples. I could detect high molecular complexes of Fgfr1a-Ub, which intensified upon 
additional Fgf8 pulse (Fig. 3.18 A). Similar pattern of band was obtained, when Fgfr1a-myc 
and HA-ubiquitin constructs were injected into tested embryos, Myc antibody used for pull-
down and HA antibody for Ub detection on a Western Blot.  
 
Figure 3.18 Fgfr1 is ubiquitylated in 
vivo in gastrulating embryos 
Immunoprecipitation on extracts from 
embryos at shield stage (A). Lanes 1 
and 2 represent pull-down of Fgfr1 
from dissociated embryos with newly 
produced antibody and detection of 
Ubiquitin (Ub) on Western blot. For 
lanes 3 and 4, cells were incubated in 
100 ng/ml recombinant Fgf8 for 30 
mins. Higher molecular weight chains 
of ubiquitin are detected. Lane 5 
represents a pull down from embryos 
expressing Fgfr1-myc and HA tagged 
Ubiquitin. Immunoprecipitation was 
performed with use of α-myc antibody, 
Western Blot detection was carried out 
using α-HA antibody. Panel B shows 
in situ hybridization with Sprouty 4 
probe to assess the influence of 
ubiquitin and ubiquitin 4KR 
overexpression in gastrulating 
embryos. An insignificant upregulation 
of Sprouty 4 was detected only upon 
Ub4KR overexpression. 
 
 
Knowing that ubiquitylation modifies Fgfrs in vivo, I tested the requirement of this 
modification for correct Fgf8 signaling in the early embryos. Overexpression of wildtype 
Ubiquitin does not affect the range of target gene induction. Ub-4KR is a mutant form of 
Ubiquitin, which blocks formation of the polyUb chains because it lacks lysines required for 
chain attachment of other moieties. I used mRNA coding for Ub4KR to examine the relation 
between ubiquitylation and Fgf8 signaling (Fig. 3.18 B). Overexpression of the mutant 
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Ubiquitin, Ub-4KR, results in a slight upregulation of Sprouty 4 induction, which should be 
quantifiable with qPCR analysis.  
 
3.2.3.6. Cloning of endocytosis deficient Fgfr1a mutant versions 
 
Assessing the role of receptor endocytosis in its signaling function requires 
decoupling of the two processes. In order to inhibit receptor endocytosis but retain signaling 
ability I cloned two mutant Fgfr1a constructs, which were studied in tissue culture and fulfilled 
these criteria in vitro (Sorokin et al. 1994) (Fig. 3.19). Both, truncation of the carboxyterminal 
domain by 58 amino acids as wells a sole point substitution Y766F in human protein (in fish 
Y753) resulted in 90% inhibition of Fgfr1 uptake but not signaling via MAPK pathway.  
Because Y753 (mouse Y766) is directly interacting with PLCγ, this pathway is not 
active in the context of mutant receptor. It is still unclear what is the in vivo function of the 
PLCγ signaling in Fgf signaling during embryonic development. The structural nature of the 
mutant Fgfr1 overexpression constructs cloned for use in zebrafish embryos is depicted on 
Fig. 3.19 A.  
3.2.3.7. Expression of Fgfr1a Y753 mutants in embryos reduces 
Fgf8 endocytosis 
 
In order to investigate whether mutant Fgfr1a causes similar reduction of endocytosis 
as in tissue culture, I injected Fgfr1a mutant RNA together with a membrane marker into the 
host embryo and implanted an Fgf8Cy5-soaked bead into the animal pole at sphere stage. In 
a time-course experiment, the punctae inside and outside of the cells were counted and 
compared after normalization. For statistical analysis I have counted punctae within whole 
frames, meaning all cells close and far from the source. Punctae overlapping with the 
membrane marker on a border of cells were considered “outside of cells”, whereas punctae 
observed within cell boundaries, were counted as “inside cells”.  
The uptake of Fgf8 is reduced noticeably but not dramatically in both mutants, 
however, it recovers and reaches almost normal levels at a steady state (after about 2h) (Fig 
3.19 B). Due to differences between embryos and brightness of the beads the standard error 
of the mean is relatively high, making the observed differences significant only at a level of 
90%. The variance can be also caused by small differences in the protein overexpression in 
the host embryos. Both mutants display decreased endocytosis rate, however, the rate of 
trafficking and more detailed analysis of receptor degradation remains to be investigated. 
Figure 3.19 Overexpression of mutant Fgfr1 inhibits Fgf8 endocytosis 
Two mutant versions of Fgfr1 were cloned in order to decouple endocytosis and signaling of Fgfr1 (A). 
Tyrosine Y753 was either replaced by phenylalanine or removed along with the c-terminal tail (bold 
font). Fgf8Cy5 coated beads were implanted at sphere stage into the animal pole of embryos 
overexpressing membrane marker and Fgfr1 versions (B). Panels C and D show representative pictures 
of the Fgf8Cy5 uptake experiments. Fgf8 released from the bead diffuses and is endocytosed by the 
cells outlined by the membrane marker RFP-GPI. The cells expressing wildtype receptor rapidly uptake 
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Fgf8. Cells overexpressing mutant Fgfr1 endocytose Fgf8 with a delay. Scale bar 20 µm. The time 
course experiments of Fgf8 uptake are quantified on panel E, error bars = SEM.  
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3.2.3.8. Endocytosis deficient Fgfr1a cause expansion of Fgf 
target gene expression 
 
The restrictive clearance model assumes that inhibition of the receptor-dependent 
endocytosis should allow further diffusion of Fgf8 and effectively an expansion of target gene 
induction. To study the effect of mutant Fgfr1a overexpression on the Fgf target gene 
expression I injected 200 pg mRNA of each mutant construct and developed an in situ 
hybridization for target genes at 80% epiboly. Indeed, both Fgfr1Y753STOP and Fgfr1Y753F cause 
an expansion of sprouty 4 and pea3, however, to drastically different levels. Where 
Fgfr1Y753STOP causes only a slight upregulation, Fgfr1Y753F results in complete ectopic 
activation of sprouty4 and pea3 (Figure 3.20 A). Such differences are not reflected by the 
ligand uptake assay.  
 
Figure 3.20 Mutant Fgfr1 causes Fgf target gene expansion 
Overexpression of mutant Fgfr1 versions causes expansion of both short and long-range Fgf target 
genes (A). Fgfr1Y753STOP causes a very small change (in order of 2-3 cell diameters). Fgfr1Y753F causes a 
dramatic expansion of both sprouty 4 and pea 3. Transplantation of cells expressing Fgfr1Y753F into the 
animal pole of wildtype embryos shows that there is no Fgf target activation in the clone (n = 24 clones 
of about 20-30 cells each), hence activation is dependent on the neighboring cells (i.e. is not cell 
autonomous, probably ligand-dependent) (B).  
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In order to understand the mechanism of Fgfr1Y753F mediated activation of Fgf 
signaling I tested ligand-dependency of Fgfr1Y753F. Cells expressing mutant receptor were 
transplanted into the wildtype embryo into the ventral side of the animal pole, where 
endogenous Fgf8 does not reach. My results indicate, that the cells in the clone (n = 24 
clones) do not express Fgf target gene sprouty 2, which points to the ligand dependent 
mechanism of receptor hyperactivation (Fig. 3.20 B). 
 
3.3. Analysis of Fgfr2  
3.3.1. Expression of Fgfr2 
 
The transcript of Fgfr2 is first detected at 90% epiboly as a weak domain in the 
paraxial mesoderm (not shown). At tailbud stage an additional domain can be detected in the 
forebrain and midbrain. At 5 and 6 somites expression becomes stronger in optic vesicles and 
midbrain (Fig. 3.21 A). As segmentation progresses more distinct sub domains in mid- and 
hindbrain specify and the paraxial mesoderm domain extends with increasing number of 
somites. Posterior part of the body is completely devoid of Fgfr2. The somitic expression of 
Fgfr2 disappears after 15 ss stage and stays only in the ventral mesenchyme (Fig. 3.21 B). 
The expression in the eye is now restricted to the developing lens.  At 24 hpf, Fgfr2 is strongly 
expressed in lenses, diencephalon, anterior midbrain and in several segments of the 
hindbrain, including R1, R4 and R6 (Fig. 3.21 B). Beyond one day during larval stages the 
transcript can be only detected in the area of the head and pectoral fins.  
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Figure 3.21 Expression pattern of Fgfr2 
Fgfr2 transcript is found at the onset of somitogenesis and is expressed in forebrain, midbrain, and 
paraxial mesoderm. Between 5 and 10 somites stage it is transiently strongly expressed in the optic 
vesicles (A). Later this expression is reduced to the lens only. Staining in the paraxial mesoderm 
disappears by 15 ss and persists only in the ventral mesenchyme. During somitogenesis Fgfr2 is 
expressed also in distinct patches in the hindbrain. By 24 hpf the expression in the hindbrain is restricted 
to rhombomeres 1,4 and 6 (B). Abbreviations: f – forebrain, h – hindbrain, m – midbrain, mes – ventral 
mesenchyme, ov – optic vesicle, pm – paraxial mesoderm, R – rhombomeres, t – tectum, vt – ventral 
telencephalon. 
 
3.3.2. Fgfr2 mutant zebrafish 
3.3.2.1. Characterization of the mutant protein 
 
We have isolated one mutation in Fgfr2 in the TILLING screen (Fig. 3.22). The 
mutation Fgfr2L545STOP is located in the first of split tyrosine kinase domains. The protein 
product arising from such mutation would lack kinase activation Y650/Y651 residues, the 
ATP-binding pocket and all downstream regulatory elements.  
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Figure 3.22 Fgfr2 TILLING 
mutant 
Mutation found in Fgfr2 is an 
early truncation, which should 
render the receptor dominant 
negative (A). The genetic 
context and the nature of 
mutations is summarized in a 
panel of chromatogram traces 
(B). 
 
 
 
 
I tested the expression of endogenous Fgfr2 in mutant larvae and wildtype siblings by 
in situ hybridization (Figure 3.23 A). I found that Fgfr2 transcript was strongly downregulated. 
It would be interesting to see a quantitative measurement of this downregulation in a Q-PCR 
experiment.  
 
 
Figure 3.23 Fgfr2L545STOP 
mutant analysis 
Homozygous Fgfr2L545STOP 
embryos (here 36 hpf) show 
much weaker Fgfr2 
expression, suggestive of 
RNA non-sense mediated 
decay (A). Fgfr2 expression 
construct, Fgfr2L545STOP, acts 
in a dominant active way, 
blocking all Fgf target gene 
expression (B). 
 
 
Also, overexpression of the cloned mutant construct Fgfr2L545STOP completely blocks 
Fgf target gene induction, similar to XFD (Figure 3.23). Both experiments suggest a strong 
Fgfr2 loss-of-function in Fgfr2L545STOP mutant homozygotes. 
 
3.3.2.2. Preliminary analysis reveals a role of Fgfr2 in growth, 
fertility and adult bone ossification 
 
Surprisingly, homozygous mutant embryos and larvae show no phenotypes that could 
be expected in connection with Fgfr2 expression pattern. None of the tests concerning 
development of brain or facial skeleton showed any abnormalities (Figure 3.24). Fgfr2 plays 
an early and essential role in mouse development. Mouse Fgfr2 knockout embryos die at 
preimplantation presumably due to failure in development of the placenta (Arman et al. 1998). 
Even though zebrafish develops ex utero I was expecting early defects also in homozygous 
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Fgfr2L545STOP zebrafish due to reports on conditional Fgfr2 knockout phenotypes in mouse (Yu 
et al. 2003).  
 
Figure 3.24 Larval pharyngeal region in Fgfr2L545STOP 
Larvae of Fgfr2L545STOP +/- incross develop normally, at 
least in the first week. Some developmental delay is 
observed but not very significant. Pharyngeal arches and 
jaws develop normally compared to wildtype siblings. 
 
 
 
 
 
 
 
 
Nevertheless, the adult homozygous fish (at least two months old) were found 
significantly smaller then their heterozygous or wildtype siblings (Figure 3.25 A-E). The fish 
survived well (see genotyping statistics in Table 4) but were on average 27% shorter. The 
penetrance of this phenotype was close to 100% independent of the genetic background (wt 
strain), which allowed detecting homozygous mutants based on reduced size. Homozygotes 
were also unable to mate (lay eggs or fertilize eggs). 
 
Date Cross Mutant 
dCA
Ps 
No. 
finclips WT Heterozygotes Homozygotes 
04.12.07 
incross hets 
(WIK) Fgfr2L545STOP BfmI 45 13 (28,8%) 23 (51,1%) 9 (20%) 
04.12.07 
incross hets 
(AB) Fgfr2L545STOP BfmI 44 13 (29,5%) 25 (55,5%) 6 (13,3%) 
Table 8 Genotyping statistics for TILLING mutant line Fgfr2L545STOP 
 
Live homozygous fish generally had bent or wavy AP body axis with signs of 
kyphosis, i.e. curvature of the upper (thoracic) spine. Interestingly, the pathological body 
shape seems to progress with the age of fish (not shown). Therefore, homozygous 
Fgfr2L545STOP fish were stained in alizarin red for visualizing internal skeleton. Homozygotes 
display a combination of skeletal phenotypes summarized in Figure 3.25 F-M. The skulls of 
mutant fish are shorter and the position of cranial sutures is shifted to the posterior side (Fig. 
3.25 F,J). Neural spines of mutant fish are shorter and bent backwards, whereas ribs and 
anterior dorsal radials appear thinner and wavy (Fig. 3.25 H,L). The shape of the spine is 
slightly bent in the mutant fish and the hypural arches, which connect spine and tail fin, are 
thicker and disarrayed compared to the wildtype siblings (Fig. 3.25 I,M).  
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Figure 3.25 Adult phenotypes of Fgfr2L545STOP 
Adult fish in Fgfr2L545STOP incrosses vary in size. Wildtype siblings (A) and heterozygotes (B) reach over 
2 cm body length, whereas homozygous mutant fish (C, D) are on average 5 mm smaller (27%) (E), n = 
34. Alizarin red skeleton staining reveals abnormal ossification in the homozygous mutant fish 
(G,I,K,M,O) compared to their wildtype siblings (F,H,J,L,N). The mutant fish have kyphosis (G), thin and 
wavy ribs, r, and anterior dorsal radials, adr (M,O), thick and curled neural spines, ns, and hypural 
arches, ha (K). The skull appears shorter, as if all facial bones where compressed together (I).  
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3.4. Analysis of Fgfr3 
3.4.1. Expression of Fgfr3 
 
Fgfr3 transcript is first detected at tailbud stage in the prospective diencephalon and 
the anterior hindbrain. During somitogenesis it is found in distinct domains in the 
diencephalon, anterior hindbrain, anterior spinal cord, axial mesoderm and tailbud (Fig. 3.26). 
At 24 hpf Fgfr3 gets restricted to diencephalon, strong expression in the R1 and the anterior 
spinal cord. It is weakly expressed in the dorsal posterior hindbrain. It also persists as a small 
domain in the tail fin. 
 
Figure 3.26 Expression pattern of Fgfr3 
During somitogenesis (5 ss) several domains form in the anteriormost forebrain, in presumptive 
diencephalon, anterior hindbrain, anterior spinal cord and tailbud. Expression persists until 24hpf, with 
some transient axial mesoderm during midsomitogenesis. At 24 hpf Fgfr3 is expressed strongly in 
diencephalon and rhombomeres one. Expression in the posterior hindbrain is weak, while it is stronger 
in the anterior spinal cord. Some cells in the tail bud also form a small Fgfr3 domain. Abbreviations: at – 
anterior telencephalon, d – diencephalon, h – hindbrain, R1 – rhombomere 1, sc – spinal cord, tb – 
tailbud.  
 
3.4.2.  Fgfr3 knockdown 
We did not find any non-sense or interesting mis-sense mutations in Fgfr3 gene in the 
TILLING screen. I have designed two Fgfr3 translation blocking morpholinos, however, 
neither of them evoked any early developmental defects. It would be necessary to verify the 
effectiveness of these morpholinos in order to draw any conclusions. It would be greatly 
interesting to induce Fgfr3 knockdown, because of many functions associated with this gene 
in higher vertebrates (Colvin et al. 1996; Horton et al. 2007).  
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3.5. Analysis of Fgfr4 
3.5.1. Expression of Fgfr4 
 
Expression of Fgfr4 is first detected as a ubiquitous staining at blastula stages, shortly 
prior gastrulation. At the onset of gastrulation Fgfr4 transcript can be found everywhere 
except the marginal zone (Fig. 3.27 A). At about 70% epiboly the uniform staining on the 
dorsal side starts showing a gap of expression at the level of prospective posterior hindbrain 
and midline (notochord). At bud stage expression is already restricted to prospective 
midbrain, anterior hindbrain and the paraxial and lateral mesoderm. 
During somitogenesis three domains in the anterior part of the embryo can be 
distinguished (Fig. 3.27 B). They are equivalent, according to (Thisse et al. 1995), forebrain 
(diencephalon), anterior dorsal hindbrain (R1-3) and anterior spinal cord with stripes of lateral 
mesoderm on the sides. Later in somitogenesis, there is also a prominent expression in the 
posterior part of the somites and the posterior spinal cord and the more caudal and ventral 
groups of cells in the growing tail. At 24hpf Fgfr4 can be detected in the ventral 
telencephalon, diencephalon, tectum of the midbrain and the dorsal part of the anterior 
hindbrain, at the level of R1-3 (Fig. 3.27 C, D).  The transcript can be also more faintly 
detected in the anterior spinal cord in the posterior stripe beginning at the level of R7 (Figure 
3.27)  
At later stages between 36-48h low levels of Fgfr4 are present also in some 
progenitors of the heart, ear, lens, pectoral fin and branchial arches (not shown).  
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Figure 3.27 Expression pattern of Fgfr4 
Fgfr4 transcript is first found at late blastula stages. At gastrulation it is present everywhere except the 
margin. From midgastrula stages two gaps in the expression appear at the dorsal midline and in the 
hypoblast at the level of prospective posterior hindbrain (panel A). During early somitogenesis, 
expression persists in posterior forebrain, anterior hindbrain, anterior spinal cord and lateral mesoderm. 
Later during somite formation Fgfr4 is also expressed in posterior spinal cord, notocord and most caudal 
mesoderm. At 24 hpf Fgfr4 transcript can be found in ventral telencephalon, dorsal diencephalon, 
tectum and first three rhombomeres of the hindbrain. Posteriorly, Fgfr4 is present in the distal tips of the 
spinal cord, caudal mesoderm and prospective pronephric duct. Abbreviations: ah – anterior hindbrain, 
asc – anterior spinal cord, cm – caudal mesoderm, d – diencephalon, dh – dorsal hindbrain, f- forebrain, 
lm – lateral mesoderm, pf – posterior forebrain, ppd - prospective pronephric duct, t – telencephalon, vt 
– ventral telencephalon.  
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3.5.2. Fgfr4 mutant zebrafish 
3.5.2.1. Fgfr4 TILLING knockout lines 
 
Among most promising mutant lines isolated from the TILLING library, we found two 
early nonsense mutations in Fgfr4. The genetic nature of both mutations is depicted on the 
Figure 3.28.  
 
Figure 3.28 Fgfr4 
TILLING mutants 
The two early non-
sense mutations in 
Fgfr4 are expected 
to induce complete 
loss-of-function of 
this gene (A). The 
genetic context and 
the nature of 
mutations is 
summarized in a 
panel of 
chromatogram 
traces (B). 
 
 
Due to the very 5’ location of the introduced stop codons, both Fgfr4R36STOP and 
Fgfr4Y46STOP should result in complete Fgfr4 loss-of-function. However, homozygosity of 
neither of them resulted in any developmental or adult phenotype, which would distinguish 
them from the wildtype or heterozygous siblings. The recovery of homozygous fish was 
around expected 25%. 
 In order to understand whether this lack of phenotype is due to a rescue by 
alternative transcript or redundancy with other receptors - as observed in mouse (Weinstein et 
al. 1998)), I decided to perform a 5’ RACE PCR to detect possible alternative transcripts. If, 
upon mutation, fish were able to produce another isoform of the gene, the early stop could be 
circumvented. Preliminary results show two forms of fgfr4 transcript (including 5’ UTR), one of 
which excluded first 4 exons and contained an in frame ATG codon downstream of the 
detected mutations (Fig. 3.29). This result has to be, however, confirmed by testing more 
individuals. 
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Figure 3.29 Fgfr4Y36STOP and Fgfr4R43STOP alternative transcripts 
5’ Race PCR (A) of Fgfr4 reveals that wildtype embryos (lane 1) produce only a long version of the 
transcript (2kB band), whereas Fgfr4Y36STOP and Fgfr4R43STOP (lanes 2 and 3) produce two forms of the 
transcript, long and short (600 kB), As checked by sequencing, shorter product starts downstream of 
both mutations, within exon 5, which includes an alternative start codon. Presumptive alternative protein 
structure is schematized in B. 
 
The presence of other high affinity Fgfrs may explain why Fgfr4 is actually not 
essential for early development. This hypothesis is, however, questionable in light of 
experiments with the use of Fgfr4 morpholino knockdown described below.  
 
3.5.2.2. Fgfr4 morpholino knock down 
 
In order to create embryos with Fgfr4 loss-of-function both translation and splice 
blocking morpholinos were designed and tested (Figure 3.30). Among splice blockers I have 
isolated one, which led to complete intron retention (see e8-i8/9 in Fig. 3.30 C). Such 
transcript includes a premature termination codon and the resulting protein stops after the 
second Ig domain (hence, also after the potential alternative start codon). The early 
phenotype (24h) is characterized by a slight developmental delay, cell death in the hindbrain 
and small eyes (Fig. 3.30 D). 
Subsequently all translation blockers were tested. The efficiency of MO ATG was 
assessed based on ability to block translation of injected Fgfr4-RFP, however, it caused 
developmental arrest (Fig. 3.30 C). MO 5’UTR showed phenotype similar to this of Fgfr4 MO 
e8, suggesting it being specific for Fgfr4 loss of function. 
To see whether the cell death in the hindbrain, which was quite extensive at higher 
doses of morpholinos, is really due to Fgfr4 loss of function or rather a morpholino toxicity 
problem, I coinjected Fgfr4 MO and p53 MO (Fig. 3.30 D).  This control is widely accepted as 
one way to detect morpholino toxicity and stress effects, which are triggering p53-dependent 
pathway to apoptosis (Robu et al. 2007). Coinjections led to a reduction of cell death in the 
brain, suggesting that it might be Fgfr4 independent (being rather a toxicity effect). Other 
phenotypes, such as small eyes, messy morphology of the hindbrain and fin growth defect 
were not rescued, which was confirmed for both 5’UTR and e8 morpholinos. 
 
Figure 3.30 Fgfr4 morpholino design and analysis of phenotypes 
Four morpholinos were designed to block donor splice sites in Fgfr4 gene (A). One of them, Fgfr4 MO 
e8/I8-9 showed complete retention of the intron leading to production of an alternative transcript, 
encoding a premature stop codon (A, B). Additionally, three translation blocking morpholinos were 
designed (C) and by phenotype similarity Fgfr4 MO 5’UTR1 was chosen. Both chosen morpholinos 
(termed e8 and 5’UTR from now on) caused highly similar phenotypes, best characterized at 24 hpf by 
small eyes and cell death in the hindbrain area. Coinjection of p53 morpholino coinjection reduced cell 
death greatly (D). Other observed Fgfr4 knock down phenotypes will be described below. For 
morpholino sequence information see Appendix 5.5. 
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3.5.2.3. Late phenotypes suggest pleiotropic involvement in 
organogenesis during early zebrafish development 
 
Young Fgfr4 morphants larvae develop complex phenotypes, which may arise 
partially as secondary effects of the Fgfr4 loss-of-function (Figure 3.31). Two-day-old larvae 
exhibit either hindbrain edema or irregular hindbrain morphology suggestive of segmentation 
defects. Morphant larvae have small eyes and edematous pericardial sac. Later in 
development the larvae fail to develop pectoral fins (strongly reduced in hypomorphic 
situation). The body axis is bent and the jaw is bent and displaced.  
Morpholino has a limited activity in developing embryos due to dilution of MO in 
dividing cells, and looking at later stages is almost certainly a very complex situation. For the 
clarity of analysis, I therefore decided to look at stages of gastrulation and segmentation, 
because late phenotypes are a combination of secondary effects due to early knockdown and 
specific late knockdown effects. Inspired by phenotypes during late organogenesis I focused 
mainly on pectoral fin and myotome development. In the following I will describe only the very 
early involvement of Fgfr4 in morphogenesis and tissue specification of the pectoral fins.   
 
Figure 3.31 Summary of early 
Fgfr4 loss of function defects 
A two-day larva injected with Fgfr 
morpholino develops hindbrain 
edema and small eyes. A four-day-
old larva shows a variety of defects 
including jaw development defects, 
small eyes and deformed or missing 
pectoral fins. Some individuals 
develop also bent body axis.  
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3.5.2.4. Fgfr4 is essential for pectoral fin field specification and fin 
induction 
 
Fgfr4 is very dynamically expressed during early development (see above). It is 
distinctly present during gastrulation in presumptive paraxial mesoderm while during early 
segmentation it is present in lateral mesoderm and somites. Expression of Fgfrs in mesoderm 
is likely important for the perception of Fgfs and connected fate decisions in the mesoderm 
and its derivative structures. Thus, Fgfr4 is a very good candidate for an early Fgf signaling 
marker of structures derived from lateral mesoderm.  
I analyzed fin development in Fgfr4 morphants at four stages of development (Fig. 
3.32). Firstly, I took 9-somite stage as an onset of the fin field specification (as labeled by the 
expression of the earliest fin field marker - tbx5). Secondly, at 20-somite stage, I looked again 
at tbx5 to control for potential delays in fin field specification. I then looked at 30 hpf embryos, 
when fins start to outgrow and the AER is specified and lastly, at 4 dpf to assess the overall 
morphology of the fins after Fgfr4 knockdown.  
Fgfr4 knockdown leads to a change in the tbx5 domain already at the stages when its 
expression first comes up i.e. 9 somites. Double ISH experiments with myoD, a marker of 
somitic muscle precursors, allowed assessing precisely the position of the labeled lateral 
mesoderm as compared to somite number.  At the 9 somites stage the lateral tbx5 expression 
demarcates presumptive fin (level of somites 1-3) and heart primordium (more anterior). 
Disruption of Fgfr4 leads to shortening of the tbx5 domain and the expression in the fin field is 
not recovered over time. Later in development at the time of fin induction AER is not specified 
(no dlx2a expression) and the fin bud is not formed (Figure 3.28). Consequently, many of the 
4-dpf morphant larvae (0.2 mM MO) develop either no fins or reduced fins, which may be due 
to incomplete Fgfr4 knockdown (higher morpholino injection doses, such as 0.4 mM MO, lead 
to complete loss of fins). 
 
  Two fins Reduced fins One fin No fins Total 
WT 42 0 0 0 42 
Fgfr4 MO e8 3 15 14 13 45 
Table 9. The distribution of fin phenotypes in Fgfr4 morphants 
 
 
Based on morpholino analysis Fgfr4 is likely to act upstream of Tbx5 at gastrulation or 
early segmentation stages. Fgfr4 expression in the lateral mesoderm at 5-somite stage 
supports this notion (Fig 3.27). The expression in the fin field persists only until about 20-
somites stage (Fig 3.32), where at later stages Fgfr1a and Fgfr2 can be found in outgrowing 
fins.  
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Figure 3.32 Fgfr4 in involved in fin field specification 
Fgfr4 knockdown results not only in defects of fin growth but also fin induction (A). Tbx5 identifies the fin 
field at around 10 somite stage. At this stage the posterior part of the lateral mesoderm domain (at the 
level of first 3 somites) seems to be weaker or gone in Fgfr4 morphants. This expression is not 
recovered later in development and leads to impaired fin induction. The AER does not develop as 
demonstrated by the dlx2a staining at 30 hpf. The expression of Fgfr4 in the lateral mesoderm at 
essential fin field specification stages complements the evidence of Fgf signaling at these early stages. 
A pool of embryos injected with Fgfr4 morpholino develop a range of fin reduction, which is probably due 
to partial mosaicism in efficiency of Fgfr4 knockdown (B). 
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3.5.2.5. Fgfr4 acts downstream of retinoic acid 
 
In order to determine the position of Fgfr4 in the cascade of genes specifying the fin 
field, I concentrated on the retinoic acid (RA) – the first morphogen required for fin 
specification. Inhibition of retinoic acid signaling during gastrulation and segmentation leads to 
complete loss of fins. Therefore, I examined the expression of Fgfr4 upon RA inhibition using 
DEAB inhibitor (10-5 M) in the timeframe between 30% epiboly and fixation time (TB, 5 or 10 
somites).  
Surprisingly, preliminary data show a dramatic change in fgfr4 expression, which may 
be due to different proportions between tissues specialized upon RA signaling. At tailbud 
stage, the hindbrain domain of fgfr4 is expanded, which is consistent with previous reports 
concerning hindbrain patterning by RA (Maves and Kimmel 2005). In contrast, the 
mesodermal domain of fgfr4 expression is significantly shorter, which suggests that RA is 
required for establishment of the pool of mesoderm (Fig 3.33 A-D). This has to be, however, 
verified by co-labeling with mesodermal markers.  
Consistently, at 5 and 10 ss, upon DEAB treatment, fgfr4 expression in the hindbrain 
is enlarged and fused with the spinal cord domain. Anterior spinal cord domain is much 
weaker and lateral mesoderm domains seem to be strongly reduced compared to the wildtype 
(Fig 3.33 E-H). The staining in the posterior halves of somites (paraxial mesoderm) is also 
downregulated. Taken together, fgfr4 expression shifts upon DEAB inhibitor treatment 
suggest that it acts downstream of retinoic acid in the fin field specification.  
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Figure 3.33 Fgfr4 acts downstream of retinoic acid 
Embryos treated with DEAB inhibitor between 30% epiboly and tailbud show shifts in Fgfr4 expression. 
At tailbud mesoderm domain appears much reduced, whereas hindbrain domain expands (A-D). At 5 
and 10 somites hindbrain domain fuses with the spinal cord domain, whereas the lateral mesoderm 
expression cannot be seen any longer. Also the staining in the posterior part of the somites appears 
downregulated in DEAB treated embryos (E-H). Abbreviations: Asp – anterior spinal cord, D – 
diencephalon, H – hindbrain, LM – lateral mesoderm, numbers stand for first 5 somites, asterisks 
demarcate the level where lateral mesoderm domain is missing. Fluorescein probes (in red) demarcate 
adaxial mesoderm (myoD) and rhombomeres 3 and 5 of the hindbrain (krox20). 
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4. Discussion  
4.1. Fgfr1a mutant lines 
 
In mouse, the role of FGFR1 has been extensively studied in multiple conditional 
knockout approaches. FGFR1 loss-of-function leads to abnormal gastrulation and embryonic 
lethality due to mesoderm and midline defects (Deng et al. 1994; Yamaguchi et al. 1994). 
Through conditional knockout techniques FGFR1 was shown to play role in mesoderm 
migration, somitogenesis, limb growth, neural crest migration, skeletal development and 
neuronal differentiation at the midbrain-hindbrain boundary (MHB) (Ciruna et al. 1997; 
Partanen et al. 1998; Trokovic et al. 2003; Trokovic et al. 2005; Jukkola et al. 2006). 
In contrast, medaka headfish mutant, encoding a dysfunctional Fgfr1aW181C, Fgfr1 
loss-of-function did not reveal its role at the MHB, but it did lead to loss of all posterior body 
structures, suggestive of its involvement in the early Fgf signaling during development and 
formation of the paraxial mesoderm (Yokoi et al. 2007; Shimada et al. 2008). 
In order to isolate Fgfr loss-of-function mutants in zebrafish I have participated in the 
TILLING screen. At first we designed TILLING amplicons based on the previous zebrafish 
genome assemblies, Zv4 and Zv5, in order to target specific exons in receptor genes. Both of 
used genome assemblies contained incomplete and erroneous annotation of many genes. 
Despite my efforts I did not find any Fgfr duplicates in these versions of the zebrafish 
genome. After closer analysis of the new genome assembly Zv7 (released in July 2007) and 
other genomes, it became apparent that many teleosts have two FGFR1 genes, including 
zebrafish, medaka, stickleback and pufferfish, which is consistent with the teleost genome 
duplication hypothesis (Nicolas Rohner, Thomas Becker, personal communication). In carp, 
two Fgfr1a related genes were found, which is consistent with carp-specific genome 
duplication by hybridization (allotetraploidy) (David et al. 2003).  
The screen for zebrafish TILLING mutants has yielded in some non-sense and mis-
sense mutations that occurred to have little or no value for functional studies. Among three 
disruptive mutations found in Fgfr1a I did not find expected severe phenotypes, which we 
could later explain by the complementary function of Fgfr1b.  
4.1.1. Fgfr1aY328STOP and Fgfr1aF681C 
 
Fgfr1-3 have been shown to produce various isoforms, reported for both human and 
zebrafish genes (Partanen et al. 1998; Scholpp et al. 2004; Eswarakumar et al. 2005). These 
isoforms result from alternative splicing of mRNA by incorporation of alternative exons 7, 8 or 
9, which encode the IgIII domain versions IIIa, IIIb and IIIc, respectively. The early 
Fgfr1aY328STOP mutation, which by prediction should result in a complete Fgfr1IIIb loss-of-
function, did not reveal any phenotype, suggesting that Fgfr1aIIIb is not produced or 
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dispensable. However, in order to draw conclusions, one would have to analyze this mutant 
on the protein level and show that isoform IIIb is indeed, not produced. On the other hand, 
Partanen and others argue that IIIb and IIIc isoform act redundantly in development, where 
isoform IIIc dominates over IIIb. Consistently, knockout mice carrying a disrupted version of 
FGFR1IIIb develop normally (except for a slight tail growth defect) (Partanen et al. 1998). In 
addition to the possible redundancy between splice versions, in fish the second Fgfr1 may 
compensate for the loss of Fgfr1IIIb (see section 4.3).  
 Among the isolated mis-sense mutations we found a mutant carrying the F681C 
substitution. It was chosen for closer investigation because of high conservation of F681 
residue in the kinase domain II (see appendix 5.1). So far, there have been no reports 
suggesting its functional significance. Although the molecular consequences of the mutation 
are not clear, they could be addressed in the tissue culture assays such a kinase activity 
assay and receptor internalization assay.  In the context of zebrafish development, the F681C 
mutation appears to be unimportant.   
 
4.1.2. Fgfr1W761STOP mutant is likely a loss-of-function allele 
 
The potential of dominant negative Fgfr proteins in embryological studies has been 
initiated in the study of Fgf signaling in Xenopus embryos (Amaya et al. 1991). It has been 
shown that overexpression of dnFGFR1 (XFD), obtained by removing the tyrosine kinase 
domains of the cytoplasmic receptor tail, has a potential to block Fgf signaling, which leads to 
gastrulation defects and loss of mesoderm formation. The ability to block Fgf signaling is 
explained by the heterodimerization of XFD with wildtype receptors, thereby disabling their 
activation. In order to study receptor function in Fgf8 signaling I was interested in obtaining 
mutant fish with dominant negative or endocytosis deficient Fgfr1, which is the prime 
candidate for an early Fgf8 receptor.  
From my observations, the Fgfr1aW671STOP TILLING mutants carried a functionally 
disrupted version of Fgfr1a. The truncation of the protein does not render Fgfr1a dominant 
negative, but it does affect its endogenous expression levels, endocytosis and signaling (see 
below). There are two possible explanations for Fgfr1a transcript downregulation, one being a 
regulation of the hypomorphic receptor expression as an element of a feedback loop, the 
other being a spontaneous mRNA degradation by non-sense mediated decay. The latter is 
often observed in early stop mutations, as a way to prevent the production of deleterious 
dysfunctional proteins (Alberts 2002). In case of Fgfr1aW671STOP mRNA decay is a more 
probable explanation as an autoregulatory loop before the onset of zygotic transcription (8 or 
16 cell stages) is rather unlikely.  
Cloning of a mutant Fgfr1aW671STOP expression construct allowed me to assess the 
molecular nature of the truncated protein. Based on overexpression experiments I concluded 
that Fgfr1aW671STOP is a hypomorph, which is endocytosed slower and has a potential to inhibit 
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Fgf signaling upon overexpression. It would be interesting to clarify, whether the receptor is 
activated properly. Altered activation could result in altering the threshold of sensitivity to 
Fgf8, thereby shortening the range of signaling (lower Fgf8 concentrations are not able to 
activate the receptor anymore, see section 4.8).  
Due to a combination of the non-sense mediated decay and signaling defects I 
regarded mzFgfr1aW671STOP as partial loss-of-function mutants. However, I did not find any 
serious developmental defects, which was inconsistent with the reports about strong 
phenotypes in mouse or medaka Fgfr1 mutants (Ciruna et al. 1997; Shimada et al. 2008).  
The allelic complementation of Fgfr1aW671STOP and Fgfr1aR705H (the spiegel danio 
mutant Fgfr1 allele) supported the notion that the truncation of Fgfr1a causes its partial loss-
of-function. However, the molecular nature of the R705H is not clear and needs further 
investigation. Because adult individuals of both mutants show similar scale mispatterning 
phenotypes we expect Fgfr1aR705H to act also as a hypomorph, although the lethality of 
homozygous Fgfr1aW671STOP suggests stronger loss-of-function.  
Interestingly, the degree of scale loss is dependent on the genetic background. Tupfel 
long-fin fish do not exhibit any defects, whereas Tübingen fish show a variable loss of scales. 
We hypothesize that there is perhaps a genetic silencer in the TL fish, which rescues the 
scale development in Fgfr1a mutants. Similar variability of the phenotype, which is dependent 
on the unknown modifier gene, was observed in carp fish carrying Fgfr1 mutations, which 
supports the idea of a rescue locus, present only in some strains (Nicolas Rohner, personal 
communication). The direct comparison of the two species, carp and zebrafish, demonstrates 
how the analysis of polymorphisms in genes, may provide an interesting insight into the 
pathways involved in morphological changes in evolution, such as importance of Fgf signaling 
for the patterning of the dermal skeleton.  
 
4.2. Fgfr1a and Fgfr1b morpholinos 
 
In order to complement my observations of Fgfr1a loss-of-function mutant I tested 
several morpholinos. Consistent with the mutant analysis, morpholino injected embryos 
showed only slight brain cell death phenotype but no other obvious defects. This result is only 
partially consistent with the phenotype published for Fgfr1a morpholino knockdown, which 
indicated the role of Fgfr1a in the maintenance of midbrain-hindbrain boundary (Scholpp et al. 
2004; Trokovic et al. 2005). Morphant embryos at stages I have looked at (until 36 hpf) did not 
reflect a requirement for Fgfr1a in sustaining MHB marker gene expression.  
Similarly, in Fgfr1b morphants the gross morphology of embryos remained like 
wildtype. A few individuals showed slight tail growth reduction, but not to a significant level. 
The expression patterns of both genes are almost completely overlapping, which suggests 
their redundant function in early development.  
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Morpholino knockdown may not always phenocopy the mutant phenotype for a 
variety of reasons. The blocking efficiency of morpholino may be lower than that of a 
mutation. Additionally, some phenotypes observed in morpholino-injected animals may be 
non-specific, stress induced off-target effects.  Also, morpholino have a limited time of stability 
and cannot phenocopy late onset phenotypes.  
 
4.3. Fgfr1 duplication and redundant function during 
zebrafish development 
 
During evolution due to gene duplication one of two paralogous genes may lose its 
function (Hashiguchi and Nishida 2005), act redundantly (Martin and Kimelman 2008) or 
specify separate functions to act independently (Jovelin et al. 2007). In zebrafish, both Fgfr1 
morpholinos evoke very mild phenotypes, which did not agree with reported functions of Fgfr1 
in other vertebrates. I have therefore tested for possible receptor redundancy by injecting 
Fgfr1b morpholino into the Fgfr1W671STOP mutant. This full Fgfr1 loss-of-function caused 
progressive loss of posterior structures in most injected embryos. The expression of the 
markers of various brain parts did not reveal any defects but the mesodermal marker 
confirmed significant loss of mesoderm. I conclude that paralogous fgfr1 genes cooperate 
during tail development, which is supported by their similar expression patterns. Only 
interference with the activity of both fgfr1 genes disrupts mesoderm 
specification/maintenance, which to a certain extent resembles headfish (medaka) Fgfr1a 
loss-of-function. Presumably, the two copies of fgfr1 gene in medaka adopted different 
functions than their respective zebrafish homologs, which would provide us with additional 
information concerning differences between those species in basic patterning mechanisms 
during development (Furutani-Seiki and Wittbrodt 2004). However, little is known about the 
second copy of medaka fgfr1 and it is possible that it lost its activity altogether. This could be 
addressed by examining its expression pattern and the loss-of-function analysis.  
It would be also interesting to investigate the function of the carp fgfr1 genes, which 
were found as four homologous alleles of the zebrafish fgfr1a (justified by tetraploidy in carp). 
Mutation in one or two of carp Fgfr1 alleles results in scale defects as well. Whether carp also 
possesses homologous fgfr1b copies remains for further investigation (Nicolas Rohner, 
personal communication). 
At postembryonic stages, the functions of Fgfr1a and Fgfr1b seem to diverge also in 
zebrafish, at least in some tissues as evidenced by the scale phenotype in Fgfr1a loss-of-
function. In situ hybridization on skin of youngster fish shows that only FGFR1a is expressed 
in the developing dermal skeleton, whereas Fgfr1b is downregulated (Nicolas Rohner – 
personal communication). Therefore, the loss of only one of fgfr1 genes is sufficient to disturb 
scale development.  
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4.4. Functionality of Fgfr1a-eGFP/mRFP 
 
In an attempt to study Fgfr1 function in vivo I have used several Fgfr1 fusion protein 
constructs, all of which showed subcellular localization expected for a transmembrane 
protein, in plasma membrane and intracellular organelles. However, tagging the terminus of 
the receptor (both C- and N- termini) caused ectopic activation of target genes upon higher 
mRNA injection levels. It is possible that a tag increases protein stability, hence, leads to a 
dose dependent hyperactivation of the receptor. The stability could be affected by partial 
steric blockage of the assembly of the intracellular complex responsible for protein 
degradation. For example, the ESCRT complex is known to regulate the degradation vs. 
recycling of tyrosine kinase receptors (Raiborg et al. 2003; Raiborg et al. 2008). The N-
terminal fusion may be activated in a ligand independent manner, and it was not used for 
trafficking studies. As the exact reasons for the autoactivation of the C-terminal fusion is 
unclear, the levels of overexpression were kept moderate in order to avoid gain-of-function 
phenotypes.  
4.5. Fgfr1 trafficking at a steady state 
 
I showed that Fgfr1 is found in the same endocytic structures as Fgf8 in a 
transplantation assay. This interaction could be predicted despite previous reports that Fgf8 
has a very low mitogenic activity in association with FGFR1IIIc (Zhang et al. 2006). Fgfrs are 
high affinity receptors, presumably interacting with many ligands, where affinity is a function of 
ligand availability and concentration. Importantly though, in vivo studies on mouse and 
medaka suggest pairing of Fgf8 and Fgfr1. Mouse FGFR1 mutant displays similar to FGF8 
loss-of-function deformity of the MHB (Jukkola et al. 2006) and Fgfr1 mutant in medaka, hdf, 
phenocopies the morpholino knockdown of Fgf8 in this species (Yokoi et al. 2007). 
Additionally, I was interested in the role of receptor dependent endocytosis in Fgf8 signaling, 
which was postulated to delimit the range of target gene induction. I therefore, decided to 
concentrate on Fgfr1a trafficking and the regulation of receptor endocytosis in Fgf8 signaling.  
In tissue culture experiments performed on HeLa cells, different Fgfrs were shown to 
take up Fgf1 in clathrin-dependent endocytosis as evidenced by colocalization with EEA1, an 
early endosome marker. All FGFRs, except for FGFR4, are directed to lysosomal degradation 
and are recycled only to a minimal extent (Haugsten et al. 2005).  
I observed intracellular fate of Fgfr1a in embryos at sphere stage, which I considered 
representative of low signaling state, due to low and ubiquitous expression of Fgf target 
genes at this stage. In my observations, consistently with previous tissue culture reports, 
Fgfr1 is taken up through clathrin dependent endocytosis as evidenced by partial 
colocalization with Rab5 and Cellubrevin. A low degree of colocalization with Caveolin 
suggests that both pathways, clathrin dependent endocytosis (CDE) and non-clathrin 
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endocytosis (NCE), can be involved in receptor internalization. The ratio of both routes of 
endocytosis may depend on the ligand concentration, which was earlier suggested for EGF 
receptor downregulation (Sigismund et al. 2005; Sigismund et al. 2008). Our knowledge of 
EGFR trafficking indicates that CDE and NCE play different roles and are employed 
differentially in response to low and high levels of EGF. Whether the functions of alternative 
uptake routes are distinct in regulating Fgfr fate (degradation/endocytosis) remains to be 
elucidated.  
Fgfr1 in zebrafish embryos shows no overlap with Rab11 recycling endosomes. 
Despite some overlap with Cellubrevin (also labeling rapid-recycling endosome species and 
exocytic structures (Annaert et al. 1997)) it seems that the level of recycling at steady 
signaling levels is low, which would be consistent with tissue culture reports (Haugsten et al. 
2005). Rab11 perinuclear recycling endosomes should be optically resolvable and none were 
observed overlapping with Fgfr1 (Ullrich et al. 1996). The notion that Fgfr1 is mainly directed 
to degradation is also supported by a large degree of colocalization with Rab7-positive late 
endosomes. However, additional study of recycling in dissociated cell culture would shed 
more light on this matter as some cell culture studies suggest that many fluid (ligand) and lipid 
(receptor) phase cargos are constitutively recycled rapidly after early vesicle sorting 
(Gruenberg and Maxfield 1995). The question of Fgfr1 recycling would, therefore have to be 
addressed in appropriate tissue culture assays.  
Importantly, it appears that tissue culture observations overlap to a certain extent with 
the situation in zebrafish embryos. Perhaps, this can serve as an argument that the trafficking 
behavior of Fgfr in response to stimulation can be extrapolated from tissue culture to the 
situation in the living organism. However, I have not observed any nuclear translocation of the 
Fgfr1a, which was reported in some tissue culture studies (Myers et al. 2003; Reilly et al. 
2004; Bryant et al. 2005). It is possible, that nuclear translocation takes place in more 
specialized cell types and that in undifferentiated embryonic cells this mode of signaling is not 
employed.  
It would be greatly interesting to analyze pathways of Fgfr1a trafficking in context of 
Fgf8 signaling at high ligand concentrations, which would provide additional information as to 
how Fgf8 is delimited. Cells close to the Fgf8 source may play a restrictive role, by uptake 
and direct degradation of receptors and Fgf8. They can, on the other hand, play a permissive 
role, where at high concentrations Fgf8 is rapidly recycled, hence, allowed to spread further in 
the tissue.  
 
4.6. Importance of ubiquitylation for Fgf signaling 
 
I observed that Fgfr1a is ubiquitylated in vivo and that fgf8 signaling increases the 
state of receptor ubiquitylation. Overexpression of Ub4KR, a poly-chain deficient ubiquitin 
mutant, leads to slight upregulation of sprouty 4 induction. This provides indirectly some 
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evidence that polyubiquitylation may regulate Fgf signaling. During this study a publication 
was released by Haugsten et al. 2008, showing that Fgfr1 ubiquitylation is dispensable for its 
internalization. Similar to EGFR though, lack of ubiquitylation changes FGFR1 trafficking 
inside the cells, where it is sorted to recycling rather than degradation, because of lack of 
degradative polyubiquitylation signals for the sorting machinery. K63 (endocytosis) or K48 
(degradation) are the best-studied polyUb chains. Without them the protein is theoretically 
more prone to being recycled and not downregulated. Therefore, Ub4KR may change the Fgfr 
trafficking rather than its endocytosis. It would be interesting to look in more detail at the 
dynamics of the Fgfr downregulation in a ubiquitylation deficient state and to assess the role 
of Fgfr1 ubiquitylation in the establishment of the Fgf signaling range.  
In search for components of the ubiquitylation pathway, which would suggest its 
involvement in Fgf8 organizer activity I looked also at the expression patterns of ubiquitin, 
ubiquitin-ligase, Cbl, and the ubiquitylation dependent adaptor protein Grb2. All those factors 
are involved in ubiquitylation of tyrosine kinase receptors, therefore could be expressed in 
restricted fashion during the patterning of the embryo, however, they are expressed 
ubiquitously. I concluded that the ubiquitylation machinery is probably constitutively present in 
all cells and the regulation of Fgfr state is dependent on other cellular components.  
 
4.7. A role of Y753 and c-terminus in Fgfr1 trafficking 
 
The carboxyterminal domain of Fgfr1 is known to include one of tyrosines targeted to 
autophosphorylation. Y766 (Y753 in fish) on Fgfr1 has been shown to directly bind 
phospholipase C-γ (PLCγ) enabling signaling through this pathway (Mohammadi et al. 1991). 
Activated PLCγ can hydrolyse phosphatydyloinositol-4,5-diphosphate (PIP2) to inositol-1,4,5-
triphosphate (IP3) and diacylglycerol (DAG). IP3 induces Ca2+ release from intracellular 
stores, whereas DAG activates protein kinase C (PKC). In turn activated PKCδ is able to 
phosphorylate and stimulate Raf therefore leading to activation of the MAP kinase pathway in 
a Ras-independent manner (Ueda et al. 1996; Thisse and Thisse 2005). However, no 
significance was shown for Fgf-induced activation of PLCγ in vitro (Eswarakumar et al. 2005) 
and in vivo in zebrafish (Lawson et al. 2003; Ma et al. 2007). In mouse, the FGFR1Y766F 
mutation reveals the role of this tyrosine in the dorsoventral patterning (Partanen et al. 1998). 
Also uncovered was the importance of Y766 and the entire C-terminal domain for endocytosis 
(Sorokin et al. 1994; Sorensen et al. 2006). I have cloned mutant constructs of Fgfr1a, 
Fgfr1aY753F and Fgfr1aY753STOP, to directly address the question of receptor dependence of 
Fgf8 “restrictive clearance”.  
Observations of Fgf8Cy5 uptake into cells expressing wildtype or mutant receptors 
confirmed earlier reports about the importance of Y766 (Y753 in fish) in receptor 
internalization. However, I also found that in embryos Fgf8 is taken up by cells expressing 
mutated receptors, which may be due to heterodimerization with the wildtype receptors still 
Discussion 
 
 
 
98
present in the cells. The extent of Fgf8 endocytosis was slightly lower for both Fgfr1aY753STOP 
and Fgfr1aY753F expressing embryos, compared to the control embryos expressing wildtype 
Fgfr1a. Small differences in endocytosis were not reflected by the expansion of the target 
gene induction, which was drastic for Fgfr1Y753F mutant. I have confirmed that this 
hyperactivation is dependent on ligand induction in a transplantation assay, where Fgfr1aY753F 
overexpressing cells placed in wildtype embryos do not show ectopic target gene expression. 
Because, reduced endocytosis seems to be insufficient to produce observed drastic target 
gene expansion (as both mutants show similar uptake reduction), I assume there must be 
another mechanism of target gene activation with overlapping effects, i.e. the rate of receptor 
degradation or the duration of signaling. In this context, Fgfr1 endocytosis would not be alone 
responsible for Fgf8 signaling range.  
Overall, the current evidence suggests that Y753 and the C-terminal domain of last 
58 amino acids are important for Fgfr endocytosis and signaling, despite conflicting reports 
from tissue culture assays showing that it induces MAPK signaling to a similar extent as the 
wildtype receptor (Sorokin et al. 1994). In vivo, small differences in the rate of trafficking or 
protein degradation may have dramatic effects. Therefore, it would be interesting to quantify 
mutant receptor trafficking in colocalization assays. The biological relevance of these 
observations has to be, however, interpreted carefully, because protein overexpression assay 
address the mechanism of receptor function rather than its specificity and activation control in 
vivo at endogenous levels.  
 
4.8. The role of Fgfr1 in Fgf8 morphogen gradient 
formation 
 
Based on my observation of Fgfr specificity in the early development of zebrafish, it is 
unlikely that Fgfr1a alone mediates Fgf8 signaling during early development. Most probably, 
Fgfr1b is equally involved, as well as Fgfr4, all of which are strongly expressed during 
gastrulation. Nevertheless, the study of Fgfr1a function and endocytosis provides some 
information, which may be relevant for all these receptors. In the wildtype situation, Fgf8 is 
thought to induce different target genes at different thresholds of Fgf concentration (Fig. 4.1 
A). The tyrosine 753 and the C-terminal domain of Fgfr1a are important for endocytosis, 
which has functional relevance for the range of Fgf8 spreading and target gene induction. 
Given that the rate of receptor activation is unchanged, inhibition of the ligand endocytosis 
may lead to the expansion of Fgf8 spreading and the target gene expression (Fig. 4.1 C). 
Importantly, the rate of Fgfr1a activation is likely to determine the threshold of sensitivity to 
Fgf8, hence target gene induction. As illustrated by overexpression of the hypomorphic 
Fgfr1aW671STOP, the change of the threshold of Fgf8 mediated receptor activation, may lead to 
the shortening of the Fgf8 signaling range (Fig 4.1 B). Alternatively, an overexpression of Fgfr 
may lead to an increased uptake of the ligand, which could also affect the range of signaling. 
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In the embryo, Fgf signaling is strongly autoregulated by feedback loops of receptor and 
ligand expression. Therefore, it is likely, that receptor overexpression would either decrease 
endogenous receptor production or increase ligand expression. Either way, the 
overexpression of wildtype Fgfr1 has no effect on target gene induction. In order to 
understand the mechanism of Fgf8 signaling it will be still necessary to address some basic 
questions in Fgf8 morphogen signaling:  
1. what is the threshold of Fgf8 concentration for activation of each target gene,  
2. how does the cellular response differ between high and low Fgf8 concentrations 
and finally,  
3. are there any actively regulated elements in the Fgfr downregulation machinery or 
is the ligand-dependent endocytosis a constitutive property of the early embryonic cells.  
 
Figure 4.1 Theoretical model of Fgf8 range of signaling 
 
4.9. The essential role of Fgfr2 in zebrafish  
 
The conditional knockout of Fgfr2 in mesenchyme and chondrogenic cells (under 
Dermo1/Twist2 promoter) in mouse resulted in complex skeletal phenotypes suggesting the 
role of Fgfr2 in osteoblast function and skeletal growth (Yu et al. 2003).  Homozygous mutant 
mice are dwarfish and are characterized by reduced bone length and bone density. Fgfr2 was 
shown to be dispensable for osteoblast differentiation, but required for osteoblast proliferation. 
Teleost osteogenesis differs from mammalian, however, similar to the mammalian situation, in 
zebrafish the major mode of building cellular and acellular bones is by periosteal 
osteogenesis, which depends on the activity of osteoblasts (Moss 1961; Moss 1963). 
The Fgfr2 mutant isolated from the TILLING screen is characterized by a late 
nonsense mutation L545STOP. This leads, according to my results, to the likely non-sense 
mediated decay of Fgfr2 mRNA as well as protein loss-of-function, rendering it dominant 
negative. The protein that is produced in very small amounts and has a dominant negative 
character but is unlikely to act in a dominant manner during embryo development. Being both 
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restricted by a specific expression pattern and present in uncompetitive amounts Fgfr2L545STOP 
is unlikely to preserve its function. Therefore, I assumed Fgfr2L545STOP homozygotes are 
strong loss-of-function mutants. However, in order to provide more reliable evidence that 
Fgfr2 is the only locus affected in Fgfr2L545STOP fish, it would be necessary to generate another 
mutant allele in Fgfr2 or a rescue construct. Nevertheless, the reduced body size and fragility 
of the mutant bones, especially ribs, are consistent with the phenotypes observed in mice with 
conditional Fgfr2 knockout in bones. Differences in some bone growth (neural spines and 
hypurals appear thicker than wildtype) may result from various modes of osteogenesis, such 
as fibroblastic metaplasia, employed to build these bones. It would be very interesting to 
investigate closer the growth of the mutant fish as well as molecular and cellular causes of the 
bone growth defects observed.  
The reasons for differences in body size of the mutant fish are most difficult to study, 
as there are many environmental and physical factors that may cause a slower growth rate, 
such as inability to compete for food with the wildtype siblings or the deformity of the jaws. A 
limited control over these factors is the main problem in research of adult individuals. Mice 
Fgfr2IIIb -/- embryos are also smaller at birth, which excludes such factors as inability to feed 
due to malfunction of the jaws.  It would be interesting, therefore, to determine the 
environment-independent causes for a slower growth.  
Similarly, it would be challenging to determine the basis of infertility in the mutant fish. 
Sterility may originate either from behavioral or physical problem and is left for further 
elucidation. Interestingly, this phenotype could be explained by two reports in which FGFR2 
was described to play a crucial role in Sertoli cell differentiation during male sex determination 
(Schmahl et al. 2004) as well as germ cell migration and survival in mice (Takeuchi et al. 
2005).  It would be fascinating to closer investigate, whether such essential processes as 
germ cell migration and Sertoli-like cell differentiation are to some extent conserved between 
zebrafish and higher vertebrates (Kurita and Sakai 2004).  
Surprisingly, the overall phenotype in homozygous Fgfr2L545STOP zebrafish is rather 
mild compared to the severe FGFR2 or FGFRIIIb knockout in mouse (Arman et al. 1998; De 
Moerlooze et al. 2000).  FGFR2 knockout mice die at preimplantation due to defects in 
development of the placenta. Disruption of the important FGFR2IIIb isoform leads to multiple 
defects at birth including a complete agenesis of lungs and limbs, dwarfism, various skeletal 
abnormalities and skin defects. What is surprising is that mutant zebrafish develop normal 
limbs (fins), as opposed to the Fgfr2∆III knockout mice (Xu et al. 1998). This could be 
explained by different functions of both Fgfr2 and Fgfr4 during early development of zebrafish 
as compared to mice. As I observed, Fgfr4 seems to play an important role in the induction of 
fin field in zebrafish, which has not been reported for other vertebrates. Provided that the 
phenotypes observed in zebrafish indeed reflect Fgfr2 loss-of-function, one could conclude 
that FGFR2 adopted mammal specific function and in teleosts, such as zebrafish, and it is 
rescued by redundant functions of other Fgfrs.  One cannot exclude a possibility though, that 
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Fgfr2L545STOP causes an incomplete loss-of-function, hence, some preservation of its functions 
in specific organogenesis events.  
 
4.10. Fgfr4 in zebrafish development  
 
FGFR4 has been shown to play a crucial role in limb muscle differentiation in chick 
(Marics et al. 2002). The role of FGFR4 in chick limb was shown to be dependent on FGF8 
signaling from the somites and necessary for differentiation of all muscle types during limb 
growth. This and other functions of chick FGFR4 (FREK) was previously suggested based on 
the expression and structure analysis of the protein (Halevy et al. 1994; Marcelle et al. 1994). 
Interestingly, FGFR4 in chick is strongly expressed in three mesoderm-derived structures: 
kidney, cartilage and striated muscle.  
In mouse, despite FGFR4 expression in endoderm and mesoderm-derived structures 
(muscle, lung, kidney, pancreas and other), the disruption of FGFR4 did not cause any 
apparent defects. Its redundant function with FGFR3 in lung development was shown by 
double FGFR3/FGFR4 knockout (Weinstein et al. 1998).  Although FGFR4 occurred to be 
dispensable for mouse development, some evidence was provided for a unique function of 
FGFR4 in promoting myogenic differentiation by heterodimerization with FGFR1 (Kwiatkowski 
et al. 2008).  
In zebrafish, Fgfr4 is expressed in a similar fashion to that of the chick or frog, 
although in fish and frog it is strongly expressed during gastrulation in contrast to mouse and 
chick. It is, however, structurally different from all FGFR4s of other species as its extracellular 
domain comprises of four Ig-like domains, instead of two or three. This in consequence 
suggests its different affinity to Fgf ligands (Thisse et al. 1995). A functional divergence of 
Fgfr4 between zebrafish and higher vertebrates, such as chick and mouse, is also supported 
by my and others observations of zebrafish Fgfr4 loss-of-function (see below).  
Recently Fgfr4 was associated with the function of Fgf19 in eye and lens 
development (Tamimi et al. 2006; Nakayama et al. 2008). In human tissue culture 
experiments FGF19 was shown to bind exclusively to FGFR4 (Xie et al. 1999), however in 
zebrafish, Fgfr4 has a different extracellular structure and it seems that both Fgfr2 and Fgfr4 
may mediate Fgf19 signaling. In zebrafish, both Fgfr2 and Fgfr4 morpholino knockdown was 
shown to inhibit lens formation, whereas later in development Fgf19 knockdown disrupted 
development and maintenance of the periocular mesenchyme. This late phenotype was 
associated with Fgfr4 based on expression pattern analysis, in which Fgfr4 is uniquely 
expressed in the cornea and the ciliary margin of the larval eye (Tamimi et al. 2006).  My 
observations support these results to a certain extent, as Fgfr4 morphants exhibit strongly 
reduced in size and sometimes misshapen eyes. Further analysis with use of appropriate 
markers needs to follow.  
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Also the mesodermal defects are consistent with the expression pattern, because 
Fgfr4 morphants display irregular somites, abnormal jaws and lack of pectoral fins. This, 
however, suggests a much more exclusive role of Fgfr4 in mesodermal derivatives in 
zebrafish as compared to other vertebrates.  Compared to the Fgfr1 loss-of-function Fgfr4 
seems to be restricted in its exclusive activity to the intermediate and lateral mesoderm, 
where it is expressed in a unique fashion. This notion is supported by the observations in 
medaka, where Fgfr1 was shown to promote axial but not lateral mesoderm (Shimada et al. 
2008). It would be greatly interesting to inactivate all early mesoderm Fgfrs, Fgfr1a, Fgfr1b 
and Fgfr4 in order to assess the extent of their cooperation in the early formation of the 
mesoderm.  
 
4.11. Pectoral fin development in zebrafish 
 
I found that Fgfr4 knockdown disrupts fin field specification as well as fin induction 
and growth. This finding is novel and introduces important changes to our understanding of 
the role of Fgfs in the fin induction process. So far, there was no evidence in zebrafish for 
such early involvement of Fgf signaling in fin field specification.  
Experimental data from chick suggested limb inducing activity of Fgf8 from the 
somites (Crossley et al. 1996). Also in mouse, Fgf8 was shown to play an inductive role in fin 
outgrowth (Sun et al. 2002; Mariani et al. 2008). However, earlier activity of Fgf8 could not be 
addressed with the promoter used for the disruption of the gene (Moon and Capecchi 2000). 
In zebrafish, Fgf8 expression in the anterior three somites, i.e. the level of fin induction on the 
lateral sides, is present only at the time of their formation, later the mRNA of Fgf8 gets 
strongly downregulated, thereby making it an unlikely candidate for an inducer of the lateral 
plate fate. One cannot exclude the possibility though, that the critical timeframe when Fgf 
signaling is needed falls between tailbud and early somite formation. Why do Fgf8 mutant, 
ace, form perfect fins then? It is possible that in zebrafish this process takes more ligands, 
which are acting redundantly. The Fgf candidate that has been implicated in many processes 
together with Fgf8a and Fgf3 and is expressed in the somites, is Fgf17b (Cao et al. 2004).  
Retinoic acid signaling had been shown to be the earliest factor specifying the 
prospective fin field (Grandel et al. 2002; Keegan et al. 2005; Marques et al. 2008). In case of 
hindbrain, somite or heart patterning Fgfs and RA signaling were shown to be signaling in a 
codependent fashion, suggesting an interplay between these pathways (White et al. 2007; 
Marques et al. 2008). I observed, that upon RA inhibition, Fgfr4 is expressed in an altered 
fashion, which is consistent with the observations found in the early embryogenesis of 
Xenopus (Shiotsugu et al. 2004). This suggests that Fgfr4 acts downstream of RA signaling, 
although the influence of Fgfr4 knockdown on RA remains to be investigated. In the future 
experiments it will be interesting to address some open questions such as: what is the nature 
of the RA and Fgfs interplay in establishing the fin anlage, how is RA involved in lateral 
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mesoderm specification and what are the Fgf ligands, which specify the fin field via Fgfr4. Is 
Fgfr4 acting upstream of a late inductive factor, Wnt2b?  
I have provided some evidence suggesting that the role of Fgfrs during earliest 
stages of limb development diverged between zebrafish and mice. In mouse, FGFR2 and 
FGFR1 have been shown to be involved in induction and outgrowth of the limb, respectively 
(Xu et al. 1998; Xu et al. 1999). I have found that in zebrafish Fgfr4 instead of Fgfr2 functions 
in the earliest stages of limb formation, whereas Fgfr1a loss-of-function results in weak fin 
defects (see Fig. 3.7 in Results). However, because Fgfr2 is also expressed in the lateral 
plate mesoderm and fin buds, it is still unclear, whether it has a function in limb growth. 
Surprisingly, Fgfr2L545STOP mutants did not display any fin growth defects. Given the 
involvement of Fgfr4 in the specification of the fin field, I would like to propose a refined model 
of the signaling cascade involved in fin formation, which in a temporally simplified manner 
summarizes known factors in pectoral fin formation  (Fig. 4.2). 
 
Figure 4.2 Current model of signaling cascade 
in pectoral fin induction 
Fgfr4 is a novel Fgf signaling member in the 
cascade. It is unknown whether Fgfr4 acts 
epistatically upstream of the fin outgrowth factor, 
Wnt2a. It is also unclear, which ligands actively 
signal through Fgfr4 in fin field specification. 
Abbreviations: im – intermediate mesoderm, fb – 
fin bud, AER – apical ectodermal ridge.  
 
 
 
 
 
 
 
4.12. Functions of Fgfrs in Fgf8a signaling and early 
development 
 
Early during development Fgf8a is acting together with its paralog, Fgf24 and a 
member of the synexpression group, Fgf3. Together, Fgf8a and Fgf24 have been shown to 
promote posterior mesoderm development, and each gene separately is sufficient to do so 
(ace mutants displaying only a weak segmentation phenotype) (Reifers et al. 1998; Draper et 
al. 2003). The double knockdown of Fgfr1a and Fgfr1b to a certain extent resembles the loss 
of mesoderm seen in Fgf8a/Fgf24 double mutant. Based on phenotypic similarities, as well as 
comparable expression patterns, I conclude that Fgfr1a and Fgfr1b mediate Fgf8a and Fgf24 
signals in mesoderm formation. However, other Fgf8/24 dependent tissues and organs, such 
as developing brain, heart, ear or pectoral fins may be dependent also on other receptors.  
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Fgf8 is also essential for the maintenance of the midbrain-hindbrain boundary. 
However, the double Fgfr1a and Fgfr1b knockdown did not affect the expression of MHB 
markers. Preliminary results suggest that there might be a redundancy between Fgfrs 1a, 1b 
and 4 in the maintenance of this organizer (data not shown). Interestingly, Fgfr3 and Fgfr4 are 
expressed in rhombomere 1 and Fgfr2 is expressed in the midbrain, both structures adjacent 
to MHB. Additionally, Fgfr3 has been shown to undergo expansion in the absence of Fgf8, 
which indicates a regulatory interaction (Sleptsova-Friedrich et al. 2001). It will be of great 
interest to investigate this issue closer by inducing e.g. triple knockdown situations with 
Fgfr1a, Fgfr1b and Fgfr3 or 4.  
Another, Fgf8 related observation relates to limb induction, where the role of Fgf8 is 
still not clear for zebrafish development. However, the new evidence for the role of Fgfr4 in 
pectoral fin specification opens new possibilities for the early involvement of the Fgf ligands. 
Fgf8a is most likely involved in a redundant fashion together with other Fgfs. It would be worth 
investigating, which Fgf ligands act via Fgfr4 in the early fate determination within the lateral 
mesoderm.  
 
4.13. TILLING as a method to generate knockout mutant 
fish 
 
Targeted identification of the Fgfr mutants was, to a certain degree, disappointing. 
We did not recover any early nonsense mutations in fgfr1-3 genes (except for Fgfr1aIIIb 
isoform), and those we did recover in Fgfr4 were not disrupted, presumably due to alternative 
start of translation. The late nonsense mutations in turn, were difficult to interpret because of 
a complex genetic situation of the mutant fish. A combination of non-sense mediated decay 
and partial functional protein impairment is hard to interpret, because of problems in telling 
hypomorphs and null mutants apart.  
Additionally, one is confronted with the accumulation of background mutations, which 
have to be eliminated through repeated and time-consuming rounds of outcrosses into 
wildtype backgrounds. Because the probability of obtaining null mutations is very low, it is 
challenging to prove allele specificity by complementation. Optimally, one needs to recover 
two presumptive null alleles in one gene or find a complementary mutant from the forward 
genetic screen. Control experiments with use of morpholinos may solve the question of 
specificity, however, only for early embryonic phenotypes.  
Taken together, I found that the TILLING method can contribute to our understanding 
of gene function in development and adult homeostasis, however, it is beneficial to 
complement this approach with other, already established (e.g. morpholino) or newly 
discovered (e.g. zinc fingers) gene manipulation technologies. 
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5. Appendix 
Appendix 1. Protein alignment of all zebrafish FGF receptors 
 
Dr_FGFR1a   (1) ---------------------------------------------------------------------- 
Dr_FGFR1b   (1) ---------------------------------------------------------------------- 
Dr_FGFR2    (1) ---------------------------------------------------------------------- 
Dr_FGFR3    (1) ---------------------------------------------------------------------- 
Dr_FGFR4    (1) MLSILKVFIAICFMELVCSRSITSGEPRAKDIRVSRHILTPGYPENATVLVGGHVKLVCKLHQPASTRLQ 
 
 
 
Dr_FGFR1a   (1) ------------------MKMMMIMKTTLLLISVLLTQALQSQGR-----------------PAIQDEAP 
Dr_FGFR1b   (1) ---------------------------MISLSAAVSLRMLKS---------------------------- 
Dr_FGFR2    (1) -----------------MFARGWLLGALLLMTLATVSVARPSLKI-----------------DLVNTSAP 
Dr_FGFR3    (1) ------------------MVPLCLLLYLATLVFPPVYSAHLLSP------EP-------TDWVSSEVEVF 
Dr_FGFR4   (71) WFKKDSNRLGPDGSPVLTALTPLLENLSKVNIFPLVNISLEDAGEYVCKAENSAGQATRSAWVEVLSEVS 
 
 
Dr_FGFR1a  (36) AEPTS--------YTLDSGEKLELSCKAKEDTQKVTWTKDLVPLVDGEHTRLRNDQMEIEKVEPTDSGLY 
Dr_FGFR1b  (16) ------------------------------------WRLLVLLLILTQLCTVQ--------SRP---AVT 
Dr_FGFR2   (37) EEPPTKNQNCVPVLFSVHPGELLKLKCPLSGADDVIWTKDSSSLRPDNRTLVTRDWLQISDATPKDSGLY 
Dr_FGFR3   (40) LEDYVAG----------VGDTVVLSCTPQDFLLPIVWQKDGDAVSSSNRTRVGQKALRIINVSYEDSGVY 
Dr_FGFR4  (141) EEPTEEPSEH---LLLELGDVLKLRCDTN-RPGAVQWFKSGVRVQHNARIQIRAAVMEIADVTYEDSGVY 
 
 
Dr_FGFR1a  (98) ACFAQGLNSNHTEYFNISVTDEE---DEVDSSSEEAKLS----NDQ-NLPMAPVWAQPDKMEKKLHAVPA 
Dr_FGFR1b  (39) EQG----------HIVASSEDED---DDESSSEENKPSS----SQE-LLPMAPRWAQPEKMEKKLHAVPA 
Dr_FGFR2  (107) SCSATGSRDCDVFSFIVNVTDAISSGDDEDDTERSDDVG----ADG-EQMRLPYWTFPEKMEKKLHAVPA 
Dr_FGFR3  (100) SCRHAHKSMLLS-NYTVKVIDSLSSGDDEDYDEDEDEAG----NG---NAEAPYWTRSDRMEKKLLAVPA 
Dr_FGFR4  (207) VCMLRGTKEALR-NFTITVADAVGSGDDDDEDNGLDDIGPETENDQVYISRAPYWTHTQRMEKKLYAVPA 
 
      Ig Domain II 
 
Dr_FGFR1a (160) SKTVKFRCQANGNPTPTLKWLKNGKEFKRDQRIGGFKVREHMWTIIMESVVPSDRGNYTCLVENRHGSIN 
Dr_FGFR1b  (91) SKTVKFRCQAEGNPIPKLRWLKNGKEFKRDQRIGGYKLREHMWTIIMESVVPSDKGNYTCLVENEYGSIN 
Dr_FGFR2  (172) ANTVKFRCAAAGNPKPKMRWLKNAKPFRQEDRMGGYKVRLQHWTLIMESVVPSDKGNYTCLVENQYGSIN 
Dr_FGFR3  (162) ANTVKFRCPAAGNPTPSIHWLKNGKEFKGEQRMGGIKLRHQQWSLVMESAVPSDRGNYTCVVQNKYGSIK 
Dr_FGFR4  (276) GNTVKFRCPATGSPLPTIRWLKNGREFRGEHRIGGIKLRHQHWSLVMESVVPSDRGNYSCVVENKYGSIA 
 
 
       
Dr_FGFR1a (230) HTYQLDVVERSPHRPILQAGLPANRTAVVGSDVEFECKVFSDPQPHIQWLKHIEVNGSRYGPDGLPYVRA 
Dr_FGFR1b (161) HTYQLDVVERSPHRPILYAGLPANRTAVVGSDVEFVCKVFSDPQPHIQWLKHIRVNGSQLGPDGLPYVRV 
Dr_FGFR2  (242) HTYTLDVVERSPHRPILQAGLPANVTVQVGQDAKFVCKVYSDAQPHIQWLQHYTKNGSRYGPDGLPYVRV 
Dr_FGFR3  (232) HTYQLDVLERSPHRPILQAGLPANQTVVVGSDVEFHCKVYSDAQPHIQWLKHIEVNGSQYGPNGAPYVNV 
Dr_FGFR4  (346) HTYLLDVLERSPHRPILQAGLPKNTTAIVGGDAQFLCKVYSDAQPHIQWLKHIEMNGSRYGPDGIPYVKI 
 
     Ig Domain III 
 
Dr_FGFR1a (300) LKTAGVNTTDKEMEVLQIRNVSLEDAGEYTCLAGNSIGHSHHSAWLTVYKA-VPPTQLPNQ--TYLEVLI 
Dr_FGFR1b (231) LKTAGLNTTDKEMEVLQLRNVSFEDAGEYTCLAGNSIGISHHSAWLTVVKAPTAPSAVPSQ--SYLEVL 
Dr_FGFR2  (312) LKTAGVNTTDKEIEVLYLPNVTFEDAGEYTCLAGNSIGISYHTAWLTVHPAETNPIETDYPP-DYVEIAI 
Dr_FGFR3  (302) LKTAGINTTDKELEILYLTNVSFEDAGQYTCLAGNSIGYNHHSAWLTVLPAVEMEREDD-----YADILI 
Dr_FGFR4  (416) VKTGSLNMS--EVEVLYLTNISMEDAGEYSCLAGNSIGFSHQSAWLTVLSEEDVAKEVDLMEAKYTDIII 
 
     TM 
 
Dr_FGFR1a (367) YCVGFFLICVMVGTAVLAKMHSSAKKSDFNSQLAVHKLAKSIPLRRQVTVSVDSSSSMHSGGMLVRPSRL 
Dr_FGFR1b (299) YCIGFFLIFLMVGIATIVKIRSSSKKSDFNSQLAVHKLAKSIPLRRQVSVESSSS--LNSGVMLVRPSRL 
Dr_FGFR2  (381) YCIGVFLIACMVVIVVVCRMRTSAKKPDFSSQPAVHKLTKQIPLRRQVSSDSSSS--MSSSTPLVRITTR 
Dr_FGFR3  (367) YVTSCVLFILTMVIIILCRMWIN--TQKTLPAPPVQKLSK-FPLKRQVSLESNSS--MNSNTPLVRIARL 
Dr_FGFR4  (484) YASGFLALVMAIVIVVLCRMQVHP-SREPFDTLPVQKLSK-FPLRRQYSVESNSS--GKSSASLMRVARL 
 
          
 
Dr_FGFR1a (437) SSSGSPMLSGVSEYELPQDPRWEVQRDRLVLGKPLGEGCFGQVMMAEAMGMDKEKPNRITKVAVKMLKSD 
Dr_FGFR1b (367) SSSGTPMLSGVSEYELPQDPCWEVSRERLVLGKPLGEGCFGQVVMGEAIGLDKDKPNRITKVAVKMLKSD 
Dr_FGFR2  (449) RSS--AHDDPIPEYDLPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD 
Dr_FGFR3  (432) SSSDGPMLPNVSELELPSDPKWEFTRTKLTLGKPLGEGCFGQVVMAEAIGIDKEKPNKPLTVAVKMLKDD 
Dr_FGFR4  (550) SSSCSPMLAGVMEFELPYDPDWEFPRENLTLGKPLGEGCFGQVVRAEAYGINKENQDHMATVAVKMLKDD 
 
      Tyrosine Kinase I 
 
Dr_FGFR1a (507) ATEKDLSDLISEMEMMKIIGKHKNIINLLGACTQDGPLYVIVEFAAKGNLREYLRVRRPPGMEYCYNPDQ 
Dr_FGFR1b (437) ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEFASKGNLREYLRARRPHGMEYCYNPDP 
Dr_FGFR2  (517) ATEKDLSDLVSEMEMMKMIGRHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIAR 
Dr_FGFR3  (502) GTDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK 
Dr_FGFR4  (620) ATDKDLADLISEMELMKVMDKHKNIINLLGVCTQDGPLYVLVEYASKGSLREYLRARRPPGMDYTFDVTK 
 
            
  
 
Dr_FGFR1a (577) VPVENMSIKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 
Dr_FGFR1b (507) LPIESMSIKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDVHHIDYYKKTTN 
Dr_FGFR2  (587) VSDEPLTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTESNVMKIADFGLARDVHNIDYYKKTTN 
Dr_FGFR3  (572) IPNETLTFKDLVSCAYQVARGMEYLASKKCIHRDPAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 
Dr_FGFR4  (690) VPEEQLTFKDLVSCAYQVARGMEYLASKRCIHRDLAARNVLVTEDNVMKIADFGLARGVHQIDYYKKTTN 
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      Tyrosine Kinase II 
        X      C          H 
 
Dr_FGFR1a (647) GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDRPSTCTHEL 
Dr_FGFR1b (577) GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLREGHRMDKPSACTQEL 
Dr_FGFR2  (657) GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPNPGIPVEELFKLLKEGHRMDKPANCTNEL 
Dr_FGFR3  (642) GRLPVKWMAPEALFDRVYTHQSDVWSYGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHEL 
Dr_FGFR4  (760) GRMPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPSNCTHEL 
 
 
 
Dr_FGFR1a (717) YMMMRDCWHAVPSQRPTFKQLVEDLDRTLSMTSNQEYLDLSVSLD-QFSPNFPDTRSSTCSSGEDSVFSH 
Dr_FGFR1b (647) YLMMKDCWHAVPTQRPTFKQLVEDLDRTLSLISNQEYLELSVPLEPMYSQVILNERSSTCSSEQDSVFLQ 
Dr_FGFR2  (727) YMMMKDCWHAISSHRPTFKQLVEDLDRILTLATNEEYLDLCAPVE-QYSPSFPDTRS-SSSSGDDSVFSH 
Dr_FGFR3  (712) YMIMRECWHAVPSQRPTFRQLVEDHDRVLSMTSTDEYLDLSVPFE-QYSPTCPDSNS-TCSSGDDSVFAH 
Dr_FGFR4  (830) YMKMRECWHAVPTQRPTFKQLVEELDRVLVSIS-DEYLDLSTPFE-QYSPSCEDTSS-SCSSDNDSVFTH 
 
 
Dr_FGFR1a (786) DAGADEPCLPKFPPHPNRGVAFKKR---- 
Dr_FGFR1b (717) EPGPEDPCIP---PSQQPMRSFKKR---- 
Dr_FGFR2  (795) DPLADEPCLP---KYQHINGGIKT----- 
Dr_FGFR3  (780) DPLPEEPCLP---KHHHSNGVIRT----- 
Dr_FGFR4  (897) DALSTEPCLL---GYHDVHSRMDLKTTMR 
 
Appendix 2. Protein alignment of FGFR1a and b 
 
 
Dr_FGFR1a    (1) MKMMMIMKTTLLLISVLLTQALQSQGRPAIQDEAPAEPTSYTLDSGEKLELSCKAKEDTQ 
Dr_FGFR1b    (1) ---------MISLSAAVSLRMLKS------------------------------------ 
Consensus    (1)           I L A L    L S                                     
                   
 
Dr_FGFR1a   (61) KVTWTKDLVPLVDGEHTRLRNDQMEIEKVEPTDSGLYACFAQGLNSNHTEYFNISVTDEE 
Dr_FGFR1b   (16) ---WRLLVLLLILTQLCTVQ--------SRP------AVTEQG-------HIVASSEDED 
Consensus   (61)    W   LL LI      L           P      A   QG       H   S  DED 
                    Ig Domain I 
 
Dr_FGFR1a  (121) DEVDSSSEEAKLSNDQNLPMAPVWAQPDKMEKKLHAVPASKTVKFRCQANGNPTPTLKWL 
Dr_FGFR1b   (52) DDESSSEENKPSSSQELLPMAPRWAQPEKMEKKLHAVPASKTVKFRCQAEGNPIPKLRWL 
Consensus  (121) DD  SS E    S    LPMAP WAQPDKMEKKLHAVPASKTVKFRCQA GNP P LKWL 
                      Ig Domain II 
 
Dr_FGFR1a  (181) KNGKEFKRDQRIGGFKVREHMWTIIMESVVPSDRGNYTCLVENRHGSINHTYQLDVVERS 
Dr_FGFR1b  (112) KNGKEFKRDQRIGGYKLREHMWTIIMESVVPSDKGNYTCLVENEYGSINHTYQLDVVERS 
Consensus  (181) KNGKEFKRDQRIGGFKLREHMWTIIMESVVPSDKGNYTCLVEN HGSINHTYQLDVVERS 
                  
 
Dr_FGFR1a  (241) PHRPILQAGLPANRTAVVGSDVEFECKVFSDPQPHIQWLKHIEVNGSRYGPDGLPYVRAL 
Dr_FGFR1b  (172) PHRPILYAGLPANRTAVVGSDVEFVCKVFSDPQPHIQWLKHIRVNGSQLGPDGLPYVRVL 
Consensus  (241) PHRPIL AGLPANRTAVVGSDVEF CKVFSDPQPHIQWLKHI VNGS  GPDGLPYVR L 
  
 
Dr_FGFR1a  (301) KTAGVNTTDKEMEVLQIRNVSLEDAGEYTCLAGNSIGHSHHSAWLTVYKA-VPPTQLPNQ 
Dr_FGFR1b  (232) KTAGLNTTDKEMEVLQLRNVSFEDAGEYTCLAGNSIGISHHSAWLTVVKAPTAPSAVPSQ 
Consensus  (301) KTAGLNTTDKEMEVLQIRNVS EDAGEYTCLAGNSIG SHHSAWLTV KA   PS LP Q 
                       Ig Domain III 
                                                    
Dr_FGFR1a  (360) TYLEVLIYCVGFFLICVMVGTAVLAKMHSSAKKSDFNSQLAVHKLAKSIPLRRQVTVSVD 
Dr_FGFR1b  (292) SYLEVLIYCIGFFLIFLMVGIATIVKIRSSSKKSDFNSQLAVHKLAKSIPLRRQVSVESS 
Consensus  (361) SYLEVLIYCIGFFLI LMVG A I KI SSAKKSDFNSQLAVHKLAKSIPLRRQVSV    
                   TM 
 
Dr_FGFR1a  (420) SSSSMHSGGMLVRPSRLSSSGSPMLSGVSEYELPQDPRWEVQRDRLVLGKPLGEGCFGQV 
Dr_FGFR1b  (352) SS--LNSGVMLVRPSRLSSSGTPMLSGVSEYELPQDPCWEVSRERLVLGKPLGEGCFGQV 
Consensus  (421) SS  L SG MLVRPSRLSSSGSPMLSGVSEYELPQDP WEV RDRLVLGKPLGEGCFGQV 
                  
 
Dr_FGFR1a  (480) MMAEAMGMDKEKPNRITKVAVKMLKSDATEKDLSDLISEMEMMKIIGKHKNIINLLGACT 
Dr_FGFR1b  (410) VMGEAIGLDKDKPNRITKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 
Consensus  (481) MMAEAIGLDKDKPNRITKVAVKMLKSDATEKDLSDLISEMEMMKIIGKHKNIINLLGACT 
                    Tyrosine Kinase I 
 
Dr_FGFR1a  (540) QDGPLYVIVEFAAKGNLREYLRVRRPPGMEYCYNPDQVPVENMSIKDLVSCAYQVARGME 
Dr_FGFR1b  (470) QDGPLYVIVEFASKGNLREYLRARRPHGMEYCYNPDPLPIESMSIKDLVSCAYQVARGME 
Consensus  (541) QDGPLYVIVEFAAKGNLREYLR RRP GMEYCYNPD LPIE MSIKDLVSCAYQVARGME 
                  
 
Dr_FGFR1a  (600) YLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 
Dr_FGFR1b  (530) YLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDVHHIDYYKKTTNGRLPVKWMAPEAL 
Consensus  (601) YLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 
                    Tyrosine Kinase II 
                            X                                H 
Dr_FGFR1a  (660) FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDRPSTCTHELYMM 
Dr_FGFR1b  (590) FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLREGHRMDKPSACTQELYLM 
Consensus  (661) FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS CT ELYLM 
                  
 
Dr_FGFR1a  (720) MRDCWHAVPSQRPTFKQLVEDLDRTLSMTSNQEYLDLSVSLD-QFSPNFPDTRSSTCSSG 
Dr_FGFR1b  (650) MKDCWHAVPTQRPTFKQLVEDLDRTLSLISNQEYLELSVPLEPMYSQVILNERSSTCSSE 
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Consensus  (721) MKDCWHAVPSQRPTFKQLVEDLDRTLSL SNQEYLDLSV LD  FS       RSSTCSS  
                  
 
Dr_FGFR1a  (779) EDSVFSHDAGADEPCLPKFPPHPNRGVAFKKR 
Dr_FGFR1b  (710) QDSVFLQEPGPEDPCIP---PSQQPMRSFKKR 
Consensus  (781)  DSVF  D G DDPCIP   P  N   AFKKR 
 
 
 
Appendix 3. Primer sequences for genotyping TILLING mutant 
fish 
Fgfr primers TILLING mutants - annealing temp. 57ºC for all  
    
304-zf-FGFR2-7-
fwd-out Tilling outer TGATAAGACGAAGCTTGCAG   
305-zf-FGFR2-7-
rev-out Tilling outer ATGCATGTGTGAATCCTGAG 434 
306-zf-FGFR2-7-
fwd-in Tilling inner 
TGTAAAACGACGGCCAGT 
TCAGCTGAGCAGGAAATAGG   
307-zf-FGFR2-7-
rev-in Tilling inner 
AGGAAACAGCTATGACCAT 
CAGTTGGTTGTGTGGAACAG 288 
    
308-zf-FGFR1-
1819-fwd-out 
TILLING 
outer GCGGTCATAAAGGGATAAAG   
309-zf-FGFR1-
1819-rev-out 
TILLING 
outer TGATGACACGTACAACTGGAG 692 
310-zf-FGFR1-
1819-fwd-in Tilling inner 
TGTAAAACGACGGCCAGT 
ATGTACTTTCATCCCAGCAG   
311-zf-FGFR1-
1819-rev-in Tilling inner 
AGGAAACAGCTATGACCAT 
ACACACTCTCACCACACAAC 475 
    
528-FGFR1-7-fwd-
out Tilling outer AGAAATCAGAATCTGCCAAG   
529-FGFR1-7-rev-
out Tilling outer AAAGGAGCGACGAGAAGAC 427 
530-FGFR1-7-fwd-
in Tilling inner 
TGTAAAACGACGGCCAGT 
CCACAGATTGTCCTAACCAG   
531-FGFR1-7-rev-
in Tilling inner 
AGGAAACAGCTATGACCAT 
AGCTTGATTACCACCGTTTC 313 
    
545-FGFR4-23-
rev-out Tilling outer CCAATGGTTAACCTAGCTGAC 678 
546-FGFR4-23-
fwd-in Tilling inner 
TGTAAAACGACGGCCAGT 
AAACAGTGGTGATCTTTGTGAG   
547-FGFR4-23-
rev-in Tilling inner 
AGGAAACAGCTATGACCAT 
ACCGCCCTGAAGATGAG 598 
544-FGFR4-23-
fwd-out Tilling outer TCCTTTGTTTGTGGCTTTG   
 
Appendix 4. Morpholino sequences 
 
Fgfr1a 
Translation blockers: 
ATG Block:  GCAGCAGCGTGGTCTTCATTATCAT 
5’ UTR1:  ATCATCTTCATTATTATTATCAAAG 
5’ UTR2: CAAAGATCCTCTACATCTGAACTCC 
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Fgfr1b 
Splice blocker: 
E1/I1-2: CAAGAGAGCGCATGCTGCTTACGTA 
 
Fgfr4 
Translation blockers: 
ATG:  TGAAAACCTTTAAGATGCTCAACAT 
5’UTR1: GATGCTCAACATCTTGCTGAGGTAA 
5’UTR2: CAGCTTCAAATGCTGACTCCAGGCA 
 
Splice blockers: 
E6/I6-7: GGATATGTAGACCTGGTCATTTTCG 
E8/I8-9: GCAAGCAGAAGCCCTCTTACCCAAC 
E15/I15-16: GAAGCTAATTGAGCCCTTACTCTTT 
E16/I16-17: TTTATAACTCACATTAGTTGTCTTC 
 
p53 
Standard: (Robu et al. 2007) 
 
Appendix 5. Primers for morpholino validation 
 
Fgfr1b 
Forward:  TGATCCTAACCCAGCTCTGC 
Reverse:  GGCATGAAGCTTTTTCTCCA 
 
 
Fgfr4 
FR4 e6 for 1:      GTTTCAGAGGAGCCAACTGAG 
FR4 e6 for 2:     GAGGAACCATCAGAGCACCT      
FR4 e6 rev1:  TAGCTATCACTTTAAAACCGC   
FR4 e6 rev 2:  CCGCAAATTAATGGGAATG  
FR4 e8 for 1:   CACCATACTGGACTCACACTCA   
FR4 e8 for 2:  GGATGGAAAAGAAGCTGTATG   
FR4 e8 rev 1:  ATGTACAGCCTCGAGTGAACC   
FR4 e8 rev 2:   TGGTGCCTATGATGCAGC   
FR4 e15 for 1:   GCTGTACGTGCTGGTTGAA   
FR4 e15 for 2:  GCATCAAAAGGTAGCCTACG   
FR4 e15 rev 1:   GCTAGTAATACGATCCAGCGC   
FR4 e15 rev 2:   CGCCTGCTTGCTAACAGA   
FR4 e16 for 1:  GCATTCACAGAGATTTAGCCG   
FR4 e16 for 2:  GTTCTTGTGACAGAAGACAATGTG   
FR4 e16 rev 1:  CTGAAATTGGAAACAACAGGG   
FR4 e16 rev 2:  GCTGTGAGCGGGACAGTTAG   
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Appendix 6. Table of cloned constructs for this study 
 
Number Name Gene Vector 
1 Fgfr1-GFP Fgfr1a pCS2+ 
2 Fgfr1-RFP Fgfr1a pCS2+ 
3 GFP-Fgfr1 Fgfr1a pCS2+ 
4 Fgfr1-MYC Fgfr1a pCS2+ 
5 5'UTR-Fgfr1GFP Fgfr1a pCS2+ 
6 Fgfr1Y753STOP Fgfr1a pCS2+ 
7 Fgfr1Y753F Fgfr1a pCS2+ 
8 Fgfr1W671RFP Fgfr1a pCS2+ 
9 Fgfr1b full Fgfr1b pCR2TOPO 
10 Fgfr1b_ish Fgfr1b pCR2TOPO 
11 Fgfr2L545STOP Fgfr2 pCS2+ 
12 Fgfr4 full Fgfr4 pCR4TOPO 
13 Grb2 Grb2 pCS2+ 
14 HA-Ub Ubiquitin pCDNA3.1 
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6. Software and websites 
 
6.1. Software 
    
Name of the application  Used for 
Vector NTI for Mac Sequence analysis, primer design, construct 
design, alignments 
Finch TV 1.4.0 Sequencing chromatogram analysis 
LAS AF 1.8.2 Confocal image acquisition and analysis 
ImageJ Confocal image/colocalization analysis  
CellF Stereomicroscope data acquisition 
Adobe Photoshop CS2 Image analysis and preparation 
Adobe Illustrator CS2 Figure assembly 
EndNote 8.0  Literature library 
Excel Statistical analysis 
 
6.2. Websites 
 
URL Used for 
http://helix.wustl.edu/dcaps/dcaps.html Primer design for single nucleotide 
polymorphism analysis 
http://www.gene-tools.com/ Morpholino design and order 
http://www.cbs.dtu.dk/services/SignalP/ Signal peptide prediction 
http://vega.sanger.ac.uk/index.html Zebrafish genomic DNA analysis, manual 
annotation data source 
http://www.ensembl.org/Danio_rerio/index.ht
ml 
Zebrafish genomic DNA analysis, automated 
annotation data source 
http://zfin.org/ Zebrafish Research Database 
http://www.expasy.org/sprot/ Protein structure prediction 
http://www.proweb.org/input/ (CODDLE) Codon Analysis For Predicting TILLING 
Lesions 
http://limstill.niob.knaw.nl/ LIMSTILL for Identification of mutations by 
sequencing and TILLING, prediction tool 
http://www.ihop-net.org/UniPub/iHOP/ Protein Interaction Network Prediction 
http://fluorescence.nexus-
solutions.net/frames6.htm 
Chromophore Spectra Analysis 
http://www.microscopyu.com/articles/livecelli
maging/fpintro.html 
Fluorescent Protein Properties  
http://members.aol.com/_ht_a/lucatoldo/myh
omepage/JaMBW/3/1/7/index.html 
Antigenicity Plot for prediction of best 
peptides in antibody production 
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